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Abstract 
There are many surgical implanted devices in current use and all are 
prone to biomaterial-related infections (BRI) associated with staphylococcal 
biofilm formation. BRI are usually associated with S. epidermidis or S. aureus 
and are characterized by treatment failure and chronicity resulting in re- 
operation, removal of the implant, and loss of function or death. 
Staphylococcal small colony variants (SCVs) may be generated by exposure to 
sublethal concentrations of antibiotics or nutrient limitation which may occur 
in biofilms. Although the characteristics of S. aureus SCVs have been well 
studied, little information on SCVs of S. epidermidis and their potential role in 
BRI is currently available. This study was designed to investigate the 
biochemical and phenotypic characteristics of S. epidermidis SCVs to further 
identify characteristics which may contribute to their ability to cause these 
increasingly important infections. 
Exposure to two to four times the gentamicin MIC led to the emergence of 
stable S. epidermidis SCVs, and the ability to produce SCVs was strain 
dependent. These variants were isogenic by PFGE and less immunogenic by 
western blotting, and SDS-PAGE analysis of whole cell preparations and cell 
wall fractions showed altered protein profiles when compared to wild type 
strains. 
S epidermidis SCVs were resistant to aminoglycosides such as amikacin 
and/or netilmicin and they were thiamine and/or menadione auxotrophs. 
Chemiluminescence assays showed a decreased ATP content reflecting the 
deficiency in electron transport systems which results in a growth rate 
- 
all 
characteristics similar to those of S. aureus SCVs. 
Analysis of virulence factor production indicated that S. epidermidis SCVs 
showed increased lipolytic and proteolytic activity when compared to those of 
S. aureus. Some S. epidermidis SCVs showed phase variation in 
exopolysaccharide production which enabled them to be more adherent to 
uncoated plastic 
-a property that may also be important for the later stages of 
development of biofilms. 
V 
Invasion assays demonstrated that some S. epidermidis and S. aureus SCVs 
were internalised by HUVECs by a receptor-mediated mechanism which 
differed from that of the wild type strains. Interaction of staphylococci with 
HUVECs induced cytokine production but SCVs stimulated production of IL1, 
IL-6 and IL-8 at lower concentrations than their related wild type parents in the 
first 6 hours of co-incubation. SCVs were also less damaging to the HUVEC 
cell line after 24 hours when compared to wild type strains. 
This study supports the suggestion that a switch to the S. epidermidis SCV 
phenotype could be a mechanism exploited by the wild type strains to facilitate 
their survival inside the host. The chronicity and increased antibiotic resistance 
associated with BRI could in part, be explained by the characteristics of SCVs 
identified in this study. In particular the ability to survive intracellularly 
combined with reduced immunogenicity and resulting decreased cytokine 
production, may contribute to persistence of infection. Although SCVs are 
resistant to some antibiotics, surviving intracellularly may further protect 
staphylococci from other drugs which are unable to enter mammalian cells. 
Resistance may be further enhanced for some strains in biofilms where 
enhanced polysaccharide production may also limit antibiotic access. 
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1: 1 Staphylococcus 
Members of the Staphylococcus genus are gram-positive cocci about 1 gm 
in diameter and are most often seen as grape-like clusters of cells in gram-stained 
specimens. They have a unique cell wall peptidoglycan characterized by multiple 
glycine residues in an inter-peptide bridge, which renders them susceptible to 
lysostaphin. 
Staphylococci are usually facultative anaerobes, capable of generating energy 
by respiratory or fermentative pathways. They are catalase-positive and usually 
oxidase-negative. 
Staphylococci evolved as free-living organisms. They have typically been 
regarded as non-invasive extracellular pathogens that damage host cells after 
adhering to the extracellular matrix. Sir Alexander Ogston, a late nineteenth 
century Scottish ophthalmic surgeon, who was the first to bring Staphylococcus 
aureus to prominence by demonstrating the important role of the organism (which 
he termed Staphylococcus Pyogenes aureus) in suppurative post-operative 
infections. He appreciated immediately that the investigation of the defence and 
immunology of the host was as important as the biology of staphylococci for 
understanding of staphylococcal diseases. 
A variety of phenotypic characteristics are used to identify a bacterial species, 
including colony morphology, cell wall composition, fatty acid composition, 
resistance to certain antibiotics and various biochemical activities (Kloos, 1990). 
The ability of S. aureus to clot blood plasma, with its connotations of virulence, 
has been used to divide staphylococci into two major groups: the Coagulase- 
Positive and Coagulase-Negative Staphylococci (CoNS). 
Staphylococci have been, and continue to be, a major cause of human disease, 
especially in the hospital setting. They are responsible for a significant number of 
serious infections in the normal population, such as endocarditis, osteomyelitis, 
and septic shock. S. aureus appears to differ considerably from the CoNS with 
respect to its pathogenicity, in that it elaborates a large number of extracellular 
virulence factors, while the CoNS, which are rather indolent pathogens, generally 
11 
produce few if any of these factors. CoNS rely much more on their ability to 
colonise and infect catheters and other indwelling medical devices from which 
they may spread systemically. 
Again members of the genus Staphylococcus exhibit a characteristic phenotypic 
variation. Staphylococci can acquire a very slow metabolic rate, in a phenotypic 
alteration termed Small Colony Variants (SCVs). Slow growing bacteria have 
been known to be resistant to antibiotics since 1942, it being well recognised that 
active cell wall synthesis is necessary for antibiotics such as penicillin to be 
bactericidal (Schnitzer et at, 1943; Czens et at, 1986). 
S. aureus SCVs were described for the first time in 1932 by Hoffstadt and 
Youmans as pinpoint bacterial colonies (less than 1 mm) that grew very slowly 
and often required magnification to be seen (Hoffstadt and Youmans, 1932). 
Documenting the emergence of colonial variants in cultures of CoNS and S. 
aureus is important, because the presence of atypical colonial forms in a 
diagnostic culture is usually interpreted as evidence of contamination and is 
disregarded. SCVs have been recovered from patients with persistent infections, 
particularly those patients who have experienced long disease-free intervals. 
SCVs have also been isolated from patients who are chronically exposed to 
aminoglycosides, suggesting that these clinical situations are those in which SCVs 
should be suspected and that clinical laboratories should carefully search for these 
forms of bacteria (Proctor and Peters, 1998). 
The use of synthetic materials for temporary or permanent implantation has 
been accompanied by the emergence of a new challenging entity, namely, 
biomaterials-related infections (BRI). The pathogenesis of BRI is a complex 
process with various contributing factors, such as bacterial virulence, 
physicochemical properties of the biomaterial, and alterations in host defence 
(Boelens et at, 2000 (a)). 
The pathogenesis of these biomaterials-related infections, which are often due to 
staphylococci, is related to bacterial adherence to host tissue and artificial surfaces 
within the host (Hogt et at, 1986). The infecting organisms are either introduced 
during implantation of the prosthesis or are carried to the biomaterial surface by a 
12 
temporary bacteremia, where they adhere and grow to form a biofilm 
(Neut et al., 2001). 
A series of studies have reported that some isolates of S. epidermidis which 
produced a mucoid growth in vitro that adhered to the walls of culture tubes, were 
more commonly associated with sepsis, including intravenous catheter-related 
bacteremia and other prosthetic device-associated infections (Ishak et al., 1985; 
Kotilainen, 1990; Peters et al., 1982; Rogers, 1979; deSilva et al., 2002). Implant 
infections are usually persistent until removal of the prosthesis (Zimmerli et al., 
1994; Zimmerli and Ochsner, 2003), and are often associated with a high mortality 
especially in patients with cardiovascular prostheses (Lyte et al., 1996; Zimmerli 
and Widmer, 1991), and BRIs therefore represent a major problem in modem 
medicine. 
1: 1: 1 Coagulase-Positive Staphylococcus in Human Disease 
S. aureus is coagulase-positive, and the best known and by far most studied 
species of disease-causing bacteria. The pathogenic capacity of S. aureus is the 
combined effect of extracellular factors and toxins together with the invasive 
properties of the strain. In general, S. aureus is not considered a significant 
intracellular pathogen when compared with genera such as Listeria and Shigella. 
However, there is growing evidence that S. aureus has the ability to invade and 
persist within eukaryotic cells (Hamill et al., 1986; Sinha ei al., 1999). From a 
clinical standpoint, this observation could yield insights into mechanisms relevant 
to persistent and recurrent staphylococcal infections and to better understanding of 
at least a subset of instances where staphylococcal infections are refractory to 
antimicrobial therapy. 
S. aureus infections result from direct contamination of a wound, e. g. 
postoperative staphylococcal wound infections or infection following trauma. 
If S. aureus disseminates and bacteraemia ensues, acute haematogenous 
osteomyelitis or potentially fatal endocarditis, meningitis, or pulmonary infections 
can result. 
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Methicillin 
- 
resistant Staphylococcus aureus (MRSA) was first observed in the 
1960's soon after the introduction of cloxacillin into clinical use (Cookson and 
Phillips 1990), and is known to be highly transmissible leading to highly 
publicised hospital outbreaks. Often this occurs when a patient or health care 
worker is colonized with an MRSA strain and, through contact with others, 
spreads the strain to others who are susceptible to infection. Interestingly, by the 
1980s, a high number of methicillin-resistant Staphylococcus epidermidis (MRSE) 
strains were also being isolated from nosocomial infections (Jones et al., 1989; 
Karchmer et al., 1983). 
1: 1: 2 Coagulase-Negative Staphylococci in Human Disease 
Over the last three decades other staphylococci associated with human 
disease have been recognized and well documented. Several members of CoNS 
other than S. epidermidis have been associated with BRI such as Staphylococcus 
haemolyticus and Staphylococcus warneri (Kloos and Bannerman, 1994). 
They have also been isolated in native valve endocarditis (Kloos and Bannerman, 
1995). Staphylococcus saprophyticus is an important opportunistic pathogen 
infecting the urinary tract and is second to Escherichia coli as the most common 
cause of urinary tract infection (UTI) in the community (Hovelius and MSrdh, 
1984). 
S. epidermidis, as the name implies, is one of the most common bacteria of the 
skin flora. However, it requires a predisposed host in order to change from a 
normal inhabitant of the human skin to an infective agent, and therefore clearly has 
to be described as opportunistic. In contrast to S. aureus, S. epidermidis does not 
usually cause pyogenic infections in non-compromised patients, with the only 
exception being native valve endocarditis (Caputo et al., 1987). This is due to its 
distinctly reduced arsenal of toxins compared to S. aureus. Because of the lack of 
severely tissue-damaging toxins, S. epidermidis infections are usually sub-acute or 
chronic. Lambe et al (1990) studied CoNS virulence factors and correlated their 
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production with disease progression (abscess formation) in mice. He and his 
colleagues found that while S. epidermidis possessed a variety of virulence factors 
such as a-haemolysin and 8-haemolysin, lipase and esterase, the production of 
these exoenzymes did not always correlate with the formation of abscesses in mice 
(Lambe at al., 1990). 
S. epidermidis very often becomes the major infective agent in compromised 
patients, such as intravenous drug abusers and immuno-compromised patients 
(patients under immuno-suppressive therapy, AIDS patients, and premature new- 
borns). The port of entry into the human body in all of these infections is usually 
an intravascular catheter (Domingo et al., 2001) or a dirty injection. 
1: 1: 2: 1 Staphylococcal Biomaterial-Related Infections and Biofilms 
The majority of BRI are caused by the relatively non-pathogenic CoNS, 
especially S. epidermidis. The pathogenesis of S. epidermidis BRI is characterised 
by the ability of this species to colonise the implant surface by the formation of a 
thick, multilayered biofilm. Biofilm formation is often the cause of the difficulty 
in eradicating the biomaterials related infection, due to an impaired penetration of 
antibiotics, resistance of inherent biofilm organisms to antibiotics, and the effect of 
the biofilm on the host immune response. The biofilm present on infected devices 
plays an important role in the pathogenicity of the infecting organism. Biofilms 
protect the embedded staphylococci and reduce the efficacy of antimicrobial 
killing and host defences (von Eiff et al., 1999), often necessitating removal of the 
implanted device (Hodgson et al., 1995; Hoyle and Costerton, 1991; Zimmerli et 
al., 1994). 
The extracellular substance surrounding the multilayered cell clusters, often 
referred to as `slime' in the past, is composed of bacterial products of different 
chemical composition. In recent years, the components have in part been 
identified, and biochemical and genetic investigations have produced a much more 
defined idea of what a staphylococcal biofilm consists of and how it is produced. 
In the course of BRIs, two different stages have been distinguished. 
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(1) The primary attachment which may either proceed as direct attachment of the 
bacteria to the biomaterial surface or via binding to host-derived matrix proteins 
which have previously coated the biomaterial (Fletcher, 1976; Heilmann et al., 
1996(b); Hussain et al., 1997). (2) The formation of multi-layered cell clusters 
with cell-cell adherence depending on the production of a `slimy' extracellular 
substance (I-Teilmann and Götz, 1998). 
The attachment of S. epidermidis to uncoated biomaterial is dependent on the 
physico-chemical properties of the biomaterial, the suspending medium and the 
bacterial surface. The main parameter determining bacterial adhesion is the 
hydrophobicity of the bacterial surface (Vacheethasanee et al., 1998). In fact, 
detergent-like substances of artificial and bacterial origin interfering with the 
hydrophobic interaction have been shown to lower the degree of adhesion 
(Vacheethasanee and Marchant, 2000). Adherence is obviously a crucial step in 
the initiation of BRI. After implantation of the medical device, the polymer 
material rapidly becomes coated with plasma and extracellular matrix proteins 
such as fibronectin, fibrinogen, vitronectin, thrombospondin, and von Willebrand 
factor (Cottonaro et al., 1981; Dickinson and Bisno, 1989; Kochwa et al., 1977) 
forming what is called conditioning film. 
For S. aureus proteins have also been identified that are involved in biofilm 
formation, such as the accumulation-associated protein (AAP), the clumping factor 
A (CIfA), the staphylococcal surface protein (SSPI), the biofilm-associated 
protein (Bap), MSCRAMMS (Götz, 2002), extracellular adhesion protein (Eap) 
(Hussain et al., 2001) and extracellular matrix protein-binding protein (Emp) 
(Hussain et al., 2001), all of which mediate the attachment to extracellular matrix 
substrates and eukaryotic cells. 
The formation of multicellular cell clusters on top of the monolayer of cells 
attached to biomaterial or host cells constitutes the second stage of biofilm 
formation by S. epidermidis. Clearly, the mechanisms underlying the adhesion 
between staphylococcal cells must be different from those enabling the bacteria to 
adhere to a hydrophobic surface or to specific receptors on host cells. Several 
molecules have been proposed to be responsible for cell-cell adhesion, mostly 
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polymeric carbohydrates and proteins. Most genetic and biochemical evidence has 
been obtained for the involvement of an extracellular polysaccharide in 
intercellular adhesion, named PIA (polysaccharide intercellular adhesin). 
PIA is composed of a major polysaccharide, termed 1, and a minor 
polysaccharide II. Polysaccharide I is a linear ß-1,6-linked 2 deoxy-2-amino-D- 
glucopyranosyl homopolymer which shows N-acetylation at about 80-85% of the 
polysaccharide I monomers. Polysaccharide II is very similar in structure, but 
harbours a limited omission of phosphate and ester-linked succinate (Mack et al., 
1996). PIA also mediates haemagglutination of erythrocytes by S. epidermidis 
strains and has been found to be an important virulence factor in the pathogenesis 
of S. epidermidis BRI (Fey et al., 1999; Rupp et al., 1995). 
Capsular polysaccharide-adhesin (PS/A) is another component of the 
extracellular biofilm layer that mediates cell adhesion to biomaterials (McKenney 
et al., 1998; Muller et al., 1993; Shiro et al., 1995) and protects bacterial cells 
from opsonophagocytosis (Kojima et al., 1990; Tojo et al., 1988). PS/A is a 
virulence factor for S. epidermidis infections in animal models of endocarditis 
(Shiro et al., 1994). Chemical studies proposed that PS/A was a high-molecular- 
weight polymer of ß(l, 6)-linked glucosaminyl residues (Mckenney et al., 1998; 
McKenney et al., 1999). PIA and PS/A are closely related chemically and 
immunologically and both are synthesized by the protein products of the icaADBC 
locus (Gerke et al., 1998; McKenney et al., 1998). PIA had been proposed to be 
functionally distinct from PS/A, with PS/A mediating initial adherence to solid 
surfaces and PIA mediating accumulation of cells into biofiim (Mack et al., 1996; 
Mack et al., 1994), although data evaluating PS/A's function indicate that it can 
mediate both processes (McKenney et al., 1998). 
1: 1: 2: 2: Mechanisms of Bacterial Resistance in Biomaterial-Related 
Infections (BRI) 
The incidence of antibiotic resistance in pathogenic bacteria is rising. 
Bacterial infections respond to antibiotics alone, but implant infections do not 
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because biofilm-associated bacteria are generally less susceptible to antibiotics. 
Since implants are not vascularized, antibiotics, immune cells and substances 
active against infection can arrive only by diffusion from adjacent tissue. 
Antibiotic resistance can be achieved via three distinct routes: inactivation of the 
drug, modification of the target of action, and reduction in the concentration of 
drug that reaches the target. It has long been recognized that specific antibiotic 
resistance mechanisms can be acquired through mutation of the bacterial genome 
or by gaining additional genes through horizontal gene transfer. 
Bacteria have developed mechanisms to mitigate the growth disadvantages 
conferred by antibiotic resistance while still ensuring survival in the presence of 
antibiotics. It is well established that within biofilms there will exist huge physio- 
chemical gradients such as pH, Oxygen and nutrients. These will cause bacteria to 
express different physiologies (Gilbert et al., 1993). This will lead to some cells 
sited in biofilms becoming auxotrophic for substances like haemin, menadione, 
thiamine and CO2 (Proctor and von Humboldt, 1998). These organisms have been 
shown to be very slow growing upon plating on nutrient agar. These phenotypic 
variants have been reported to be SCVs. SCVs are considered to be responsible 
for the two major clinical characteristics of BRI: resistance to antibiotic treatment 
and chronicity. Since SCVs reproduce at a very slow rate, the antibiotics will have 
little effect on the bacterial cell. Aminoglycosides, which are commonly used in 
the treatment of BRI, are dependent on membrane proton motive force generated 
by the bacterial electron transport system (Mates et al., 1982) and are not able to 
enter SCVs because they show a defective electron transport system. For the 
reason stated above, the production of SCVs could be considered another 
staphylococcal mechanism for selecting SCVs during antibiotic therapy in BRI 
resistance. 
1: 1: 3 Pathogenicity and Virulence of Staphylococci 
Staphylococci can produce disease both through their ability to multiply 
and spread widely in tissues and through their production of many extracellular 
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substances. Some of these substances are enzymes; others are considered to be 
toxins, though they may function as enzymes. In contrast to S. aureus, little is 
known about mechanisms of pathogenesis of S. epidermidis infections. Some of 
the major staphylococcal virulence factors identified are discussed below. 
Catalase is an enzyme with biochemical properties that enhance staphylococcal 
survival in phagocytes. Catalase converts hydrogen peroxide, normally toxic, into 
water and oxygen. All staphylococci strains are catalase positive. This test has 
been used to distinguished staphylococci from streptococci which are catalase 
negative. 
S. aureus carries several surface adhesins MSCRAMMs, (microbial surface 
components recognizing adhesive matrix molecules) (Foster and Höök, 1998) that 
interact with various human or animal tissues, plasma proteins, and polypeptides 
of the extracellular matrix (Patti et al., 1994; Vaudaux et al., 1995). The 
fibronectin-binding protein A and B, the collagen-binding protein and the 
fibtinogen-binding proteins, clumping factor A and B, belong to this family. In 
general, S. epidermidis has fewer MSCRAMMs than S. aureus that mediates 
adherence to components in the extracellular matrix. 
Coagulase is one of the extracellular proteins which binds to prothrombin in the 
host to form a complex called staphylothrombin. The protease activity 
characteristic of thrombin is activated in the complex, resulting in the conversion 
of fibrinogen to fibrin (Phonimdaeng et al., 1990). Coagulase is a traditional 
marker for identifying S. aureus in the clinical microbiology laboratory. 
Coagulase may deposit fibrin on the surface of staphylococci, perhaps altering 
their ingestion by phagocytic cells and their destruction within such cells. 
Coagulase production is considered synonymous with invasive pathogenic 
potential (van der Vijver et al., 1975). 
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Fibrinogen-Binding Protein (Fbp), is the so-called `bound coagulase' 
widespread among strains of S. aureus (Cheung et al., 1995; Duthie, 1954). 
Fbp promotes virulence by attachment. 
Clumping Factor (ClfA and CIfB), is considered to be another form of 
fibrinogen-binding protein in S. aureus. The binding of clumping factors to 
fibrinogen promotes bacterial adhesion to thrombi on the surfaces of heart valves 
(Moreillon et al., 1995). CflA-related fibrinogen-binding protein was identified in 
S. epidermidis but has not yet been analysed (Nilsson et al., 1998). 
Fibronectin-Binding Protein (Fnb A and Fnb B) are believed to be important in 
the attachment of S. aureus to foreign objects (Vaudaux et al., 1995; Flock et al., 
1987; Jonsson et al., 1991). Fibronectin in plasma binds to S. aureus first 
suggested a possible role for Fn adherence as a virulence factor 
(Kuusela, 1978). 
Vitronectin-Binding Protein has been found in both S. epidermidis and S. aureus. 
This protein recognises vitronectin found in extracellular matrix sites which might 
contribute in bacterial colonization of host tissues (Liang et al., 1993). 
AtIE (accompanied transposon insertion) is a major autolysin found in both S. 
epidermidis (Heilmann et al., 1997) and S. aureus (Oshida et al., 1995). At1E 
binds strongly to vitronectin (Heilmann et al., 1997), a protein which is found in 
the extracellular matrix and in serum. 
Proteins other than AtIE contribute to biofilm formation in staphylococci such as 
the accumulation-associated protein (AAP) and the biofilm-associated protein 
(Bap) (Hussain et al., 1997). All staphylococcal isolates harbouring Bap are highly 
adherent and strong biofilm producers. In a mouse infection model, Bap is 
involved in pathogenesis, causing a persistent infection (Cucarella et al., 2001). 
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Polysaccharide Intercellular Adhesin (PIA): consists of linear ß-1,6-linked 
glucosaminoglycan which is found in S. epidermidis and S. aureus (Mack et al., 
1996). However, PIA is considered to be the major virulence factor produced by 
the CoNS. It has been shown to promote the attachment of cells of S. epidermidis 
to each other producing the biofilm (Heilmann et al., 1996; Heilmann and Götz, 
1998; Mack et al., 1996). 
Bacterial survival during an infection is dependent on the ability of the 
staphylococci to circumvent the host's defences. Virulence factors involved in 
evasion of host defences include S. aureus Protein A, which binds to the Fc 
portion of IgG antibodies (Forsgren and Sjöquist, 1966). The binding of protein A 
to IgG antibodies is involved in evading the immune response, perhaps in the 
prevention of opsonization (Verhoef et al., 1979). Bacteria will bind IgG 
molecules in an inappropriate orientation on their surface which disrupts 
opsonization and phagocytosis. 
In response to an infection, the host can produce a variety of fatty acids and other 
lipid molecules that act as surfactants to disrupt the bacterial membrane, especially 
when an abscess is formed. Virtually all strains of staphylococci of human origin 
are lipolytic. Lipase and a Fatty Acid Modifying Enzyme (FAME) provide 
nutrients for the bacteria. However, The FAME enzyme is important in abscesses, 
where it could modify anti-bacterial lipids and prolong bacterial survival. FAME 
has been proposed to function to detoxify bactericidal fatty acids at the site of an 
infection. Consistent with a role in abscess formation, both lipase and FAME have 
been reported to be expressed extracellularly during postexponential phase in 
staphylococcal strains (Götz et al., 1985). 
Lipases (Lee and Landolo, 1986) have been proposed to have a negative effect on 
immune function. It has been suggested that lipases may be important for the 
colonization and persistence of resident organisms on the skin by the release of 
free fatty acids which may promote adherence (Farrell et al., 1993). Lipases, like 
proteases (Carmona and Gray, 1987), may well represent scavenging enzymes, 
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one of whose roles is to harvest nutrients from the environment. Lipase and 
protease production have been found to be related to the pathogenicity of 
S. epidermidis in mice (Molnar et al., 1994), and S. aureus in the induction and 
progression of septic arthritis in mice (Abdelnour et al., 1993). 
Proteases have been shown to have the ability to cleave and degrade a number of 
important host proteins, including the heavy chains of all human immunoglobulin 
classes, plasma proteinase inhibitors, and elastin (Dubin, 2002; Karlsson and 
Arvidson, 2002). 
Iron uptake system, iron is the common prerequisite for all bacterial pathogens to 
establish an infection and to proliferate within the mammalian host. As do all 
bacteria, staphylococci need iron for their growth; however, the free iron 
concentration (10-18 M) in the extracellular body fluids, owing to the presence of 
high-affinity iron-binding glycoproteins such as transferrin or lactotransferrin, is 
much too low to support staphylococcal growth. There are two main mechanisms 
for iron acquisition. One mechanism involves the synthesis and secretion of low- 
molecular-mass iron chelators (siderophores), which remove iron from transferrin. 
The siderophores (staphyloferrin A and B) have been seen to be produced by 
S. epidermidis under iron-restricted conditions (Lindsay and Riley, 1994). 
The second mechanism by which bacteria assimilate iron depends on direct 
contact between the host transfenrin and a bacterial surface receptor. 
Both S. epidermidis and S. aureus isolated from infected individuals or from 
experimentally infected animals express several iron-repressible cell-wall- 
associated and cytoplasmic-membrane-associated proteins which may have a role 
in transferrin binding (Modun et al., 1998). 
Haemolysins are virulence factors involved in invasion/tissue penetration. 
a, ß and S-haemolysins are cytotoxic agents that promote invasion of tissue. 
a-Toxin (a-haemolysin) causes the formation of pores in cell membranes, which 
explains its ability to cause lysis of certain red blood cells. After binding the 
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toxin, a complex series of secondary reactions ensues, causing release of cytokines 
that trigger production of inflammatory mediators (Menzies and Kourteva, 2000). 
Although a-haemolysin is well known to be produced by S. aureus strains, CoNS 
do produce a variety of exoproteins such as a- and S haemolysins (Stout et al., 
1992). 
ß-Haemolysin (phospholipase C) has been shown to act as a sphingomyelinase 
which damages membranes rich in sphingomyelin (Wadström and Möllby, 1972; 
Katerov et al., 1994). The classical test for ß-toxin is lysis of sheep erythrocytes. 
This toxin was found to play an important role in profound cell damage in 
S. aureus-associated eye infection (0' Callaghan et al., 1997). 
ö-Haemolysin has been observed to potentiate the action of ß-haemolysin in 
vitro, enhancing its haemolytic properties (Ruzickova, 1994). Staphylococcal 
ö-Haemolysin has surfactant-like or channel-forming properties, based on its 
ability to lyse bacteria lacking cell walls (Bernheimer and Rudy, 1986). 
To date, several toxins secreted by S. aureus have been identified such as 
enterotoxin A and B (Irwin and Gascoigne, 1993). They induce vomiting and 
diarrhea when ingested at submicrograms levels as well as toxic shock, a systemic 
response to infectious agents (Zumla, 1992). Another toxin produced by some 
isolates of S. aureus, toxic shock syndrome toxin-I (TSST-1), also causes 
systemic toxic shock (Irwin and Gascoigne, 1993). These proteins are also 
referred to as superantigens because of their ability to stimulate the proliferation 
of large numbers of T-lymphocytes (Irwin and Gascoigne, 1993) and this 
activation is associated with the release of cytokines such as IL-6 and IL-8. 
1: 1: 4 Staphylococcal Virulence Regulators 
For the majority of staphylococcal diseases, pathogenesis is multifactorial, 
so it is difficult to determine precisely the role of any given factor. However, there 
is correlation between strains isolated from particular diseases and expression of 
particular virulence determinants, which suggests their role in a particular disease. 
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The application of molecular biology has led to advances in unraveling the 
pathogenesis of staphylococcal diseases. Genes encoding potential virulence 
factors have been cloned and sequenced, and many protein toxins have been 
purified. 
Virulence factors are expressed in different environmental situations. 
Tompkins et al (1992) suggested that S. aureus surface components whose 
expression is growth-dependent can adhere to human endothelial cells in vitro. 
Table 1.1 shows examples of virulence factors whose expression in related to 
growth phase. 
Table 1-1: Effect of Growth Phase on Staphylococcal Virulence Factor 
Production 
Early Log Phase Late Log Phase Stationary Phase 
Coagulase a-Toxin FAME 
Protein A ß-Haemolysin PIA 
Clumping Factor S-Haemolysin 
MSCRAMMs Protease 
Fibronectin-Binding Lipase 
Proteins Capsular Polysaccharide 
Fibrinogen-Binding 
Proteins 
Several studies have been published describing different loci which regulate 
expression of multiple exoproteins and/or virulence factors. The agr (accessory 
gene regulator) (Recsei et al., 1986) and the sar (staphylococcal accessory 
regulator) (Cheung et al., 1992) are two of these loci which have been cloned, 
sequenced, and studied in detail. 
Agr is a locus which is affected by a quorum-sensing system and therefore, the 
expression of agr-regulated targets is cell density-dependent. Generally, when cell 
density and agr activity are low, surface proteins are expressed to allow for tissue 
colonization. With increasing cell density, agr becomes active, the production of 
24 
surface protein stops, and extracellular degrading exoenzymes and toxins are 
produced (Novick and Muir, 1999). 
Mutations in agr showed that the production of most of the extracellular 
virulence factors was depressed, while the cell wall-associated proteins were over 
expressed (Ji et al., 1995; Manna et al., 1998). Table 1-2 shows how the 
phenotypic expression of specific virulence factors is affected by mutations in agr. 
Table 1-2: Effect of Agr on Virulence Factor Expression 
Decreased Expression in agr Increased Expression in agr 
Mutants Mutants 
a-Toxin Protein A 
ß-Haemolysin Fibronectin-Binding Proteins 
S-Haemolysin Clumping Factor 
Lipase Vitronectin Binding Protein 
I Protease PIA 
Capsular Polysaccharide 
FAME 
Sar, the second regulatory locus was identified in much the same manner as the 
agr locus; a Tn917TV 1 transposon insertion gave rise to a mutant displaying 
multiple changes in the phenotypic expression of several virulence factors 
(Cheung et al., 1992). The phenotype of the original sar mutant appears to be the 
inverse of the agr mutant strain (increased production of a-toxin and decreased 
production of cell wall-associated proteins) (Cheung et al., 1992). 
Further regulatory loci, such as the secondary sigma factor sigB, also influence 
the expression of virulence factors. Although agr, sar, and sigB have all 
meanwhile been found in S. epidermidis, it has remained obscure for a long time 
whether or not these loci fulfil the same tasks as in S. aureus, i. e. regulating the 
expression of virulence factors. This has mainly been because of the reduced 
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extracellular and surface-attached virulence factors in S. epidermidis compared to 
S. aureus. 
The global regulatory loci of S. epidermidis and S. aureus also influence biofilm 
formation. Agr mutants of S. aureus show increased attachment to polystyrene 
(Vuong et al., 2000). 
The sigB locus has been reported in S. aureus to influence biofilm formation. 
A transposon mutant in sigB shows decreased production of PIA and decreased 
biofilm formation in S. aureus (Knobloch et al., 2001). Kullik and Giachino 
(1997) showed that sigB is induced during stationary phase and speculated that it 
is directly or indirectly involved in the regulation of virulence genes (Kullik et al., 
1998). 
Virtually nothing is known about the regulation of potential virulence 
determinants in S. epidermidis. Until recently, agr-regulated targets of S. 
epidermidis, which are likely to include virulence determinants, have not been 
identified. Li et al (2004) had investigated agr locus and its genetic polymorphism 
in different Chinese S. epidermidis isolates. They found that genetic 
polymorphisim of agr in S. epidermidis was linked to its pathogenecity (Li et al., 
2004). 
Intercellular adhesin locus regulator (icaR) has been found to be involved in 
phenotypic variation in biofilm formation in S. epidermidis isolates (Handke et al., 
2004). IcaR gene product was found to be a transcriptional repressor which plays 
an adaptive role in S. epidermidis biofilms formation by modulating the regulation 
of ica expression in response to specific environmental conditions (Conlon et al., 
2002). 
It is obvious that there is a concerted action of the virulence determinants and 
their global regulators which lead to staphylococcal disease. In-vitro and in-vivo 
results suggest that attachment and growth are precursors to the production of most 
exotoxins (Sioderquist et al., 1998). The fact that many attachment proteins 
require ongoing cell wall assembly to become anchored to the cell wall is good 
reason for cells to produce these only during cell division, and not post 
exponentially (Cucarella et al., 2002; Heyer et al., 2002). Likewise, to have an 
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optimum effect in the immediate environment of the bacterium, extracellular 
proteins would be best produced when the cells are localized and in sufficient 
quantity to produce enough material to have a beneficial effect for the bacterium. 
This is true for those exoproteins that are enzymes such as metalloproteases or 
pore-forming invasins such as haemolysins. This suggests that sepsis due to 
staphylococcal infection is not the result of a generally disseminated 
contamination of the bloodstream. Rather, it is the result of a focal infection in 
which growing bacteria reach a cell density sufficient to lower the local pH, 
deplete available nutrients, and then produce degrading enzymes, the pore-forming 
invasins and immunomodulators, which produce the symptoms associated with the 
disease. 
1: 1: 5 Clinical Significance and Laboratory Detection of Staphylococcal 
Isolates 
While S. aureus causes infections ranging from cutaneous infections to 
toxin-induced food poisoning, CoNS are predominantly members of the normal 
skin flora and are generally considered to be non-virulent. In the last three 
decades, however, it has become clear that CoNS are important nosocomial 
pathogens with a propensity to colonize foreign material, such as indwelling 
catheters, graft material and orthopaedic prostheses (Patrick, 1990; Hall, 1991). 
CoNS are most likely to be significant causes of infection in the following 
situations: presence of implants, neonates requiring intensive care (usually having 
intravenous catheters), immunocompromised patients, some specific clinical 
disease settings such as post operative sternotomy wound infections (closed with 
wire sutures), urinary tract infection caused by S. saprophyticus, and native valve 
endocarditis. 
It is often difficult to decide whether recovery of CoNS from blood or other 
normally sterile body fluids represents contamination by skin flora or a true 
infection requiring antibiotic therapy and/or removal of biomaterial for resolution. 
Therefore, several actions should be considered to facilitate the correct 
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interpretation of culture results. It is essential that good aseptic technique be 
followed during sample collection. Similarly, care should be taken not to 
contaminate the collection bottles during sample introduction. In situations where 
the interpretation of the culture result is unclear, repeat culture(s) with strict 
attention to collection technique should usually be done. Repeated recovery of the 
same strain is indicative of infection rather than contamination. 
In the hospital microbiology laboratory, identification of staphylococci is often 
limited to a rapid screening test for S. aureus, while non-S aureus isolates are 
simply reported as CoNS. Because of their increasing importance, clinically 
significant CoNS should be identified to the species level by a reliable, simple, 
rapid, and preferably, inexpensive method (Bannerman et al., 1993; 
Kleeman et al., 1993). 
Molecular techniques have greatly enhanced the ability to better characterize 
and more accurately identify Staphylococcus spp. and their mechanisms of 
antimicrobial resistance. However, the adoption of molecular diagnostic tests has 
not been possible in most laboratories because of the increased cost and expertise 
required. 
Staphylococcus is first differentiated from other gram-positive cocci by the 
catalase test. All Staphylococcus species are catalase positive. The coagulase test 
further differentiates Staphylococcus species. For practical purposes, a 
combination of a slide and a thermonuclease (DNAse) test should recognize the 
great majority of S. aureus strains. If there is disagreement between results of 
these tests, or suggestive colonial features, a commercially available biochemical 
testing kit should be used. The testing kits such as API STAPH (BioMdrieux, 
Basingstoke, UK) are based on the biochemical characteristics to differentiate the 
staphylococcal species. 
Beginning with the use of penicillin in the 1940s, drug resistance developed in 
the staphylococci within a short time of introduction of an antibiotic into clinical 
use. Some strains are now resistant to most conventional antibiotics, and there is 
concern that new antibiotics have not been forthcoming. 
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Typing of S. aureus is often required for the investigation of an outbreak or as 
part of ongoing surveillance, whereas typing of CoNS is often used to determine 
whether two or more strains from a patient represent contamination or infection. 
A typing system must be able to characterize readily all or most strains tested, be 
reproducible, and be able to discriminate between unrelated isolates. 
These tests can be broadly divided into phenotypic, such as antibiograms and 
biotypes, or genotypic, such as plasmid analysis and pulsed-field gel 
electrophoresis (PFGE) (Bergeron and Ouellette, 1998). 
Expression analysis of S. epidermidis virulence factors by microarrays will 
answer questions such as which virulence factors are expressed in different 
environmental situations, especially in a Biofilm setting, and how regulatory 
systems work and interact. 
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1: 2 Phase Variations: Mechanisms for Bacterial Survival and Growth under 
Changing Environmental Conditions 
A potentially important property for staphylococcal survival is their ability 
to make phenotypic changes. The staphylococcus is an extremely adaptable 
micro-organism capable of changing rapidly its phenotypic and genotypic 
characteristics (Gemmell, 1995). Phase variation may represent a mechanism for 
bacterial survival and growth under changing environmental conditions 
(Chan and Foster, 1988; Ernst et al, 1999). Such information mostly comes from 
experiments in vitro, but there is a growing body of information about what 
virulence factors are produced at different periods of infection and how in vivo 
conditions select bacterial populations that are able to cause disease 
(Smith 1998; Wesson et al., 1998). 
It would seem that bacterial populations have the capacity to respond to 
different growth opportunities by the selection of suitable variants (Kurland, 
1992). Specifically, staphylococcal species have a high frequency of phase 
variation. Phase variation is a generic term for a group of genetic mechanisms in 
which the expression of a gene varies in a reversible manner from generation to 
generation at a relatively rapid rate. These phase variants differ in a variety of 
characteristics including biofilm production, antibiotic resistance and virulence 
(Christensen et al., 1990). Elek pointed out the major problem confronting 
microbiologists due to the emergence of colonial variants which could be mistaken 
for a mixed culture, or a mixed culture could be mistaken for the emergence of 
colonial variants (Elek, 1959). 
Antibiotic resistant staphylococcal variants have been recovered following 
treatment with penicillin and related antibiotics (Annear and Grub, 1973; Devriese, 
1973; Wise and Spink, 1954) and aminoglycosides (Kaplan and Dye, 1976; Lacey, 
1969; Li et al., 1995; Miller et al., 1980; Yegian et al., 1959). Variants showing 
differing degrees of phenotypic variation from the parent strain have also been 
isolated from clinical samples (Acar et al., 1978; Lacey and Mitchell, 1969) and 
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the experimental induction of variants in animals has also been reported 
(Miller et al., 1978, Musher et al, 1977). 
Previous studies have reported phenotypic variation in S. aureus in association 
with changes in colonial morphology (Lee and Bergdoll, 1985; Parisi, 1966). 
Production of toxins, haemolysins, extracellular enzymes, protein A, and 
bacteriophage susceptibility may also vary. This phenomenon is not limited to 
S. aureus, as S. epidermidis also demonstrates phase variation in biofilm 
production, antibiotic resistance and the expression of virulence-related functions 
in the pathogenesis of S. epidermidis foreign body infections. Ziebuhr et al (1997) 
have detected an intercellular adhesion gene cluster (ica) indicating that 
S. epidermidis strains from clinical material differ from saprophytic strains in 
terms of the presence of the ica gene cluster as well as in the capacities for phase 
variation, polymer adherence, autoaggregation, and in colony morphology on 
Congo red agar. Results from this study indicate that adherence, slime production, 
and resistance to antibiotics can be induced or acquired and are influenced by 
global regulators. Conlon et al (2002) found the icaR plays a role in biofilm 
formation by regulating ica operon expression and biofilm formation in a biofilm- 
forming clinical isolate of S. epidermidis. 
Staphylococci, as mentioned before, are the most important pathogens in BRI 
(Emori and Gaynes, 1993; Kawamura et al., 1994; Kloos and Bannermann, 1994). 
Phenotypic methods have been used as a discriminatory tool correlating these 
variants with their pathogenicity, infectivity and virulence. Although 
staphylococci are easy to identify by classical microbiological techniques, in some 
cases the correct species diagnosis is difficult. This might be due to the fact that at 
least some clinical staphylococcal isolates can differ in a wide range of phenotypic 
properties, leading to misinterpretations of biochemical tests (Deighton et al., 
1992(a); Deighton et al., 1992(b); Lewis et al., 1990; Proctor et al., 1995) 
therefore, genotypic identification is emerging as an alternative or complement to 
established phenotypic methods. 
Genotypic and phenotypic methods have provided new insight into the 
understanding of pathogenesis associated with staphylococcal infections due to 
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phase variations of S. aureus small colony variants as a persistent and intracellular 
pathogen. Changes in local environmental factors, both in vitro and in vivo, seem 
to affect the rates of phase change. The discovery that antibiotics are capable of 
modifying both the structural appearance and physiology of pathogenic bacteria 
when they are incorporated in the culture medium at sub-growth inhibitory 
concentrations, has led to numerous examples in which the expression of one or 
more virulence factors (both structural and soluble) is inhibited or potentiated 
(Gemmell, 1991). Accordingly, the finding that SCVs have been recovered from 
patients with unusually persistent infections, particularly those patients with long 
disease-free intervals, and from patients who are chronically exposed to 
aminoglycosides and trimethoprim sulfamethoxazole (TMP-SMZ), suggest that 
these clinical situations are those in which SCVs should be suspected and the 
clinical laboratory should carefully search for them (Proctor and Peters, 1998). 
These observations support the suggestion that SCVs are phenotypic variants 
which could be induced by antibiotic effects on the wild type leading to the 
appearance of phenotypic variations including slow growth, atypical colonial 
morphology and unusual biochemical profile (Proctor et al., 1998). 
Generally, variations could result from plasmid loss or gain, insertion or 
deletion of phage DNA, transposition of DNA sequences to a new expression site, 
or promoter inversion (Borst and Greaves, 1987). For some organisms, 
programmed gene rearrangements may control the expression of surface antigens 
and virulence determinants and thus regulate the interaction of the microorganism 
with its environment (Borst and Greaves, 1987). The purpose of these 
programmed gene rearrangements appears to be to prepare a small fraction of cells 
for environmental changes (Borst and Greaves, 1987). 
1: 2: 1 Staphylococcal Small Colony Variants (SCVs): Variants Associated 
with Persistent and Recurrent Infections 
Although S. aureus SCVs were recognized more than 80 years ago, these 
phenotypes has only been linked to persistent, resistant, and recurrent infections by 
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many researchers in the last ten years or so (Mitsujama et al., 1997; 
Proctor et al., 1995; von Eiff et al., 1997). A wide variety of other species are 
known to form SCVs, e. g. Pseudomonas aeruginosa, Salmonella typhimurium, 
Shigella species, Brucella abortus, E. coli, Lactobacillus acidophilus, Serratia 
marcescens, and Neisseria gonorrhoeae and infection with these organisms may 
also cause persistent infections (von Eiffet al., 2000). 
Even in patients whose acute infection initially seems to respond to 
antimicrobial treatment, chronic relapsing disease characterised by long periods of 
quiescence between episodes of acute illness may occur (Korovessis et al., 1991; 
Waldvogel, 1995). Specific microbiological factors associated with such antibiotic 
failure have not been fully defined, but small colony variants (SCVs) of S. aureus 
have been isolated from patients with chronic, relapsing and antibiotic-resistant 
infections (Proctor et al., 1994; Proctor et al., 1995). In the past, the frequency of 
S. aureus SCVs among clinical isolates has not been established by prospective 
studies, except for one blood culture study where stable SCVs were isolated from 
1% of patients (Proctor et al., 1995). Since then, clinical specimens from cystic 
fibrosis (CF) patients and from patients with chronic osteomyelitis, both groups of 
patients who frequently have staphylococcal infections and receive large quantities 
of antibiotics, were prospectively evaluated for the presence of S. aureus SCVs 
(Acar et al., 1978; Proctor et al., 1995) 
The longest disease free interval was 53 years, in a patient who had had 
osteomyelitis of the left femur at age 16 and whose symptoms did not recur until 
age 69 years (Proctor et al., 1995). The potential for S. aureus SCVs to cause 
resistant, persistent, and recurrent infections may arise from their ability to reside 
within host cells without causing lysis of the host cell (Balwit et al., 1994; 
Vann and Proctor, 1988). SCVs are ingested by non-professional phagocytes as 
efficiently as their parental strains, but they produce only small amounts of a-toxin 
and are therefore able to persist within the host cells for a prolonged time (Vesga 
et al., 1996; Proctor et al., 1994). As SCVs are often relatively unstable, they can 
revert to the highly virulent, rapidly growing form and lyse the host cell, once the 
host immune response has decreased or antibiotic therapy is completed. 
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Compared to SCVs of S. aureus, relatively little is known regarding infections 
caused by SCVs of coagulase-negative staphylococci (CoNS). There are only two 
well-described cases of infection due to phenotypic variants of CoNS (Baddour et 
al., 1990). Most recently, another two cases of pacemaker electrode infections due 
to SCVs of S. epidermidis and S. capitis, respectively, were described (Von Eiff et 
al., 1999). In these patients, isolates from blood cultures were obtained over at 
least a two-week interval and visible growth of SCVs on subculture plates was 
seen only after 48-72 h incubation at 37°C yielding very small colonies. The 
organisms were colonially pleomorphic and polymicrobial infection was 
suspected. For most isolates biochemical testing with API Staph strips and 
conventional macrotube testing was not possible, except for the finding of catalase 
positivity, because their limited growth over 48 hours was not sufficient to provide 
positive test results in the reaction vials. Therefore, two approaches were used to 
identify the positive blood cultures. First, analysis of a portion of the 16S rDNA 
sequence analysis confirmed the identity of the staphylococcal species as S capitis 
and S. epidermidis. Second, Smal digests of the whole bacterial genome of all 
isolates analyzed by PFGE showed that they were clonal, even though the colony 
morphology was very different. Thus, the isolates in both cases were proved to be 
from the same species and the subpopulations were also from the same clone. 
These cases show that SCVs of CoNS, as with those of S. aureus, must be actively 
sought, because they grow very slowly and can easily be missed and indicate that 
molecular techniques may be required for identification of SCVs. 
1: 2: 2 Emergence of Variant Forms after Exposure to Aminoglycosides: 
Mechanism for Development of SCVs 
In the past, most studies have addressed the problem of antibiotic-resistant 
infectious diseases from the standpoint of classic forms of antibiotic resistance 
mainly founded on the possession of resistance genes. However, bacteria such as 
S. aureus may have additional mechanisms for resisting therapy that extend 
beyond these classic mechanisms. In patients whose acute infection initially 
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responded to antimicrobial treatment, where infection recurred after long disease- 
free intervals or where infection persisted despite appropriate antibiotic treatment, 
SCVs of S. aureus were recovered. For many antibiotics, SCVs mechanism of 
resistance has not yet been identified, but it might involve some new mechanism 
related to their small colony morphology. 
S. aureus SCVs are a subpopulation, which are identified in the microbiological 
laboratory as nonpigmented, non-haemolytic, and slow-growing pinpoint colonies. 
However, they can be induced in vitro by exposure of S. aureus strains to lithium 
and barium chloride, gentian violet, acridines, and antibiotics including 
aminglycosides and penicillin (Quie, 1969; Swingle, 1934; Youmans, 1937). 
Variants were initially distinguished as (a) those strains that maintain the minute 
colony phenotype only in the presence of the selective agent (Schnitzer et al., 
1943) and (b) strains which were stable in the absence of the selective agent. 
Although many variants spontaneously revert on continued subculture, some 
strains are stable on multiple passages (Schliefer and Kloos, 1975). A number of 
variants have reverted to normal S. aureus characteristics when metabolic defects 
were compensated by supplementation of the medium with amino acids, 
menadione, thiamine, haemin, pantothenate, or incubation in a carbon dioxide 
containing atmosphere (Kloos and Schliefer, 1975; Kloos and Bannerman, 1994). 
This leads to the definition of auxotrophy, as the inability of an organism to 
synthesize a particular organic compound required for its growth. This organism 
cannot grow on a minimal medium and therefore, requires nutrient supplements 
such as amino acids added to the minimal medium. When a bacterial culture is 
incubated in a medium lacking specific nutrient, auxotrophic bacteria present in 
the culture that require this nutrient will not be able to grow. 
Many clinical and laboratory SCVs isolated as minute colonies on solid agar 
show auxotrophy for thymidine, menadione, or haemin (Acar et al., 1978; 
Kahl et al., 1998; Proctor et al., 1997; Proctor et al., 1995; von Eiff et al., 1997). 
When the medium is supplemented with these compounds, SCVs grow as rapidly 
as the parent strains. Menadione and haemin are required for biosynthesis of 
electron transport chain components (Proctor et al., 1997), while the mechanism 
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for thymidine auxotrophy formation is not likely to be related to that for the 
electron transport type SCVs (Gilligan et at, 1987). However, thymidine 
auxotrophy could arise from inhibition of the synthesis of tetrahydrofolate, a 
cofactor for the synthesis of thymidine (Jones et at, 1989) or by any agent 
interfering with DNA gyrase and topoisomerase IV, which are two essential ATP- 
dependent enzymes that function in double strand DNA breakage and rejoining to 
promote DNA unwinding during DNA replication and chromosome segregation at 
cell division (Drlica and Zhao, 1997; Wang, 1996). SCVs which are thymidine 
auxotrophs emerge due to long term treatment with trimethoprim- 
sulfamethoxazole (SXT). In addition, the often relatively unstable SCVs, 
demonstrate a number of other characteristics that are atypical for S. aureus 
making the correct identification difficult, including: reduced a-toxin production, 
delayed or absent coagulase activity, lack of haemolysins and pigment production 
(Balwit et at, 1994), failure to ferment mannitol and increased resistance to 
aminoglycosides and cell-wall active antibiotics. 
Davis and Lederberg many years ago established a way to select for auxotrophic 
bacteria. They noticed that upon exposure to penicillin, these non-growing 
auxotrophs would survive the antibiotic treatment while the majority of 
prototrophic cells will not (Davis, 1949; Lederberg, 1956). Afterwards, this 
technique was used for the selection of auxotrophic variants from many bacterial 
species 
Aminoglycosides antibiotics, such as gentamicin, kanamycin, streptomycin, and 
neomycin, inhibit protein synthesis by binding to the 30S ribosomal subunits. 
SCVs are more resistant to aminoglycosides and can be recovered in vitro from 
cultures of normal S. aureus strains exposed to gentamicin (Balwit et al., 1994; 
Musher et al., 1977; Lewis et al., 1990). 
The major mechanism of aminoglycoside resistance observed in the 
staphylococci is drug inactivation by transferases and other enzymes. However, 
SCVs have additional mechanisms for resisting antibiotic therapy, apart from these 
classical ones. The biochemical basis for the SCV phenotype has been linked to 
deficient electron transport- impaired respiratory activity (Freman and White, 
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1967; Lewis et al., 1990; Swingle, 1934), and is discussed in terms of bacterial 
auxotrophy (Goudie and Goudie, 1955; Pelletier et al., 1979; Weinberg, 1950; 
Youmans, 1937). An interruption in electron transport reduces the electrochemical 
gradient across the bacterial membrane, resulting in decreased uptake of 
antimicrobial agents such as aminoglycosides (Acar et al., 1978; Koo et al., 1996) 
which depend on this to enter the cell and reach their target site. 
Mitsujama et al (1997) had described the emergence of staphylococcal SCVs 
after exposure of wild-type parent strains to a MIC concentration of the 
fluoroquinolone pazufloxacin. Emergent SCVs were half as susceptible to 
pazufloxacin and ciprofloxacin as wild-type S. aureus. Reduced susceptibilities of 
SCVs to these compounds were not a result of mutations but rather were mediated 
by decreased fluoroquinolone uptake, perhaps as a result of permeability changes 
in the cell wall (Proctor et al., 1994). 
In comparison with SCVs of S. aureus, relatively little is known regarding 
factors that generate or properties of CoNS SCVs. Characteristics of SCVs form 
of S. epidermidis have been well described and include the following: (1) colonies 
that are translucent or sometimes opaque, (2) colonies that vary in size and are 
usually <1 mm in diameter. In the literature, SCVs isolated from cases of 
infection were not characterized for electron-transport deficiency or for their 
auxotrophism (Baddour et al., 1987; Baddour et al., 1990) until 1999, when von 
Eiff et al (1999) reported bloodstream infections caused by S epidermidis and S. 
capitis following pacemaker implantation. These SCVs were shown to be haemin 
auxotrophs. 
1: 2: 3 Pathogenicity and Virulence of Staphylococcus SCVs 
The ability to form a variant subpopulation (SCVs) affords S. aureus a 
number of survival advantages that extend beyond simply increased resistance to 
antibiotics: (1) S. aureus with normal phenotype are phagocytosed by non- 
professional phagocytes and produce large amounts of a-toxin that quickly lyses 
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mammalian cells. In contrast, while it has been demonstrated that SCVs can be 
ingested by host cells, they produce only small amounts of a-toxin and are able to 
persist within the non-professional phagocytes (von Eiff et al., 2000 (a) & (b)). 
(2) As SCVs are often relatively unstable, they can hide within the host cell, then 
revert to the highly virulent rapidly growing form and lyse the host cell, once the 
host immune response has abated and antibiotic therapy is completed. 
Thus, the intracellular position shields SCVs from host defences and decreases 
exposure to antibiotics (Kahl et al., 1998; Balwit et al., 1994; von Eiff et al., 
1997; Proctor et al., 1994; Vesga et al., 1996). 
Bayston and Wood (1997) postulated that SCVs might represent the true biofilm 
mode phenotype since some characteristics (slow growth rate, altered metabolism, 
resistance to antibiotics and auxotrophy) have been found in common. 
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1: 3 Bacterial Invasion of Host Cells 
Invasion of host cells by bacteria is a characteristic feature of a number of 
infectious diseases caused by Shigella spp, Salmonella spp, Listeria 
monocytogenes and many others. Microorganisms capable of surviving within 
phagocytes are rare; but represent very successful pathogens, such as 
Mycobacterium tuberculosis (Ernst et al., 1999). Other pathogens, such as 
S. aureus have developed strategies to evade phagocytosis. It has been suggested 
that invasion enables bacteria to evade host defences and seek out new supplies of 
nutrients or find new tissues to colonize. Bacteria have evolved a variety of 
invasion mechanisms; some common elements in these processes are evident as 
most involve the manipulation of normal host cell cytoskeletal components such as 
actin and tubulin, resulting in the invagination of host cell membrane to enclose 
the bacterium within a vacuole. This often occurs by interference with the cellular 
signalling pathways either by stimulation of inhibition of signal transduction, or 
both (Miller, 1995). During the past decade, the majority of investigations of 
bacterial invasion have employed cell culture models, where enormous amounts of 
information have been derived using epithelial, endothelial and macrophage cell 
lines to elucidate some aspects of the pathogenesis of bacterial disease. 
The first stage in an invasion process is adhesion of the invading organism to a 
host cell, which ultimately leads to invasion. Obviously after an organism has 
invaded a host cell, there are consequences for the host cell and for the bacterium 
(Finlay and Cossart, 1997). 
Invasion of a host cell by a bacterium can stimulate cytokine release, 
prostaglandin release, and expression of adhesion molecules; eventually it could 
cause cell death. Once a bacterium has invaded a host cell, it has a limited number 
of options regarding where it subsequently survives and grows. It may continue to 
live within the vacuole enclosing it, it may exit from the vacuole and live in the 
cytoplasm or it may exit the cell and maintain an extracellular existence 
(Garcia-del Portillo and Finlay, 1995). While the microbiocidal mechanisms of 
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phagocytes are extremely efficient and capable of killing most microorganisms, 
pathogenic microorganisms have developed mechanisms to resist phagocytes. 
In general, S. aureus and S. epidermidis are not considered a significant 
intracellular pathogen when compared with genera such as Listeria and Shigella. 
Staphylococci have typically been regarded as non-invasive extracellular 
pathogens that damage host cells after adhering to the extracellular matrix; 
however, there is growing evidence that S. aureus has the ability to invade and 
persist within eukaryotic cells. From a clinical standpoint, this observation could 
yield insights into mechanisms relevant to persistent and recurrent staphylococcal 
infections, and to at least a subset of instances where staphylococcal infections are 
refractory to antimicrobial therapy (Alexander and Hudson, 2001). Indeed, when 
S. aureus is incubated with endothelial cells, fibroblasts and epithelial cells, a 
massive internalization of the bacteria by the cells is observed (Hamill et al., 1986; 
Sinha et al., 1999). Hussain et al (2002) have reported that Eap contributed to the 
pathogenecity of S. aureus by promoting adhesion of whole staphylococcal cells to 
complex eukaryotic substrate. S. aureus has been reported to be capable of 
escaping killing by professional phagocytes through hiding in the intracellular 
space of other cell types (Krause, 2000). 
Vesga et al demonstrated that the intracellular milieu of endothelial cells selects 
for staphylococcal small colony variants (Vesga et al., 1996). These menadione or 
haemin auxotrophs are alpha-toxin deficient and appear capable of prolonged 
intracellular survival. 
How microorganisms are phagocytosed and killed, and why certain pathogens 
resist these mechanisms, are crucial questions for an understanding of the 
pathogenesis of infectious diseases and the development of innovative treatment 
approaches. 
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1: 3: 1 Staphylococcal Internalization by Mammalian Host Cells 
Phagocytes have been divided into: (1) professional phagocytes 
(granulocytes and macrophages) which are capable of engulfing relatively large 
microorganisms and killing them with a combination of various microbiocidal 
systems, (2) non-professional phagocytes like fibroblasts, osteoblasts, epithelial 
and endothelial cells (Krause, 2000). While the microbiocidal mechanisms of 
phagocytes in general, and in particular the professional phagocytes which are 
extremely efficient and capable of killing most microorganisms, pathogenic 
microorganisms have developed mechanisms to resist phagocytes. 
Staphylococci such as S. aureus and S. epidermidis are classically considered as 
extracellular pathogens (Lowy, 1998; Lowy, 2000). However, certain features of 
Staphylococcal diseases suggest that Staphylococci have the capacity to function 
as an intracellular pathogen. In this regard, recent experiments assessing invasion 
and intracellular survival of S. aureus in endothelial cells (Vesga et al., 1996), 
epithelial cells (Almeida et al., 1996; Bayles et al., 1998), and osteoblasts (Ahmed 
et al., 2001; Ellington et al., 1999; Hudson et al., 1995; Reilly et al., 2000) have 
suggested that intracellular survival could contribute to the persistence of the 
pathogen in S. aureus-induced endocarditis, bovine mastitis, and osteomyelitis 
causing approximately 80-90% of all cases of human osteomyelitis (Nair et al., 
2000). S. aureus has been recognised as an important pathogen for a long time 
and is responsible for significant human morbidity and mortality, causing 
infections of soft tissues, joints, bones, and the cardiovascular system (Vann and 
Proctor; 1987). Studies have shown that S. aureus adheres to cultured endothelial 
cells (Ogawa et al., 1985), and various reports indicate that 31 to 70% of S. aureus 
endocarditis occurs in patients having no known pre-existing heart disease 
(Thompson, 1982; Watanakunakom, 1973). The discovery that cultured 
endothelial cells can phagocytize S. aureus (Hamill et al., 1986; Menzies et al., 
1998; Ogawa et al., 1985) suggests that S. aureus could be phagocytized by the 
endothelium in vivo as well, with the ingested S. aureus possibly playing a role in 
41 
the initiation of S. aureus infectious endocarditis and the persistence of S. aureus 
septicaemia. 
The possibility that phagocytes, particularly neutrophils (granulocytes), could 
facilitate S. aureus infections has also been proposed by other investigators 
(Craven and Anderson, 1979; Rogers and Melly, 1965). In vitro studies from the 
1950s and 1960s demonstrated that pathogenic strains of S. aureus could survive 
for long periods of time inside both neutrophils and monocytes isolated from 
different animals and humans (Melly et al., 1960). Neutrophils have long been 
regarded as essential for host defence against S. aureus infection. Gresham et al 
suggested that the ability of S. aureus to exploit the inflammatory response of the 
host by surviving inside neutrophils is a virulence mechanism for this pathogen, 
and that modulation of the inflammatory response is sufficient to significantly alter 
morbidity and mortality induced by S. aureus infection (Gresham et al., 2000). 
There is little experimental data demonstrating the pathogenic role for 
intracellular S. epidermidis, simply because S. epidermidis has been considered for 
a long time to be apathogenic or commensal, due to its distinctly reduced arsenal 
of toxins compared to S. aureus (Vuong and Otto, 2002). S. epidermidis has 
received considerable interest in recent years because it has become the most 
important cause of nosocomial infections. S. epidermidis is one of the most often 
isolated bacterial species in hospitals in general and is recognized as the most 
important pathogen involved in nosocomial bloodstream infections and 
cardiovascular infections (Vuong and Otto, 2002). 
S. epidermidis was found to be internalized by bovine mammary epithelial cells 
in vitro emphasizing their importance as a cause of mastitis (Almeida and Oliver, 
2001). Merkel and Scofield on the other hand studied S. epidermidis interaction 
with endothelial cells. Electron microscopy demonstrated that S. epidermidis was 
internalized and appeared to exist free in the cytoplasm (Merkel and Scofield, 
2001). This could be a contribution towards explaining the relapse in native 
endocarditis (Veltrop et al., 2001) and the need for re-operation in prosthetic valve 
endocarditis (Hag! et al., 2002). 
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Survival of S. epidermidis inside macrophages has been recognized as an 
important process in the pathogenesis of BRI. Local host defense is compromised 
because of the presence of the implanted biomaterials, resulting in macrophage 
deactivation and subsequent deficient intracellular killing (Boelens et al., 2000(b)). 
Moreover, S. epidermidis isolated from infected hip prostheses was shown to have 
an enhanced capacity to resist phagocytosis and elicited a reduced inflammatory 
response, measured as the production of extracellular oxidative metabolites from 
the neutrophils (Augustinsson et al., 2001). Moran et al (1998) suggested that 
S. epidermidis which are able to produce slime possess additional properties which 
make them resistant to the action of neutrophils which could contribute to their 
intracellular survival. 
1: 3: 2 Mechanisms of Staphylococcal Invasion of Cultured Cells 
The ability of bacteria to interact with host cell receptors and trigger their 
own internalization has been clearly demonstrated for members of several bacterial 
genera including Salmonella and Yersinia (Finlay and Cossart, 1997; Pace et al., 
1993). S. aureus is hypothesized to invade tissue via interaction with host cells in 
one of four ways: (1) by binding directly to epithelial cells; (2) by invading sites 
of cellular damage where matrix proteins are exposed; (3) by migrating between 
microvascular capillary endothelial cells; or (4) by binding to host cells via plasma 
or cellular proteins that are adherent to both cell and bacteria (i. e. bridging ligands) 
(Lowy, 2000). So for S. aureus to be internalized, bacterial adherence to the host 
cell is a prerequisite for invasion. S. aureus MSCRAMMs include fibrinogen- 
binding proteins (Boden and Flock, 1994; Cheung et al., 1995), fibronectin- 
binding proteins (FnBPs) (Hynes, 1990; Jonsson et al., 1991), elastin-binding 
adhesin (Park et al., 1999), collagen-binding adhesin (Patti et al., 1992), and a 
broad-specificity adhesin (Map) that facilitates low-affinity binding of S. aureus to 
several proteins, including osteopontin, collagen, bone sialoprotein, fibronectin, 
fibrinogen, and vitronectin (McGavin et al., 1993). FnBPs are likely the most- 
important MSCRAMMs in S. aureus invasion of eukaryotic cells. 
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Eap, an analogue of Map, was found to be important in promoting adhesion of 
S. aureus to eukaryotic substrates which might contribute to S aureus 
pathogenicity (Hussain et al., 2001, Hussain et al., 2002). 
Studies comparing adhesion of FnBP mutants and their isogenic parental strains 
have revealed that FnBPs are required for S. aureus adherence to bovine mammary 
epithelial cells (Dziewanowska, 1999; Lammers et al., 1999), human endothelial 
cells (Peacock et al., 1999), and human osteoblasts (Ahmed et al., 2001). 
After bacterial adhesion to host tissues, some signaling and biochemical pathways 
are activated for the next step: the internalization process. Studies have shown that 
S. aureus utilizes the cytoskeleton (actin microfilaments, microtubules) and 
receptor-mediated endocytosis for the uptake of S. aureus into host cells 
(Alexander and Hudson, 2001). 
Receptor-mediated endocytosis (RME) involves the formation and uptake of 
clathrin-coated pits via rearrangement of the cytoskeleton. Experiments on 
S. aureus implicate actin microfilaments, microtubules, and RME in the 
staphylococcal internalization (Jevon et al., 1999). Results indicate inhibition of 
actin microfilament polymerization with cytochalasin D (cytochalasin D binds to 
the rapidly growing F-actin and induces depolymerization) decreases numbers of 
intracellular S. aureus cells by 95% in a human osteoblast cell line 
(Jevon et al., 1999) compared with controls. The use of colchicine (colchicine, 
which binds to tubulin dimers and inhibits polymerisation of microtubules) 
reduced intracellular S. aureus numbers by 40% in a human osteoblast cell line 
(Jevon et al., 1999) compared with controls. However, a decrease in 
internalization was not observed with bovine mammary epithelial cells (Almeida 
et aL, 1996); though the use of monodansylcadaverine (MDC) (transaminase 
inhibitor, which inhibits clathrin-dependent RME) decreased intracellular 
S. aureus numbers by 95% in a human osteoblast cell line (Jevon et al., 1999) 
compared with controls. These studies suggest that activation of signal 
transduction cascades plays an important role in internalization of S. aureus by 
non-professional phagocytes. Menzies and Kourteva studied the internalization of 
S. aureus by endothelial cells. Their work showed that cytochalasin D alone is 
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enough to inhibit S. aureus internalization by endothelial cells (Menzies and 
Kourteva, 1998). In an experiment to examine neutrophil concentrations that 
would be lethal to a clinical isolate of S. epidermidis, Li et al (2002) found that 
killing of S. epidermidis at all neutrophil concentrations was blocked by 
cytochalasin D confirming that killing depends on phagocytosis and not on 
microbiocidal substances secreted into the medium by neutrophils (Barkalow and 
Hartwig, 1995). 
Almeida and Oliver (2001) have studied the interaction of S. epidermidis with 
bovine mammary epithelial cells, and investigated the involvement of host cell 
signal transduction and host cell cytoskeleton rearrangement on bacterial 
internalization. The inhibitory effect on internalization caused by cytochalasin B 
and D, but not colchicine, suggests the involvement of host cytoskeleton elements, 
particularly F-actin microfilaments. Also, it appeared that S. epidermidis 
generated a self uptake signal that was transduced into the host cell using the host 
cell's own signal transduction pathways. In addition, Mamo et al (1988) reported 
that S. epidermidis bound fibronectin and collagen and that could contribute to 
adherence to mammalian cells. 
1: 3: 3 Staphylococcus aureus Small Colony Variants are Induced by the 
Endothelial Cell Intracellular Milieu: A Possible Link to Persistent Infection 
and Antimicrobial Resistance 
To the best of my knowledge, Vesga et al (1996) were the first to show that 
SCVs are induced by the endothelial cell intracellular milieu. They suggested that 
this could be a possible mechanism for the intriguing patho-physiology of tissue 
persistence of staphylococci (Vesga et al., 1996). Their experiments were 
designed to comprehend the process by which SCVs of S. aureus appear in 
subjects who have not received antibiotic treatment. Bovine endothelial cells 
were incubated with a wild type S. aureus strain for 72 h. and results showed that 
intracellular bacteria developed the SCV phenotype at a greater rate than control 
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bacteria not exposed to endothelial cells. The intracellular induction rate was 
approximately 10"3 versus a spontaneous rate of <10-7 (Vesga et al., 1996). 
On the other hand, von Eiff et al (2001) described the first known case of 
persistent and antibiotic resistant skin infection with different phenotypes and 
genotypes of S. aureus. This is also the first demonstration of intracellular 
persistence within keratinocytes. 
Recently, it has been reported that fibroblast cells are capable of restricting 
Salmonella enterica serovar typhimurium intracellular growth. Cano et al have 
shown that prolonged residence of bacteria in the intracellular environment of 
fibroblasts results in the appearance of genetically stable SCVs (Cano et al., 2003). 
Their data demonstrate that S. enterica SCVs display enhanced intracellular 
persistence in eukaryotic cells. In addition, they also suggest that S. enterica SCVs 
may be favoured in vivo. 
However, up to this date there is no publication describing CoNS SCVs induced 
by eukaryotic cells. The only data covering CoNS (S. epidermidis) SCVs, was 
their involvement in bloodstream infections following pacemaker implantation 
(von Eiffet al., 1999). 
1: 3: 4 Consequences of Internalization in Human Infections 
The ability of a bacterium to adhere, invade, evade host defences and cause 
tissue damage is largely due to its ability to produce a variety of virulence factors. 
Additionally, internalization may provide a means of protection against host 
defences and certain classes of antibiotics. The ability of S. aureus to stay alive in 
the eukaryotic intracellular environment could explain several aspects of chronic 
staphylococcal diseases and long standing colonization. Many staphylococcal 
infections that tend to become chronic (e. g., osteomyelitis and mastitis) are 
associated with multiple recurrences and do not resolve even in the presence of an 
adequate humoral immune response. 
Exploring bacterial invasion further, two aspects can be considered: (1) effects on 
host cells and (2) effect on bacteria. The two most important effects on host cells 
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are (1) cytokine release and (2) cell death. However invasion of a host cell also 
limits the options of the bacterium: (1) it may continue to live within the vacuole 
enclosing it, (2) it may live in the cytoplasm, (3) it may exit the vacuole and 
maintain an extracellular existence; (4) in staphylococcal internalization the 
production of SCVs could be another outcome (Proctor et al., 1995). 
Cytokines are inflammatory mediators which may serve to activate host defence 
systems or, because of their production, may have adverse consequences for the 
host. It has become clear over the past few years that commensal and pathogenic 
bacteria contain and release a wide range of proteins, carbohydrates and lipids 
which can induce cytokine synthesis (Henderson et al., 1996(a)). 
Lipopolysaccharide (LPS), which is a major cell wall component of Gram- 
negative organisms (Rietschel and Brade, 1992), triggers the inflammatory 
responses associated with sepsis including cell adhesion molecule expression and 
release of IL-8 in endothelial cells (Blease et al., 1998; Brown et al., 1994). 
However, currently most of the papers describing non-LPS cytokine inducing 
molecules from bacteria, have reported that they induce the formation of pro- 
inflammatory cytokines such as IL-1, TNFa, IL-6 or IL 
-8 (Henderson et al., 
1996(b)). In Gram-positive bacteria, the cell walls are made up of layer of 
peptidoglycan embedded with teichoic acids, including lipoteichoic acid (Bone, 
1994). These components were shown to stimulate cell adhesion molecule 
expression and IL-8 release in HUVECs (Kawamura et al., 1995). Endothelial 
cells are capable of producing and releasing IL-6 and IL-8 in response to exposure 
to S. aureus strains or staphylococcal exotoxins such as a-toxin, enterotoxin 
A and TSST-1 (Sioderquist et al., 1998). 
Monocytes and macrophages as well as neutrophils produce most of the 
cytokines involved in host defense but most of the cytokines can also be produced 
by other cells, including endothelial cells, fibroblasts, and lymphocytes. The early 
cytokines, TNFa and IL-1, induce an increase of adhesion molecules on 
endothelial cells and induce inflammatory cells to promote migration of 
neutrophils into the tissues invaded by bacteria. At the same time or somewhat 
later, cytokines IL-8, IL-10, and IL-12 are produced by the mononuclear cells and 
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neutrophils (Scott, 1993). IL-8 induces neutrophils to migrate through the 
endothelial cell layer into the tissue and activates the neutrophil respiratory burst 
so that the cell is better equipped to kill bacteria. However, IL-10 down regulates 
IL-8 and may play an important role in the resolution of an inflammatory response 
(Scott, 1993; Rajarathnam et al., 1994; Wang et al., 1994). 
IL-12 is gaining more attention because it upregulates the production of interferon 
y (IFN-y) by natural killer cells (NK) cells. It is worth mentioning that IL-12 -* 
IFN-y axis is of primary importance for adequate activation of the macrophage 
(Scott, 1993). One important activator of the process of chemotaxis is the 
cytokine IL-8. Other neutrophil and monocyte triggers include the platelet 
activating factor, a phospholipid that is induced by endothelial cells after 
stimulation with leukotriene, TNF-a, and IL-4. IL-8 not only induces chemotaxis 
of neutrophils but triggers their adhesion as well (Rajarathnam et al., 1994). Many 
of the triggers needed for the adhesion of neutrophils to endothelial cells, and for 
subsequent chemotaxis, are produced by the endothelial cells themselves while 
others are from the monocytes and bacteria. 
Endothelial cells were initially thought to have a passive role in vascular 
physiology, functioning mainly to modulate coagulation (Mantovani et al., 1992). 
Recent studies, however, have demonstrated a potent inflammatory role for 
endothelial cells, either by secretion of inflammatory mediators or by modulation 
of adhesion of leukocytes to their surfaces (Wang et al., 1996; Cannan 
et al., 1998). Endothelial cells are influenced by cytokine producers and are 
themselves capable of producing a number of endogenous cytokines. 
Human endothelium is capable of expressing interleukins IL-1, IL-5, IL-6, IL-8, 
monocytes chemotactic protein-1 (MCP-1), growth-related oncogene-a (GRO-a) 
protein, and colony stimulating factors, granulocytes-macrophage CSF (GM-CSF), 
and platelet-derived growth factor (PDGF) (Krishnaswamy et al., 1999). 
Endothelial cells also have been shown to express IL-11 and IL-15 
(Mohamadzadeh et al., 1996; Suen et al., 1994). 
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Subsequent studies revealed that various S. aureus strains induce EC activation 
that resulted in production of the chemokines IL-8 and monocyte chemotactic 
protein-1, surface expression of intercellular adhesion molecule-1 (ICAM-1; 
CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106), as well as 
enhanced monocyte adhesion (Veltrop et al, 1999). In addition, internalization of 
S. aureus by human umbilical vein endothelial cells (HUVECs), results in the 
synthesis of mRNA for both IL-6 and IL-1p, enhancing endothelial secretion of 
the pro-inflammatory cytokines IL-I and IL-6 (Yao et al., 1995; Yao et al., 1996), 
and eliciting procoagulant activity in these cells (Drake and Pang, 1988). 
Treatment of the HUVEC cells with cytochalasin D inhibited cytokine gene 
expression, demonstrating that cytokine induction was a consequence of bacterial 
invasion rather than adhesion (Yao et al., 1995). 
Neutrophil-activating protein, or IL-8, is a potent neutrophil chemoattractant 
and is directly involved in neutrophil recruitment (Smith et al., 1991(b)). 
Circulating levels of IL-8 are correlated with the severity of tissue damage after S. 
aureus infection (Mulligan et al., 1993). The pro-inflammatory cytokines tumor 
necrosis factor alpha (TNF) and IL-lß have been shown to induce IL-8 gene 
expression in a variety of cell types, including monocytes, neutrophils, and 
endothelial cells (Yao et al., 1996). S. aureus invasion of osteoblasts stimulates 
the secretion of IL-6, IL-12, and colony-stimulating factors (Bost et al., 1999; Bost 
et al., 2000; Yao et al., 1995). These cytokines can potentially aggravate bone 
destruction by activation of osteoclasts. 
Cytokine release induced by S. epidermidis has rarely been studied. It received 
attention in patients who were treated with continuous ambulatory peritoneal 
dialysis (CAPD) and who might suffer from recurrent peritonitis episodes caused 
by S. epidermidis. Betjes et al (1993) have shown that human peritoneal 
mesothelial cells produced high levels of IL-8 in response to IL-1(3 and TNF-a but 
not S. epidermidis. However, co-culture of peritoneal macrophages with S. 
epidermidis induced high levels of IL- I a, IL- lß, and TNF-a. Taken together, 
these data indicate that mesothelial cells are important for the recruitment of 
granulocytes into the peritoneal cavity (Betjes et al., 1993). 
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Intracellular growth and replication within host cells often leads to the death of the 
colonized cell as a result of nutrient depletion, degradation of important 
intercellular constituents and the build-up of toxic end products of bacterial 
metabolism 
- 
this is often termed necrotic cell death. However, bacterial invasion 
of the host cells can sometimes induce a second form of cell death known as 
apoptosis. Apoptosis, otherwise known as programmed cell death, is a natural 
process by which the host controls cell numbers and it is important in 
embryogenesis and the response to genetic damage. Apoptosis is a highly 
regulated process which involves the active participation of the cell and is 
controlled by complex signal transduction pathways. The apoptotic cells exhibit a 
characteristic appearance: membrane blebbing, typical chromatin condensation 
and fragmentation and the presence of apoptotic bodies (partition of cytoplasmic 
and nucleus into membrane bound-vesicles) which contain ribosomes, 
morphologically intact mitochondria and nuclear material (Cohen, 1993). 
Staphylococcal infections are typically associated with death of tissue, and 
evidence suggests that intracellular bacteria are capable of inducing apoptosis. 
S. aureus provoking apoptosis has been reported in epithelial cells 
(Bayles et al., 1998; Kahl et al., 2000; Wesson et al., 1998), endothelial cells 
(Menzies and Kourteva, 1998; Wesson et al., 1998), osteoblasts (Tucker et al., 
2000) and keratinocytes (Nuzzo et al., 2000). 
The induction of apoptosis upon infection results from a complex interaction of 
bacterial proteins with cellular proteins finally mediating apoptosis. Thus, bacteria 
are able to activate several pro-apoptotic proteins, e. g. caspases. 
Monitoring bacterial internalization provides useful information regarding studies 
on virulence and immunity of intercellular pathogens. Transmission electron 
micrographs of bovine aortic endothelial cell monolayers infected with S. aureus 
have demonstrated phagocytosis following a specific sequence of events: 
(i) adherence of S. aureus to the endothelial cells, (ii) formation of cuplike 
processes on the endothelial cell surface underlying the adherent bacteria, and (iii) 
elongation of the cup and engulfment of the bacteria within phagosomes (Lowy et 
al., 1988). Despite lysosomal fusion, the endothelial cell is unable to kill the 
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ingested S. aureus. Viable staphylococci can be isolated after treatment of 
infected endothelial cell monolayers with lysostaphin, which lyses extracellular 
staphylococci only. Uptake of S. aureus by endothelial cells offers a unique 
explanation for the frequency and persistence of invasive staphylococcal infections 
involving endothelialized surfaces such as heart valves, prosthetic vascular grafts, 
and catheterised vessels. Moreover, S. aureus invades a variety of mammalian 
cells and escapes from the endosome to multiply in the cytoplasm (Shompole et 
al., 2003). More information on staphylococcal intracellular pathogenesis is 
required to give us new strategies for prevention and treatment of staphylococcal 
diseases. The production of S. aureus SCVs by the endothelial milieu could be 
another mechanism used by staphylococci to evade host defences and cause 
chronic infections-a major observed concern in infections caused by these 
organisms. SCVs intracellular survival also suggests a possible way for S. aureus 
to resist antibiotics. 
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1: 4 Research Aims 
1: 4: 1 Introduction 
Altered phenotypes or small colony variants (SCVs) of S. epidermidis and 
S. aureus have been most frequently isolated from infected implants. Biomaterial- 
related infections (BRI) associated with SCV are characterized by treatment failure 
and chronicity resulting in re-operation, removal of the implant, and loss of 
function or even death. Therefore, BRI represents a major problem in modern 
medicine (Bayston, 2000). 
The ability to produce SCVs could be considered as a virulence factor possessed 
by some wild type strains to avoid host defenses. Resistance of SCVs to 
antibiotics and their ability to avoid host defenses due to their intracellular survival 
could be behind the difficulty in curing chronic BRI. However, the present 
knowledge of SCVs is incomplete; much more fundamental work has to be 
directed towards better understanding of the pathogenic role of S. epidermidis 
SCV in BRI. Knowing the exact pathogenesis of BRI due to staphylococcal SCVs 
might allow the development of new strategies for the prevention of foreign body 
infections. 
1: 4: 2 Aims 
The overall aim of this project is therefore to investigate the potential role 
of staphylococcal SCVs as causative organisms in chronic, recurrent and 
antibiotic-resistant BRI. Particular reference will be made to S. epidermidis SCVs, 
as these staphylococci are most frequently implicated in BRI. The specific 
experimental objectives are as follows; 
1. Determining the ability of wild type parent strains of staphylococci to produce 
stable SCVs following exposure to gentamicin in vitro. 
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2. Screening for metabolic or physiological characteristics of SCVs that might be 
connected with the true biofilm phenotype and contribute to pathogenesis of BRI. 
3. Evaluating the potential role of SCVs to initiate BRI via distinct mechanisms of 
adhesion to polymer materials or conditioning film. 
4. Investigating intercellular persistence of SCVs in infected HUVEC cells in vitro 
and their mechanisms of cell entry. 
5. Seeking to determine whether the production of cytokines by HUVECs infected 
with SCVs differs from these infected with wild type parent staphylococci, a factor 
that could contribute to persistence of SCVs in BRI infections. 
Chapter Two 
Diagnostic Methods for Identification of Staphylococcal Clinical Isolates 
and their Corresponding Phenotypic Small Colony Variants (SCVs) 
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2: 1 Introduction 
The identification of a bacterial strain is a key element in the effective 
management and control of bacterial infections. Commercial kits are now 
available to ease the testing and to decrease the completion time required to get 
the identification information to the physicians on time. 
Special consideration should be taken for the identification of the organism 
because the presence of atypical colonial forms in a culture was usually 
interpreted as evidence of contamination and has previously been disregarded 
by laboratory technicians. Probably due to this reason, until fairly recently 
S. epidermidis was often not regarded as a pathogen but as a culture 
contaminant, though it is now increasingly being recognized as a cause of 
infection in implants (Fleer and Verhoef, 1984). 
Studies on SCVs of S. aureus have shown that they are often nonpigmented, 
non-haemolytic and coagulase-negative (Bayston and Wood, 1997). 
As they give the appearance of mixed cultures, they have frequently led to 
delay in diagnosis (Proctor et al., 1995). SCVs are infrequently reported by 
clinical laboratories because they form very small colonies that are frequently 
not visible until 48-72 hours after inoculation (Proctor et al., 1995). 
Therefore, clinicians and clinical lab personnel should consider making special 
efforts to search for SCVs. 
Phenotypic variation (SCVs) within staphylococcal populations appearing in 
the presence of gentamicin could be a mechanism developed by the bacterium 
to survive in the presence of antibiotics. Entry into the SCV form is reversible 
upon growth in antibiotic-free medium. Cycling between the resistant SCV 
and the antibiotic sensitive wild colony form can occur multiple times, 
indicating that SCVs are not formed by mutation but through a regulatory 
mechanism or phase variation (Hogan and Kolter, 2002). 
Chapter two describes the identification and the characterisation of members of 
the genus Staphylococcus which exhibit a characteristic phenotypic variation. 
The identification included morphological, growth, metabolic and biochemical 
properties. The genetic identification is included in Chapter three in this thesis. 
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2: 2 Materials and Methods 
2: 2: 1 Bacterial Strains and Growth Conditions 
Clinical isolates of Staphylococcus aureus, S. epidermidis and 
S. haemolyticus from BRI were taken from laboratory 
-20°C freezer stocks 
which had been frozen in 10% vol/vol glycerol/TSB (Tryptone Soya Broth) in 
the Division of Orthopaedic and Accident Surgery at Nottingham City 
Hospital, UK. These organisms are registered by F (freezer) numbers, and for 
simplicity they are referred to in this thesis by numbers (1-28) as indicated in 
Table 2.1. 
Whenever experimental work had to be undertaken, 5 µL of the frozen stock 
was plated on Sheep Blood agar ready poured plates (Oxoid, Basingstoke, UK) 
(BA) and on Tryptone soya agar plates (Oxoid, Basingstoke, UK) (TSA), 
incubated for 24 hours at 37°C. After incubation, a portion of one colony was 
plated out again on BA and TSA and incubated for 24 hours at 37°C. 
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Table 2.1: The origin of staphylococcal isolates used in this study 
Bacterial Identification I 
Number 
Origin 
1- 171585 S. epidermidis, Arterial graft infection 
2- F1537* S. epidermidis, Ventricular peritoneal shunt 
3- F1483 S. epidermidis, Clinical isolate, laboratory modified PIA (+)* 
4- F1594 S. epidermidis, No data about the origin 
5- F1578 S. epidermidis, Pus in hip replacement 
6- F1480 S. epidermidis, Clinical isolate, laboratory modified PIA(-)** 
7- 171481 S. epidermidis, Clinical isolate, laboratory modified PIA(+) 
8- F1484 S. epidermidis, Clinical isolate, laboratory modified PIA(-) 
9- F1576 S. epidermidis, Tissue-hip replacement 
10- F1577 S. epidermidis, Septic arthritis of prosthetic knee 
11- F1490 S aureus, Canadian strain, wound abscess 
12- F 1482 S. epidermidis, Clinical isolate laboratory modified as PIA(-) 
13- F1513 S. epidermidis, Hip replacement 
14- F1365 S. epidermidis, Catheter infection 
15- F1538 S. epidermidis, Shunt valve infection 
16- F1589 S. haemolyticus, Ventrical peritoneal Shunt infection 
17- F1479 S. epidermidis, Hamburg Germany PIA (+) 
18- F1342 S. epidermidis, Shunt infection 
19- F1485** S. aureus, MRSA***, wound abscess 
20- F1596 S. aureus, Osteomyelitis 
21- F1593 S. epidermidis, Ventrical peritoneal. Shunt infection 
22- F1536* S. epidermidis, 4" Ventrical peritoneal tip 
23- F 1588 S. epidermidis, CSF 
24- F1575 S. epidermidis, Pus from hip replacement 
25- F1592 S. epidermidis, shunt infection 
26- F1512 S. epidermidis, Hip replacement 
27- F1547** S. aureus, MRSA wound abscess 
28- F22 S. epidermidis, Shunt infection 
Ox Staph ý Oxford S. aureus used as control in antibiograms 
*2 and 22 are from the same patient but different site. ** 19 and 27 are from the same patient but 
different sites. PIA(+)* = polysaccharide intercellular adhesin, PIA(-)**=the mutant. 
MRSA = methicillin resistant S. aureus, CSF = cerebrospinal fluid. 
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Table 2.1 summarises the origins of staphylococcal origin isolates from chronic 
infections which were used in this study. The isolates were S. epidermidis 
(n=23), S. haemolyticus (n=1) and S. aureus (n=4). 
S. epidermidis strains (3,6,7,8,12 and 17) are PIA (polysaccharide 
intercellular adhesin) laboratory modified strains but they were originally 
isolated from chronic infections. These PIA mutant strains were provided by 
Professor Dietrich Mack, University of Krankenhaus Eppendorf, Hamburg, 
Germany. 
2: 2: 2 Determination of Gentamicin MIC by E-Test 
E-test- Epsilometer for antimicrobial susceptibility testing of bacteria 
(AB BIODISK, Sweden) 
- 
is a quantitative technology used to determine the 
Minimum Inhibitory Concentration (MIC in mg/mL) of individual antibiotics 
on agar medium. The Etest strip for gentamicin contains a gentamicin gradient 
that covers a concentration range of 0.016 to 256mg/mL and is applied to the 
surface of pre-seeded agar plates. After 24 hours of incubation, bacterial 
growth becomes visible with an inhibition ellipse which intersects with the 
strip indicating the MIC. Gentamicin MIC determinations of staphylococcal 
strains using E-test strips were performed according to the following protocol. 
1. One well-defined isolated colony of a wild type strain was emulsified in 
phosphate buffered saline (PBS) (Oxoid, Basingstoke, UK) to achieve a 
suspension having a turbidity equivalent to a 0.5 McFarland standard 
(BioMerieux, Basingstoke, UK) 
2. A sterile swab was dipped into the suspension and the swab was streaked 
over the entire half of an iso-sensitest agar plate (Oxoid Ltd, Basingstoke, UK) 
The other half of the plate was swabbed with a control Oxford S. aureus strain 
which is susceptible to all tested antibiotics (Ox-Staph) 
3. The strip was then placed on the few millimetre gap left between the two 
areas 
4. Agar plates were incubated at 37°C for 18 hours 
5. After the required period of incubation, during which growth became 
distinctly visible, the MIC value was determined at the point of intersection 
between the zone edge and the E-test strip 
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6. In the ellipse, if small colonies were seen they were recorded as SCVs as 
indicated in Table 2.2 
2: 2: 3 Gentamicin Microbroth Dilution Assay for SCVs Production 
Microbroth dilution assay is a special susceptibility test used in the 
clinical setting and in research and was used to determine MICs for gentamicin 
in the present study. Gentamicin was tested at twofold serial dilutions, and the 
lowest concentration that inhibited visible growth of an organism was recorded 
as the MIC. Regrowth of the organisms after a certain time at concentrations 
equal or greater than the MIC triggers these heteroresistant subpopulations of 
gentamicin resistant staphylococci to emerge under antibiotic selection 
pressure. Such resistant clones may then change in the presence of 
subinhibitory concentrations of antibiotic to higher levels of gentamicin 
resistance. Microbroth dilution assay was used to generate SCVs over E-test 
because it showed reproducible results in generating stable SCVs. 
The methodology used to determine the MIC is based on similar protocols used 
by other workers (Balows, 1991; Sören and Nilsson, 1984; Taylor et al., 1982) 
and it is described below. 
1. Autoclaved and cooled Mueller-Hinton broth (MHB) (Oxoid Ltd, 
Basingstoke, UK) was supplemented 50 mg/L filter-sterilized CaCl2 
(Sigma, Poole, UK) and 25mg/L MgCl2 (Sigma, Poole, UK) solutions 
2. A gentamicin solution was made up in MHB in a sufficient amount to 
achieve the desired starting concentration. Gentamicin was added to the first 
well of a flat-bottomed microtitre tray and was serially diluted along the plate 
to produce final concentrations in the range 256 to 0.06 µg/mL 
3. Standard density turbidity (McFarland 0.5) was used to adjust the inoculum 
to 
_108 CFU/mL. The inoculum was added to the wells to a final inoculum 
concentration of 5x104 CFU per well 
4. Standard strain of Staphylococcus aureus (Ox-Staph) was used in the same 
manner with each batch of susceptibility tests to serve as control (MIC 
0.16mg/L for gentamicin) 
5. Following inoculation, the trays were sealed with tape to prevent 
evaporation and incubated for 20 hours at 35°C 
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6. Trays were read by a micro ELISA reader (SpectraCount, Packard 
Bioscience, Bangbourne, UK) at 490nm and were further incubated for another 
day to check for any regrowth in the wells where no growth was seen after the 
first incubation for 20 hours 
7. Five microlitres was taken out of the wells after two days incubation and 
plated out on TSA at 35 °C and incubated overnight to check for the presence 
of SCVs 
8. The MIC was determined as the concentration of antibiotic in the well before 
the one displaying a sudden increase in absorbency (Table 2.3). 
The concentration of gentamicin in the wells containing the re-growth of the 
bacteria was subsequently used for SCVs production. 
Based on data in Table 2.3, a protocol for producing pure and stable SCV was 
established as the following: 
A. 1 mL of bacterial suspension (0.5 McFarland) was added to 9 mL MHB 
supplemented with CaC12 (50mg/L) and MgC12 (25mg/L) and gentamicin 
indicated by MHB° in Table 2.4. Broths were incubated overnight at 35°C 
statically 
B. Next day, 1 mL of the bacterial suspension MHB° was added to another 
9mL MHB with gentamicin, as indicated by MHB1 in Table 2.4. Broths were 
incubated overnight at 35°C 
C. On the third day, 5 gL from MHB' was plated out on TSA with 3 different 
concentrations of gentamicin in order to generate the most stable SCVs and 
least revertants. The three different concentrations of gentamicin used were: 
Half the concentration in MHB', gentamicin concentration same as in MHB', 
and twice the concentrations of MHB1. Plates were incubated at 35°C for 
another day 
D. Next day all three plates were examined for SCVs. The plate with the 
highest purity of SCVs was used for further consecutive subculturing. 
Table 2.4 summarises all the consecutive subcultures with different gentamicin 
concentrations for each strain. Figure 2.1 shows S. epidermidis wild strain (26) 
plated on BA before exposure to gentamicin. Figure 2.2 shows the SCVs 
generated in the same S. epidermidis strain after exposure to successive 
subculturing on plates supplemented with gentamicin. 
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2: 2: 4 API Staph 
The API Staph (BioMerieux, Basingstoke, UK) is used as an 
identification system to identify staphylococci according to their biochemical 
profile. The strip of substrates is inoculated with a bacterial suspension, 
incubated and the results are read and interpreted with reference to the 
information contained in the kit. The identification is facilitated by the use of 
the API STAPH Analytical Profile Index or the identification software. 
Wild colonies from TSA or SCV colonies from TSA with appropriate 
concentration of gentamicin were suspended in the medium provided in the kit 
and suspensions adjusted to a density equivalent to McFarland 0.6. 
Each cupule in the test strip was filled with the bacterial suspension. 
The arginine and urea cupules were sealed with mineral oil. The strip was then 
placed in a tray (with added sterile water) provided in the kit, covered and 
placed in a plastic box and incubated overnight at 37°C. Appropriate reagents 
were then added and the assays left for 10 minutes before the API reference 
number was read. The final reference number was a 7-digit Figure produced 
by adding the triplicate scores of the individual results. The data with the 
substrates tested and the readings of a positive and a negative result are 
illustrated in the Appendix 8: 2: 1 for the identification of the strains through 
their numerical profile. Any difference in the 7-digit Figure was typed in bold 
and interpreted accordingly as shown in Table 2.5. 
2: 2: 5 Antibiotic Susceptibility Test (Antibiogram) 
The antibiogram is another digital based reference test for bacterial 
strain identification (Bayston et al., 1983). The antibiogram uses various 
antibiotic discs to determine the sensitivity of bacteria when compared to a 
fully sensitive control strain Oxford Staphylococcus aureus (OX-Staph). 
The antibiotics used and their concentrations are detailed in the Appendix 
8: 2: 3. 
Two diagnostic sensitivity test agar (D. S. T. A. ) with plates containing 7% 
defibrinated horse blood (Oxoid, Basingstoke, UK) were prepared for each 
strain (Figure 2.3). A rotary inoculator was used to plate an OX-Staph 
suspension of McFarland 0.6 density in the inner circle and the test organism 
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around the outside leaving a boundary of 3mm between the two. 
Eight antibiotic discs were placed on the boundary of each plate by a dispenser 
and the plates incubated overnight at 37°C. The degree of susceptibility was 
ascertained by comparing the zone of inhibition of the test organism to that of 
the OX-Staph. Strains were classed as resistant if their zone of inhibition were 
more than 3mm smaller than the zone produced by the OX-Staph (Bayston, 
1978). The resulting 5-digit figure, which defines the antibiogram 
produced for a particular strain was generated by combining together the 
triplicate scores. Teicoplanin and ciprofloxacin were included in the test; they 
were reported separately on separate plates. The sensitivity to methicillin was 
tested separately by spotting the test and control organisms (McFarland 0.6 
density) onto two plates of TSA agar supplemented with 4% 
polyvinylpyrrolidone (PVP) with and without methicillin (12mg/L), followed 
by incubation overnight at 30°C (Bayston, 1978). The results for these tests are 
shown in Table 2.6. 
2: 2: 6 Api Zym 
API ZYM (BioMerieux, Basingstoke, UK) is a semi-quantitative and 
rapid micromethod designed for the detection of 19 enzymatic activities. The 
system consists of a strip with 20 microwells, the base of which contains the 
enzyme substrate and its buffer. The reactions are read according to the 
reading Table in the Appendix 8: 2: 2. The Api Zym profiles were generated as 
shown below. 
1. A bacterial suspension with a turbidity of 5-6 McFarland units was prepared 
in sterile distilled water 
2. Using a pipette, 65µL of suspension was dispensed into each microwell 
3. After inoculation, the strip was placed in its box and incubated for 4 hours at 
37°C 
4. After the incubation, one drop of ZYM A (BioMerieux, Basingstoke, UK) 
reagent and one drop of ZYM B (BioMerieux, Basingstoke, UK) was added to 
each microwell 
5. The colour was allowed to develop for at least 5 minutes 
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6. The reactions were read and recorded according to the reading table placed 
in the Appendix (8: 2: 2). 
7. Each enzyme activity was assigned with a number. Any differences among 
the strains in their enzymatic activity were reported in bold font. The test was 
repeated twice for each strain. The results for these tests are presented in Table 
2.7. 
2: 2: 7 Screening for Catalase, Coagulase, Haemolysis and DNase 
Catalase, coagulase and haemolysis are standard tests used in the 
diagnostic laboratory for the identification of S. aureus strains. 
Staphylococci produce the enzyme catalase which decomposes hydrogen 
peroxide (11202) into oxygen (02) and water (H20). The catalase test has been 
used in laboratories to differentiate between staphylococci and streptococci 
which are catalase negative. 
Coagulase causes blood plasma to clot. It is present only in S. aureus but not 
in CoNS and its property is the basis for the coagulase test. Two different 
coagulase tests can be performed: a tube test for free coagulase and a slide test 
for bound coagulase, or clumping factor (Seguin et al., 1999). While the tube 
test is definitive, the slide test is used as a rapid screening technique to identify 
S. aureus. 
Haemolysis is a simple test to detect haemolysin activities causing lysis of red 
blood cells. Haemolysis is recorded as a-haemolysis, ß-haemolysis, no 
haemolysis or double haemolysis (a-, ß-haemolysis) on sheep blood agar plates 
(Laevens et al., 1996). 
The DNase test is used to screen for S. aureus strains producing DNase which 
hydrolyse the deoxyribonucleic acid supplemented in the agar. After the 
incubation period, the addition of diluted hydrochloric acid (IN HCl) causes 
the DNA to precipitate out (turbidity) and clear zones appear around DNase- 
positive colonies. 
Screening for Catalase: A portion of a colony growing on TSA was 
emulsified in one drop of water on the top of a slide. One drop of (3% v/v 
H202 in water) was added to the emulsified colony. Oxygen bubbles released 
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indicated a positive reaction. Results for SCVs and their wild type parents are 
shown in Table 2.7. 
Coa2ulase Slide Test: A small portion of a colony was emulsified in one drop 
of citrated human plasma on a slide and left for 5 minutes incubated at 37°C in 
a sealed box. Any coagulation was reported as a positive test. Results for 
SCVs and their wild type parents are shown in Table 2.7. 
Conulase Tube Test: Approximately 0.1 mL of bacterial suspension was 
added to 0.3 mL of citrated human plasma. Tubes were placed in a water bath 
set at 37°C and read at 1,2,3,4 hours and after standing at room temperature for 
an additional 20 hours. The tube was tilted on its side gently to take the 
reading. Clotting of the plasma at the bottom of the tube was recorded as a 
positive test. The tube was tilted on its side gently to take the reading. 
Data for these analyses are presented in Table 2.8. 
Haemolysis on Sheep Blood Agar: the presence of haemolysis activity was 
determined by the plating of a portion of a colony on a sheep blood agar plate 
and incubating the plate at 37°C overnight. Plates with SCVs profile were 
incubated for another day to check if they would maintain the same picture of 
haemolysis. The results were reported as a-haemolysis if the haemolysis was 
greenish in colour, while ß-haemolysis was recorded if a clear zone surrounded 
the colonies and a double haemolysis (a-, ß-haemolysis) when a clear zone of 
haemolysis was framed by a greenish colour. Results are displayed in Table 
2.8 and Table 2.9. 
DNase Agar Test: With a sterile cotton swab, 2-3 colonies were taken from 
TSA plate and placed (dotted) on DNase agar (Oxoid, Basingstoke, UK) plates. 
The plates were incubated at 37°C overnight. Next day the plates were flooded 
with IN HCl and left for 5 minutes at room temperature. A clear zone around 
the growth was recorded as positive DNase test. Results from the DNase tests 
are shown in Table 2.8. 
64 
2: 2: 8 Lysostaphin Sensitivity 
Lysostaphin is 25-kDa glycyl-glycine endopeptidase from 
Staphylococcus simulans. The enzyme's staphylolytic activity restricts its 
antibacterial activity to staphylococcal species (Schindler and Schuhardt, 
1964). The test is considered positive if the tube contents (staphylococcal 
strain and lysostaphin) turn clear after 2 hours. All the 28 strains (the wild and 
their corresponding SCVs) were studied individually. The procedure was 
carried out as described below. 
1. One isolated colony from a TSA agar plate was transferred with an 
inoculating loop to 0.2 mL PBS, and emulsified 
2. Half of suspended cells were transferred to another tube and mixed with 0.1 
mL PBS as control 
3.0.1mL of a lysostaphin solution (Sigma, Poole, UK) dissolved in PBS was 
added to the original tube to produce a final lysostaphin concentration of 
25pg/mL 
4. Control and test tubes were then incubated at 37°C for 2 hours; at half-hour 
intervals, the turbidity at 550nm was measured using a spectrophotometer 
(Pharmacia Biotech, Ultraspec 2000, UK). PBS was used as a blank 
5. If turbidity decreased in the tube containing lysostaphin, the test was 
considered positive. If reduction in turbidity had not occurred in 2 hours, the 
test was considered to be negative 
6. The test was repeated twice for each strain. Each point represents the mean 
of all the strains added together ± SD as indicated in Figure 2.4. 
2: 2: 9 Auxotrophism Assay 
Gentamicin-induced staphylococcal auxotrophs show a conditional 
drug-dependent auxotrophy. Studies on SCVs of S. aureus revealed a 
deficiency in the electron transport system that lead to the appearance of 
menadione, and thiamine auxotrophy (Jonsson et al., 2003). Examination of 
auxotrophy in this study required the constant presence of gentamicin in the 
agar plates to sustain the stability of SCVs. Supplying the cultures with the 
auxotrophic substance should transform SCVs to their wild type appearance 
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(revertants) by compensating for the metabolic defect found in SCVs. 
The method for determination in the current study is described below. 
1. Two sets of TSA plates were prepared for auxotrophism assays. Both sets 
were supplemented with the auxotrophy test substance, and one set was 
additionally supplemented with gentamicin at the concentrations shown in 
Table 2-4 (end point gentamicin concentration) 
2. Auxotrophic substances were prepared as separate stock solutions and added 
individually, and along with gentamicin when appropriate to the melted TSA at 
45°C. Auxotrophic substances used in this study included menadione sodium 
bisulfite (Sigma, Poole, UK) (10 µg/mL), thymidine 51 
-diphosphate sodium 
salt (100 pg/mL) (Sigma, Poole, UK), thiamine hydrochloride (100 µg/mL) 
(Sigma, Poole, UK) and proline methyl ester hydrochloride (100 µg/mL) 
(Sigma, Poole, UK). Plates supplied with menadione and thiamine were kept 
covered because they are sensitive to light exposure 
3. One colony of a SCV culture was taken and emulsified in 1 mL of deionised 
water and subjected to five serial dilutions (10"1-10"5). A sterile swab was 
immersed in the 10"5 dilution and used to inoculate the surface of the agar plate 
4. Plates were incubated overnight at 37°C. Next day, plates were screened 
for SCVs. Plates were incubated for an extra day at 37°C if they failed to 
show any bacterial growth after the first overnight incubation. Each plate was 
screened for revertants and reversion recorded as a percentage: 
Revertant %_ [Revertant count/Total Count] x 100% 
5. The assay was repeated twice. The results are presented in Table 2.10 
2: 2: 10 Lipolytic and Proteolytic Activities 
Many staphylococci are able to produce the exoproteins, lipase and 
protease. These enzymes are known to be virulence factors in S. aureus 
(Goguen et al., 1995; Götz et al., 1998) and may contribute to the pathogencity 
of S. epidermidis (Vuong et al., 2000). 
Lipase is synthesised as a preproenzyme forms and after secretion into the 
medium, proteolytic processing results in mature, enzymatically active forms 
(Rollof and Normark, 1992). Staphylococcal lipases have been found to have 
differences in pH optimum, calcium affinity, and substrate specificity 
66 
(Nikoleit et al., 1995; Simons et al., 1996). Tween 20 and tributyrin are two 
lipids often used in agar plate screens for staphylococcal lipolytic activity. 
Lipolysis of tributyrin is reported positive when a clear zone is observed 
around the bacterial growth; in contrast, lipolysis of Tween 20 is reported as 
positive when a turbid zone is observed around the bacterial growth. 
Production of extracellular proteases by staphylococci may represent a 
bacterial defence system which could inactivate IgG antibodies and protect 
against antimicrobial peptides such as the neutrophil defensins (Selsted et al., 
1996) and the platelet microbicidal proteins (PMPs) (Yeaman et al., 1994). 
The detection of protease activity using an agar plate-based assay usually 
involves the addition of skimmed milk. If staphylococcal strains exhibit a 
proteolytic activity, a clear zone around the staphylococcal growth will appear 
after one-day incubation. 
Lipase and protease activities were determined by an agar plate assay with 
slight modifications to the method of Vuong et al (2000). 
Lipase Assay 
1. Tributyrin agar base (Sigma, Poole, UK) was supplied with CaC12 (25mg/L). 
Autoclaved Tween 20 at 1% vol/vol was added to TSA (Sigma, Poole, UK) or 
tributyrin solution at 1% vol/vol was added to tributyrin base agar (Sigma, 
Poole, UK) at 45°C. Plates were left to solidify at room temperature 
2. Bacterial suspensions were prepared in PBS at a cell density of 6 McFarland 
unit standards 
3. Bacterial suspension (25µL) was placed on the plates and left to dry. Dried 
plates were incubated for 2 days at 37°C 
4. A clear zone appearing on tributyrin plates and a turbid zone on Tween 20 
plates were considered as a positive indication of the presence of lipase 
5. The test was repeated twice for each strain. Results for SCVs and their 
parents are presented in Table 2.11 
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Protease Assay 
1. Sterile skimmed milk (Sainsbury, Nottingham, UK) was added at a final 
concentration of 1% wt/vol to autoclaved 1% wt/vol tryptone (Sigma, Poole, 
UK), 0.5% wdvol yeast extract (Sigma, Poole, UK), 0.5% wt/vol NaCl (Sigma, 
Poole, UK), and 1.5% wt/vol agar (Sigma, Poole, UK) at 45°C. The contents 
were mixed well and poured into plates and left to solidify and dry 
2. Bacterial strains were prepared exactly as described for the lipase assay as in 
section 2: 2: 10 
3. The result was considered to be positive for the presence of protease if a 
clear zone was observed around the growth after 24 hours incubation at 37°C. 
4. The test was repeated twice for each strain. Results for these tests are 
presented in Table 2.11 
2: 2: 11 Comparative Growth Curves for Staphylococcal Wild Type Strains 
and SCVs 
Several studies have showed that clinical S. aureus isolates as well as 
CoNS have the capacity to change their phenotypic features (Baddour and 
Christensen, 1987; Deighton et al., 1992(a, b); Baselga et al., 1993; Proctor et 
al., 1995). There are specific properties which correspond with these features 
such as colony morphology, growth rate and antibiotic susceptibility (Ziebuhr 
et al., 1999). 
The Vialight ' MDA Kit (BioWHITTAKER, CAMBREX, Nottingham, UK) 
is based upon the bioluminescent measurement of ATP that is present in 
metabolically active cells and allows an indirect measurement of bacterial 
growth to be determined. In the present study growth was monitored for the 
wild strains and SCVs in MHB with and without gentamicin supplementation. 
ATP contents per cell were determined for the wild type strains and their SCVs 
as described below. Plating of aliquots of the cultures on MHA plates was also 
carried out to enable the detection of any reversion to wild type. 
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1. A bacterial suspension was made in MHB with standard density turbidity 
(McFarland 0.5) for the wild strains or their corresponding SCV 
2. One millilitre from the suspension was mixed with 9 mL of MHB to produce 
10 -1 dilution, and then 2mL was taken from this and transferred to 18 mL of 
MHB to produce a 10.2 dilution was obtained 
3. The 20 mL 10"2 diluted suspension was divided into two equal volumes. 
One was used as control and the other supplemented with gentamicin. 
Gentamicin concentrations for wild types were the MIC. However, gentamicin 
concentrations for SCVs were the concentrations which resulted in most stable 
maintenance of SCVs as indicated in Table 2.4 
4. The suspensions were shaken at 150 rpm at 37°C 
5. Triplicate aliquots of 125µL were taken at zero, 1,3,6, and 12 hour time 
points and transferred to a 96 well plate (white walled, clear-bottomed 
chemiluminescence plates) (BioWHITTAKER, CAMBREX, Nottingham, UK) 
6. With a sterile loop, a small volume was also taken from the suspensions and 
plated out on MHA with and without gentamicin to screen for revertants. 
Data from these screens are presented in Table 2.12 
7.125µL of Bactolyse (a solution used to extract ATP) was added to the wells 
containing the staphylococcal cultures and extraction was allowed to occur for 
at least 5 minutes at room temperature 
8. The plate was then transferred to a luminometer with a dispensing system, 
where 25µL of ATP Monitoring Reagent (formulated luminescence cocktail) 
was automatically added to each well 
9. The light emission was measured and the results expressed as relative light 
units are Figure 2.5 and 2.6 
10. For calculating the amount of ATP per cell, aliquots at zero time were 
diluted and plated out for CFU (cell forming unit) count. The count was then 
adjusted for 125µL. Since RLUs obtained were proportional to the ATP 
content of the bacterial cells, a relative measure of ATP content was calculated 
using RLU data according to the following equation: 
RLU per cell = Relative Light Units (RLU)/Count of bacteria in 125µL 
11. The assay was repeated twice for each strain. The readings shown in 
Figure 2.5 and 2.6 are means ±SD. 
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2: 3 Results 
Table 2.2: Gentamicin E-test results for the staphylococcal isolates used in 
this study 
Strain No. Gentamicin MIC readings Gentamicin concentrations at which 
(mg/L) SCVs emerged (mg/L) 
1(SE)* 4 none 
2(SE) 0.125 none 
3 (SE) 0.064 0.75-1.0 
4(SE) 16 >96 
5(SE) 32 512 
6(SE) 0.064 none 
7(SE) 0.25 1-5 
8(SE) 0.047 1-4 
9(SE) 0.38 none 
10(SE) 16 64 and 1024 
11(SA)** 1.0 none 
12(SE) 19 none 
13(SE) 0.06 0.5-1.0 
14(SE) 16 >32 
15(SE) 0.19 none 
16(SH)*** 0.064 none 
17(SE) 0.125 0.25-0.75 
18(SE) 0.064 none 
19 (SA) 0.032 none 
20(SA) 0.50 none 
21(SE) 64 512 
22(SE) 0.125 none 
23(SE) 0.25 none 
24(SE) 12 none 
25(SE) 24 256 
26(SE) 32 none 
27(SA) 32 none 
28 (SE) 0.06 0.5-1 
Oxford S. aureus I 0.16 none 
*S>r S. epidermidis. ** SA=S. aureus, ***SH =S haemolyticus, none= no SCVs detected 
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Data in Table 2.3 summarises gentamicin MIC (mg/L) obtained by E-test for 
staphylococcal isolates. Gentamicin concentration in the ellipse at which 
SCVs emerged was two fold the MIC or more. Only twelve out of twenty 
eight staphylococci tested produced SCVs. 
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Table 2.3: Gentamicin MIC determined by microbroth dilution 
Strain No. Gentamicin MIC readings 
(mg/L) 
Gentamicin concentrations at which 
SCVs emerged mL 
1(SE)* 4 none 
2(SE) 0.25 none 
3 (SE) 0.25 0.5 
4(SE) 8 64 
5(SE) 16 none 
6(SE) 0.064 none 
7(SE) 0.25 0.125 
8(SE) 0.125 0.25 
9(SE) 64 none 
10(SE) 128 none 
11(SA)** 2 1 
12(SE) 0.125 none 
13(SE) 0.125 0.25 
14(SE) 16 none 
15(SE) 0.125 none 
16(SH)*** 0.125 0.25 
17(SE) 0.125 none 
18(SE) 0.125 0.25 
19 (SA) 0.25 none 
20(SA) I none 
21(SE) 32 128 
22(SE) 0.125 none 
23(SE) 0.125 0.5 
24(SE) 32 none 
25(SE) 16 32 
26(SE) 32 64 
27(SA) 32 128 
28 (SE) 0.06 0.125 
Oxford 
S. aureus 
0.16 none 
*SE = S. epidermidis, ** SA =& aureus, ***SH =S haemolylicus 
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The data in Table 2.3 summarises the gentamicin MIC (mg/L) obtained by 
microbroth dilution. SCVs from 14 strains were isolated from wells with re- 
growth on day two. 
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Table 2.4: Consecutive subcultures in TSA supplemented with gentamicin 
for the production of stable SCVs 
Strain 
No. 
Starting point 
(MHIB with gentamicin 
mg/mL) 
Serial plating out (TSA plates with gentamicin 
Collecting 
point 
(TSA plates 
with 
gentamicin 
Ending point 
(TSA plates 
with 
gentamicin 
mg/L) 
MHB° MHB' mg/L) mg/L) 
3(SE) 0.5 1 T1-+T1-), T5 
-ý T5 -ý 5 
4(SE) 64 128 T512-)-T512--, T1024-+ T1024 
-ý ( 2048 
7(SA) 0.125 1 T0.5-+T1-*T2-+T5 
-4T10--T23-* 
T64-ß 526 
8(SE) 0.25 
-3 
1 
-3 
T1-+T1-, T5 
- 
T10-ß 23 
11(SA) 1 2 T1-. T2-i T5-+T5 
-* 
T10 
-ý 23 
13(SE) 0.25 
-3 
1 
-4 
T0.5-*T0.5 
-+ TI- 2 
16(SH) 0.06 1 T5-, T10 
-4 T32. -º 526 
18(SE) 0.125 1 T1-*T5-+T10 
-º 
T32 
-3 64 
21(SE) 128 256 T512->T1024 
-4 T2048 -ý 4096 
23(SE) 0.5 1 T0.5-T1-T5-T5 
-º 
T5 
-4 256 
25(SE) 32 1024 T256 
-+ T1024-* 2048 
26(SE) 32 
-3 
512 
--> 
T512 
-3 T1024-). 1024 
27(SA) 128 1024 T1024 
-+ 1'2048-* 2048 
28(SE) 0.125 1 T1-ºT5 
-3 T5 -+ 23 
-3 = consecutive plating. SE = S. epidermidis, SA = S. aureus, SH = S. haemolyticus 
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Table 2.4 summarises the consecutive subcultures at different gentamicin 
concentrations to produce pure and stable SCVs. This procedure was repeated 
whenever SCVs strains were needed for further experimental work. 
Each arrow illustrates one subculture on that particular day. After 5-7 
subcultures, reversion was unlikely to occur because of the continuous and 
corresponding increase in gentamicin concentration. 
The procedure shown in Table 2.4 consisted of 4 steps. The starting point 
included growing wild type in MHB with gentamicin MICs at which SCVs 
emerged (MHB°) as shown in Table 2.3 then subculturing into MHB with 
gentamicin at a concentration of 2MIC (MHB'). Serial plating consisted of 2- 
5 consecutive subcultures onto TSA with gentamicin >2 fold the MIC. Serial 
plating ended with a collecting point where SCVs were transferred to plates or 
broths supplemented with gentamicin at concentration indicated in the ending 
point in Table 2.4. 
FIG 2.1: S. epidermidis strain 26 wild type before exposing to gentamicin 
Figure 2.1 shows the morphology S. epidermidis wild strain colonies when 
plated on BA. The colonies are z1 mm in diameter. 
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FIG 2.2: S. epidermidis strain 26 SCVs after exposure of wild type to 
successive concentrations of gentamicin 
Figure 2.2 shows the morphology of S. epidermidis after experiencing 
successive subculturing on gentamicin supplemented agar plates. These are 
S. epidermidis SCVs at their collecting point plated on BA. SCVs colonies 
appeared to be < 0.5 mm in diameter. 
76 
Table 2-5: Api Staph scores and their interpretation for staphylococcal 
strains and their corresponding SCVs 
Strain No. Api Staph Interpretation 
Score 
3 (SE) W 6706113 SCVs showed negative reaction for NIT and PAL 
3 (SE) S 6704113 
4 (SE) W 6706113 SCVs showed negative reaction for ADH 
4 (SE) S 6706112 
7 (SE) W 6706112 SCVs showed negative reaction for ADH and URE 
7 (SE) 
_§ 
6706110 
8 (SE) W 6706113 No Differences but weaker reactions in case of SCVs 
8 (SE) S 6706113 
11 (SA) W 6736153 SCVs showed negative reaction for URE 
11 (SA)S 6736151 
13 (SE) W 6606013 SCVs showed positive reaction for VP but negative for 
13 (SE) S 6706111 URE 
16 (SH)W 6616151 SCVs showed positive reaction for MNE and URE but 
16 (SH)S 6716113 negative for NAG 
18 (SE) W 6706043 SCVs showed positive reaction for VP and SAC but 
18 (SE) Sý 6706113 negative for NAG 
21(SE) W 6606113 SCVs showed positive reaction for MNE 
21 (SE) S 6706113 
23 (SE) W 6606113 SCVs showed positive reaction for MNE and negative 
23 (SE) S 6706153 for NAG 
25 (SE) W 6606111 SCVs showed positive reaction for MNE 
25 (SE) S 6706111 
26(SE) W 6306112 SCVs showed positive reaction for MAN and negative 
26 (SE) S 6326113 for ADH 
27 (SA) W1 6306113 SCVs showed positive reaction for LAC but negative 
27 (SA) S 6706111 for URE 
28 (SE) W 6606111 SCVs showed positive reaction for MNE and URE but 
28(S E) S 6704112 negative reaction for NIT 
(SE) W=S epidermidis wild strain, (SE) S=S epidermidis SCV, SA =S aureus 
SH =S. haemolyticus 
Table 2.5 summarises the Api Staph results (bold font) which showed the 
differences in metabolic profile between the wild strains and their 
corresponding SCVs. The interpretation of the observed differences is shown 
in the third column. The abbreviations for the substances are shown in the 
Appendix 8: 2: 2. Based on the results, SCVs differed from wild strains in their 
metabolic activity in one or more tests. However, for S. epidermidis strain 8, 
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SCVs carried the same Api Staph profile as their wild type parent but showed 
weaker reactions with the substrates compared to the wild strain. 
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Table 2.6: Antibiogram Staph Score for staphylococcal wild type strains 
and their corresponding SCVs 
No Strain. Antibiogram 
Staph score 
Interpretation 
3 (SE) W 51000 Cip(R), Tec (S) SCVs showed resistance to gentamicin, 
amikacin teico lanin and sensitivit to 
3 (SE) S , 
p 
, 
y 
I 00240 Cip (R), Tec (R) penicillin. 
4 (SE) W 40354 Cip(R), Tec (S) SCVs showed resistance to methicillin, 
trimethoprim netilmicin and 
4 (SE) S 43370 Cip (R), Tec (S) , , sensitivity to vancomycin 
7 (SE) W 60000 Cip (S), Tec (S) 
J 
SCVs showed resistance to gentamicin 
and amikacin 
7 (SE) S - 60240 Cip (S), Tec (S) 
8 (SE) W 45402 Tec (S), Cip (R) SCVs showed resistance to gentamicin, 
amikacin and vancom cin and 
8 (SE) S 45246 Tec (R), Cip (R) 
y 
ciprofloxacin 
11 (SA) W 06000 Tec (R), Cip (R) SCVs showed resistance to 
clindam cin amikacin and entamicin 
11 (SA)S 06660 Tee (R), Cip (R) 
y 
,g , 
netilmicin 
13 (SE) W 00000 Tec (S), Cip (S) SCVs showed resistance to gentamicin 
and teico lanin 
13 (SE) S 00240 Tec (R), Cip (S) p 
16 (SH)W 44000 Tec (S), Cip (S) SCVs showed resistance to gentamicin, 
amikacin netilmicin cefuroxime 
16 (SH)S 44261 Tee (S), Cip (S) , , 
18 (SE) W 00000 Tee (S), Cip (S) SCVs showed resistance to 
18 (SE) S 00744 Tec (S), Cip (S) clindamycin, amikacin, gentamicin, 
vancomycin and rifampicin 
21(SE) W 43210 Tec (S), Cip (S) SCVs showed resistance to amikacin 
21 (SE) S 43270 Tec (S), Cip (S) and netilmicin 
23 (SE) W 40001 Tee (S), Cip (S) 
SCVs showed resistance to entamicin 
23 (SE) S 40241 Tec (S), Cip (S) 
g 
, 
amikacin. 
25 (SE) W 44670 Tec (S), Cip (R) ý SCVs is resistant to methicillin 
25 (SE) S 46670 Tec (S), Cip (R) 
26(SE) W 40200 Tec (S), Cip (S) SCVs showed resistance to amikacin, 
d i i i i illi 
26 (SE) S 00240 Tec (S), Cip (S) an sens t v ty to pen c n 
27 (SA) W 40200 Tec (S), Cip (S) SCVs showed resistance to amikacin, 
27 (SA) S 40240 Tec (S), Cip (S) sensitivity to penicillin 
28 (SE) W 00000 Tec (S), Cip (S) SCVs showed resistance to gentamicin 
28 (SE) S 00200 Tec (S), Cip (S) 
(SE) W=S epidernddis wild strain, (SE) S= S epidermldis SCV. SA =S aureus. Sl I=S baemolyticus. 
R= resistant to antibiotic. S= susceptible to antibiotics 
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Table 2.6 shows the antibiograms profiles in 5 digits. Some SCVs were more 
resistant to some aminoglycosides like gentamicin, amikacin, netilmicin but 
were sensitive to penicillin and vancomycin compared to their wild type 
parents. 
FIG 2.3: Antibiotic susceptibility test for S. epidermidis strain 23 and 
its SCVs showing antibiotic resistant SCVs when compared to the 
wild type 
Figure 2.3 shows the SCVs and their wild strains susceptibility to gentamicin 
(indicated with arrow). SCV was resistant to gentamicin resulting in bacterial 
growth around the disc; however, its corresponding wild strain was inhibited 
by gentamicin (clear zone). 
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Table 2.7: The enzymatic activities for staphylococcal strains and their 
SCVs as determined by Api Zym 
Strain No. Positive Enzyme No Interpretation 
3 (SE) W* j 2,3,4,11,12,16 SCVs showed deficiency in alkaline 
3 (SE) S** 4,11,12 phosphatase, esterase, a-glucosidase 
4 (SE) W 2,3,4,11,12,16 SCVs showed deficiency in esterase and 
4 (SE) S 2,4,11,12 a-glucosidase 
7 (SE) W 2,3,4,6,11,12,16 SCVs showed deficiency in leucine 
7 (SE) S 4 2 3 11 12 13 16 20 a'ylamidase, but enzymatic activity in 
, , , , , ' a 
-galactosidase and a -fucosidase 
8 (SE) W 2,3,4,11,12,16 SCVs showed deficiency in alkaline 
8 (SE) S 3,4,11,12,16 phosphatase 
11 (SA) W 2,3,4,11,12,16 SCVs showed deficiency in alkaline 
11 (SA)S 3,11,12 phosphatase, esterase lipase, a 
-glucosidase 
13 (SE) W 2,3,4,11,12,16 SCVs showed enzymatic activity in lipase 
13 (SE) S 2,3,4,5,8,11,12,16 and cysteine arylamidase 
16 (SH)W 2,3,4,11,12,16 SCVs showed enzymatic activity in 
16 (SH)S j 2,3,4,11,12,10,16 j a 
-chymotrypsin 
18 SEW 2,3,4,11,12,16 SCVs showed enzymatic activity in lipase 
18 E) S 2,3,4,5,11,12,16 
21(SE) W 2,3,4,11,12,16 SCVs showed enzymatic activity in 
21 (SE) S 2,3,4,11,12,14,16 a 
-galactosidase 
23 SE) W! 2,3,4,11,12,16 SCVs showed deficiency in esterase lipase 
23 (SE) S 2,3,11,12 and a 
-glucosidase 
25 (SE) W 2,3,4,11,12 j SCVs showed enzymatic activity in 
25 (SE) S 2,3,4,11,12,14,16 a-galactosidase and a 
-glucosidase 
26(SE) W 2,3,4,11,12,16 j SCVs showed enzymatic activity in lipase 
26 (SE) S 2,3,4,5,11,12,16 
27 (SA) W 3,4,11,12,16 SCVs showed deficiency in acid 
27 (SA) S 3,4,12,16 phosphatase 
28 (SE) W 2,3,4,11,12,16 j SCVs showed deficiency in a 
-glucosidase 
28 (SE) S 2,3,4,11,12 
(SE) W=S epidermidis wild strain, (SE) S= S epidermidis SCV. SA =S aureus. SH =S 
haemolyticus. 
The differences in enzymatic activities have been indicated in bold font in 
Table 2.7. The results indicated that SCVs differed in their enzymatic 
activities when compared to the wild strains. SCVs were shown to be deficient 
in one or more of the enzymes screened including lipases, esterases and 
glucosidases and phosphatases. However, other SCVs (16,18,21 and 26) 
showed additional activities (lipase, galactosidase and a-chymotrypsin) which 
were not present in their wild type parent. 
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Table 2.8: Catalase, coagulase, DNAse and haemolysis activities on sheep 
blood agar plates for the differentiation of S. aureus wild and SCVs strains 
Strain No. Catalase Coagulase DNas Haemolysis on 
Slide Tube e sheep BA 
11 (SA)W ++ + at 2 hours + ß-haemolysis 
11 (SA) S+- + overnight + 
- 
haemolysis 
27 (SA)W ++ + at 4 hours + ß-haemolysis 
27 (SA)S +- + overnight + 
- 
haemolysis 
(SA) W=S. aureus wild strains. (SA) S=S. aureus SCVs 
Further biochemical tests on S. aureus wild and SCVs including assays for 
catalase, coagulase, DNAse and haemolysis are summarised in Table 2.8. 
All Staphylococcal strains tested showed positive results in catalase and DNase 
test. SCVs were non-haemolytic and coagulase negative (slide test). 
Coagulase and haemolysin production has been considered to be important in 
staphylococcal pathogenesis. Vesga et al (1995) suggested that S. aureus 
SCVs could survive intracellularly because they did not produce sufficient 
coagulase and haemolysins, as compared to their wild parent. This is thought 
to enable SCVs to survive longer in host cells without lysing them. 
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Table 2.9: CoNS haemolysis on sheep blood agar 
Strain No. I Haemolysis on Sheep BA 
3 (SE) W 
-Haemolysis 
3 (SE) S *- Haemolysis 
4(SE) W a-Haemolysis 
4(SE) S a 
-Haemolysis 
7(SE) W- Haemolysis 
7(SE) S- Haemolysis 
8(SE) W- Haemolysis 
8 (SE) S 
- 
Haemolysis 
13 (SE) Wa 
-Haemolysis 
13(SE) S a 
-Haemolysis 
16(SH) W ß-Haemolysis 
16(SH) S a, ß 
-Haemolysis 
18 (SE) W a 
-Haemolysis 
18 (SE) Sa 
-Haemolysis 
21(SE) W a, 
-Haemolysis 
21 (SE) S a, ß 
-Haemolysis 
23(SE) W a 
-Haemolysis 
23 (SE) S 
- 
Haemolysis 
25(SE) W 
- 
Haemolysis 
25(SE) S 
- 
Haemolysis 
26(SE) W Haemolysis 
26 (SE) S 
- 
Haemolysis 
28 (SE) W 
1 - 
Haemolysis 
28 (SE) S ý 
- 
Haemolysis 
*- = negative haemolysis; SE= S. epidermidis; SH= S. haemolyticus; W= wild strains; 
S= SCVs 
The results displayed in Table 2.9 indicated that S. epidermidis SCVs 
haemolysin production did not differ from wild strains. 
However, S. haemolyticus SCVs showed an increase in haemolytic activity 
(around double) when compared to their wild strain. 
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FIG 2-4: Influence of lysostaphin on the lysis of staphylococcal 
strains 
--6 Control (W) -1. ysostaphin (W) 
Control (S) l. ysostaphin (S) 
Lysostaphin had different effects on staphylococcal wild and SCVs strains. 
Each point in Figure 2.4 represents the mean of the lysostaphin sensitivity 
assays of the fourteen staphylococcal strains shown in Table 2.4 tested 
individually. Figure 2.4 indicated that SCVs are more resistant to lysostaphin 
lytic action, since lysis occurred more slowly than wild type strains within the 
2 hr incubation period. This resistance could be explained by change in cell 
wall composition which reduces lysostaphin activity or delays it. 
0 30 60 120 
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Table 2.10: Screening for auxotrophy in SCV strains on TSA plates with 
and without gentamicin 
SCVs Thymidine Thiamine Proline 
Strain Menadione 100 mg/L 100 mgIL 100 mgIL 
No. 10 mg/L Auxotrophic 
Substance 
+-+-+-+ 
Gen Gen Gen Gen Gen Gen Gen Gen 
3(SE) 85% 80% 15% I 1% 89% 82%1 15% 1% Menadione 
Rev Rev Rev Rev Rev Rev Rev Rev Thiamine 
4(SE) 91% 87% 18% 3% 95% 91% 18% 3% Menadione 
Rev Rev Rev Rev Rev Rev Rev Rev Thiamine 
7(SE) ' 80% 
-* 
5% S 70% 62% 5% S Menadione 
Rev Rev Rev Rev Rev Thiamine 
8(SE) 97% 92% 8% 5% 100% 90% 8% 6% Thiamine 
Rev Rev Rev Rev Rev Rev Rev Rev Menadione 1 
11(SA) 76% 71% 3% 1% 89% 85% 80% 76% I Thiamine 
1 Rev Rev Rev Rev Rev Rev Rev Rev Menadione 
Proline 
13(SE) 95% 
- 
6% 4% 81% 77% 6% 5% Menadione 
Rev Rev Rev Rev 
, 
Rev Rev Rev Thiamine 
16(SIi) 92% 
- 
3% 2% 3% 2% 3% 1% Menadione 
Rev Rev Rev Rev Rev Rev Rev 
18(SE) 98% 92% 10% 2% 85% 
- 
10% 2% Menadione 
Rev Rev Rev Rev Rev Rev Rev Thiamine 
21(SA) 75% 60% 10% 2% 100% 
- 
10% 3% Menadione 
Rev Rev Rev Rev Rev Rev Rev 
23(SE) 76% 69% 10% 3% 65% 60% 10% 2% Menadione 
Rev Rev Rev Rev Rev Rev Rev Rev Thiamine 
25(SE) 96% 86% 15% 2% 15% 2% 15% 2% Menadione 
Rev Rev Rev Rev Rev ; Rev Rev Rev 
26(SE) 12% 1% 12% 2% 60% 50% 12% 1% 
Rev Rev Rev Rev Rev Rev Rev Rev Thiamine 
27(SA) 98% 95% 8% 1% 80% 30% 8% 1% Menadione 
_Rev 
Rev Rev Rev Rev 
1 
Rev Rev Rev Thiamine 
28(SE) 90% 10% 2% 80% 70% 10% 2% Menadione 
Rev Rev Rev Rev Rev Rev Rev Thiamine 
*(-) 
= no growth at all. Gen+= plates with gentamicin, Gen- = plates without gentamicin. 
Where no growth was detected in the initial screen, the auxotrophy assay was repeated on 
TSA plates containing half the original concentration of gentamicin. No growth was 
observed under these conditions. All SCVs showed variable levels of reversion in the 
presence of medium supplementation with the auxotrophic substances. 
The results in Table 2.10 showed that staphylococcal SCVs are menadione 
and/or thiamine auxotrophs. Auxotrophic SCVs were reported if two sets of 
plates (Gen + and Gen 
-) showed 50-100% revertants or no growth at all. 
However, the appearance of 100% SCVs or less than 50% revertants was 
recorded as no auxotrophy to the screened substance. 
85 
It is believed that the auxotrophic substance compensates for the defect found 
in SCVs' metabolic pathway(s) (Proctor et al., 1997). The repaired pathway 
will cause reversion of SCVs to the wild strains rendering them susceptible to 
gentamicin. This would explain the lack of growth of some strains indicated in 
the auxotrophy assays in the presence of high concentrations (>MIC) of 
gentamicin (Table 2.10) e. g. SE 13 and SH 16 in the presence of menadione. 
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Table 2.11: Protease and lipase activities of staphylococcal wild type 
strains and SCVs 
Protease Lipase Activity Notes 
Strain No. Activity 
Tween 20 Tributyrin 
3 (SE) W* I-- No difference in lipolytic and 
3 (SE) S** proteolytic activity between SCVs and 
wild type 
4 (SE) W+-- No difference in lipolytic and 
, ýý, proteolytic activity between SCVs and 
" tar) JT- 
- wild type 
7 (SE) W+- 
- 
No difference in lipolytic and 
7 (SE) S+ proteolytic activity between SCVs and 
wild type 
8 (SE) W+_ + No difference in lipolytic and 
8 (SE) S+- proteolytic activity between SCVs and + 
wild type 
11 (SA) W-+ 
- 
No difference in lipolytic and 
11 (SA) S_+ 
_ 
proteolytic activity between SCVs and 
I wild type 
13 (SE) W-- 
- 
No difference in lipolytic and 
13 (SE) S proteolytic activity between SCVs and 
wild type 
16 (SH) W-- 
- 
SCV showed lipolytic activity against 
16(SH)S 
-- 
+ 
tributyrin compared to their i 
corresponding wild strain 
18 (SE) W-- 
- 
SCV showed protease activity and 
lipase activity against tributyrin 
18 (SE) S++o comp do w ineKr 
corresponding wild strain 
21(SE) W+ No difference in lipolytic and 
21 (SE) S+_ proteolytic activity between SCVs and 
wild type 
23 (SE) W 
-- 
No difference in lipolytic and 
between SCVs and roteol tic activit 
23 (SE) S-; ý+ 
p y y 
wild type 
25 (SE) W+i-- SCV showed lipase activity against 
when to their 25 (SE) S+_+ 
corresponding wild strain 
26(SE) W+-- No difference in lipolytic and 
-ý -1 proteolytic activity between SCVs and 26 (SE) S+-- wild type 
27 (SA) W+ No difference in lipolytic and 
27 (SA) S+ proteolytic activity between SCVs and 
wild type 
28 (SE) W + 
-+ No difference in lipolytic and 
proteolytic activity between SCVs and 
28 (SE) S± 
_ý 
+ wild type 
*SE (W) =S epidermidis wild type, SE(S) =9 epidermidis SCVs, SA =S aureus, Sl I =& haemolyticus 
87 
Table 2.11 summarises the results of the analysis of the lipolytic and 
proteolytic activity levels of the fourteen-staphylococcal strains with their 
corresponding SCVs. This study showed that only 2 staphylococcal CoNS 
SCVs (strains 16,25) exhibited differences in lipolytic activity compared with 
their wild type parents (against tributyrin). Further, only one S epidermidis 
SCV (strain 18) showed a difference in lipolytic and proteolytic activities when 
compared to their wild types. 
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FIG 2-5 Growth curves for wild type strains in MHB 
supplemented with and without gentamicin. 
-b--Wild/MHB f Wild/MHBgentamicin 
The growth of the staphylococcal wild types was monitored through 4 time 
points. Each point in Figure 2.5 represents the mean value in RLU (Relative 
Light Units) for all the strains measured individually. Wild strains in MHB 
without gentamicin were used as controls. In the first three hours it was 
noticed that gentamicin resulted in a decrease in RLU when compared to 
controls. Aliquots that were taken at 3 hours and plated on MHA showed a 
decrease in CFU/mL (data not shown). This decrease was due to the 
bactericidal effects of gentamicin on the wild type cells. However, after 3 
hours the RLU started to increase, and aliquots at 6 hours showed increased 
CFU/mL. It is believed that the emergence of gentamicin resistant 
staphylococcal strains (SCVs) were responsible for the increase based on data 
presented in Table 2.12. After 6 hours, the growth rates were similar to each 
other but the outcome at 12 hours showed that the CFU/mL (data not shown) 
was less in the presence of gentamicin when compared to controls, probably 
due to the gentamicin bactericidal action which took place at the start of the 
culture (data not shown). Staphylococcal wild type ATP contents were 
calculated from the curve and found to range from 4x 10-2 
- 
3.7x 10-2 RLU/Cell. 
036 12 
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FIG 2-6 Growth curves for the SCVs in MHB with and 
without gentamicin through four different time points. 
--SCV/MHB f SCV/MHB gentamicin 
Figure 2.6 represents the growth of staphylococcal SCVs strains through 4 time 
points. Each point on the curve is the mean value of all the fourteen 
staphylococcal SCVs RLU tested individually. There was not any significant 
difference in RLU in the first 6 hours between staphylococcal SCVs strains 
grown in the presence of gentamicin or in antibiotic free MHB. The second six 
hours showed an increase in RLU in both curves with higher staphylococcal 
CFU/mL in the absence of gentamicin (data not shown). It is believed that 
reversion to the wild type had occurred in the second six hours and it is 
responsible for the increase in RLU in controls. Data in Table 2.12 showed 
that revertants had appeared at that time point, supporting the observed 
increase in RLU. The ATP contents of the SCVs were calculated from the 
curve and found to be in range of 3.9x 10-5 
- 
4x 10"5 RLU/Cell. 
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Table 2.12: Monitoring staphylococcal morphology at five time points 
after growing in MHB in the presence and absence of gentamicin 
Strains Zero Time 1 Hour 3 Hours 6 Hours 12 Hours 
Wild Wild Wild Wild Wild Wild 
Wild/Gen Wild Wild Wild+SCV I Wild Wild iI1 
SCV SCV SCV SCV+*Rev SCV+Rev Rev 
SCV/Gen SCV SCV SCV SCV I SCV+Rev 
*REV= revertants (SCVs revert to wild type status). Gen=gentamicin 
Data in Table 2.12 shows the staphylococcal morphology at five different time 
points when growth was monitored as in Figure 2.5 and Figure 2.6. It is 
obvious that after three hours incubation staphylococcal morphology had been 
affected by the presence or the absence of gentamicin. SCVs appeared after 3 
hours incubation of wild strains in the presence of gentamicin, and revertants 
appeared in cultures where SCVs growth was monitored without a stabilising 
concentration of gentamicin. However, after 6 hours incubation of wild types 
with gentamicin, SCVs were no longer detected. The reasons could be that the 
fast growth of wild strains could mask the appearance of SCVs, or that growth- 
associated decreases in the pH of the MHB could affect gentamicin ability to 
select for SCVs (Massey et al, 2001). 
SCVs produced by microbroth dilution maintained stability through the first 
6 hours when gentamicin was supplemented, however, after 12 hours 
incubation in the absence of antibiotic revertants appeared. 
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2: 4 Discussion and Conclusions 
This Chapter describes a systematic study in the following aspects of 
SCV physiology: 
(a) Generating stable staphylococcal SCVs by treating the wild staphylococcal 
strains with increasing concentrations of gentamicin above the MIC. 
(b) The use of diagnostic laboratory tests to screen for any virulence factors 
expressed by staphylococcal strains and to identify variation in expression of 
these factors between wild type and SCV staphylococci. 
(c) The study of selected features of the metabolism of SCVs, that might 
correlate with their phenotypic variations. 
Strains of interest were isolated from chronic infections mainly BRI (Table 
2.1). SCVs are known to be associated with chronic infections, particularly 
those that are persistent and recurrent. SCVs have been isolated from sites of 
infection and following both in vitro and in vivo exposure to aminoglycosides 
(Looney, 2000; Proctor et al., 1995, Wise and Spink, 1954). 
In the current study SCVs were produced by exposing the wild type 
staphylococcal strains to serial passages in gentamicin above the MIC. MICs 
for gentamicin were determined by microbroth dilution for the wild type 
strains. This method was favoured over the E-test (Table 2.2) since the E-test 
failed to indicate the optimal concentration at which SCVs could be produced, 
and subsequently maintained in pure culture for several passages (Table 2.3). 
At the end of the selection assay, fourteen-staphylococcal strains out of twenty- 
eight produced stable SCVs which were then characterized (Table 2.4). Two of 
the strains were S. aureus, one was S. haemolyticus and eleven were S. 
epidermidis. The reason why some wild strains failed to produce SCVs is still 
unknown and this observation has not been considered in detailed in the current 
literature on staphylococcal SCVs. However, it is possible the gentamicin 
selection for SCVs could be species and strain dependent. 
In order to begin to investigate the possible role of SCVs in BRI, virulence 
factor production by wild strains and their corresponding SCVs was 
investigated. The majority of virulence factors were screened using standard 
laboratory tests. Some virulence factors were selected for study based on 
previously published data from the literature. Metabolic profiles, auxotrophy 
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and growth rates of SCVs and their wild type strains were also compared to 
look for any pattern unique to the SCV phenotype. 
Lipases and proteases are exoenzymes which are known to be 
staphylococcal virulence factors. These two classes of enzymes are important 
in allowing dissemination by tissue destruction (Goguen et al., 1995). In this 
current study, S. haemolyticus (16) SCVs showed lipolytic against tributyrin 
and protease activities which were not shown by their wild type parental strain. 
However, while S. epidermidis SCVs (18 and 25) had differences in lipase 
activity, S. aureus SCVs had no difference in their lipolytic or proteolytic 
activity when compared to their corresponding wild type strains (Table 2.11). 
Overnight incubation on sheep blood agar plates revealed that S. aureus 
SCVs were non-haemolytic, while the coagulase test showed delayed tube 
coagulation with human plasma. However, S. aureus SCVs sustained the 
ability to degrade DNA (Table 2.8). The haemolytic activity of coagulase- 
negative SCVs did not differ from wild type although S. haemolyticus SCVs 
strain 16 showed double haemolysis when compared to the wild strain parent 
(Table 2.9). 
API Staph for staphylococcal identification revealed that the CoNS SCVs 
were unable to ferment NAG (N-acetyl-glucosamine) and to use arginine, but 
were able to ferment MNE (mannitol), while in contrast to their parental 
strains, S. aureus SCVs were urease negative (Table 2.5). Based on API Staph 
results, a conclusion can be drawn that staphylococcal SCVs are variants with 
altered metabolic pathways. These variants, of which there are different 
classes, have many atypical characteristics one of which is a defect in 
metabolic pathways which could be responsible for their slow growth and 
minute colony morphology. However, it is not possible to identify exactly 
which pathway is defective based solely on Api Staph results. The ApiZym 
profiles showed that the majority of SCVs have altered enzymatic activity in 
esterase, lipase, a-glucosidase and alkaline phosphatase irrespective of whether 
they were S. aureus or CoNS (Table 2.7). 
Reduced activity of the electron transport system can account for most of the 
features typically seen in S. aureus SCVs. Based on the results presented in 
this study, CoNS SCVs features such as slow growth could be explained by 
reduced ATP cell content. Clinical and laboratory-generated S. aureus SCVs 
are frequently observed to be auxotrophic for menadione or thiamine, two 
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components required in the biosynthesis of menaquinone and cytochromes, 
components of the electron transport chain. Screening for auxotrophy in this 
study revealed that S. aureus and CoNS SCVs are menadione and/or thiamine 
auxotrophs. Only one S. aureus SCV was shown to be a proline auxotroph 
(Table 2.10). The decrease in electron transport activity in SCVs that was 
observed in the present study may provide a mechanism for their persistence 
within host tissues (Proctor et al., 1995). Down regulating some aspects of 
their metabolic profiles, would enable staphylococcal SCVs to produce 
multiple changes that may contribute to their pathogenesis. 
SCVs are reputed to be slow growing organisms (Goudie and Goudie, 1955; 
Proctor et al., 1997) when compared to their wild type parents. Decreased 
availability of ATP would lead to slow growth, and hence small colonies. 
In this study, ATP activity (as represented by RLU per cell in the Vialight 
MDA assay) indicated that wild strains contained three logs more ATP than 
SCVs. The growth curves indicated that staphylococcal wild types entered log 
phase in about 3 hours, but that SCVs with a slower rate of growth entered log 
phase in about 6-7 hours (Figures 2.5 and 2.6). 
Reversion on the other hand is important in the staphylococcal SCVs 
pathogenesis since reversal of the SCV phenotype might form the basis for 
recurrent infections. Reversion may represent a mechanism for bacterial 
survival and growth in response to environmental conditions. In this study, 
it was important to realise that entry to SCVs status is reversible upon growth 
in medium without antibiotics, showing it as not being mutation but a 
regulatory mechanism or phase variation (Table 2.12). 
Lysostaphin, a peptidase has recently been studied as a potential therapeutic 
agent for use against S. aureus (Patron et al., 1999). In this study, assessing 
lysis by lysostaphin indicated that S. aureus and CoNS SCVs were more 
resistant to lysostaphin than their corresponding wild type strains (Figure 2.4). 
Among S. aureus isolates the development of resistance to lysostaphin is 
known to be mediated by alterations in the crossbridge of the muropeptide of 
the cell wall (Climo et al., 2001) and CoNS (Ehlert et al., 2000). Based on 
these results, it could be concluded that SCVs may be more resistant to 
lysostaphin due to alterations in their cell wall composition (Figure 2.4). 
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Antibiograms showed that SCVs were resistant to gentamicin. Resistance to 
gentamicin was also accompanied by resistance to other aminoglycosides such 
as amikacin and for netilmicin Table 2.6. Other researchers such as Miller et al 
(1980) also reported the same results when they used a S. aureus mutant with a 
SCV phenotype and found this mutant to be resistant to gentamicin, amikacin 
and netilmicin. 
From the data presented in the literature, it is evident that there is no 
definitive means by which to either identify SCVs, or to predict the clinical 
usefulness of various regimes to identify their virulence factors. Therefore, the 
experiments described in this Chapter were intended to acquire and improve 
knowledge of aspects of SCVs' virulence (such as the production of secreted 
virulence factors) which might contribute to the pathogenesis of BRI. 
However, this is a pilot study of SCV virulence and it is recognised that it will 
be necessary to investigate other aspects of staphylococcal virulence in 
addition to the conventional ones described in this Chapter to provide a more 
complete profile of how the virulence of SCVs may differ from their wild type 
parents. 
Having developed a method for generating SCVs and undertaken their 
preliminary characterization, these organisms were then used to further 
investigate specific aspect of the role of SCVs in the pathogenesis of BRI. 
These studies are described in Chapters 3-6. 
Chapter Three 
Genotypic and Further Phenotypic Characterisation of Staphylococcal 
Wild and Small Colony Variant Strains 
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3: 1 Introduction 
This Chapter investigates further the phenotypic and genotypic 
similarities and difference between staphylococcal SCVs and their wild-type 
strains. The typing systems used in the following comparisons have 
conventionally been classified as phenotypic techniques, those that detect 
characteristics expressed by the microorganisms, and genotypic techniques, 
those that involve direct DNA based analysis of chromosomal genetic 
elements. 
One method of monitoring phenotypic variations is by the use of sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), a widely 
used technique which is used for a variety of protein characterisation 
applications, both general and specific. Immuno-reactivity of Western blotted 
proteins, two-dimensional gel electrophoresis, and peptide mapping are related 
techniques used for investigation of the identity of specific proteins. Such 
techniques are also routinely used to study unknown proteins, to determine if 
they are similar to, or have any structure in common with, known proteins. 
SDS-PAGE has been used successfully as a taxonomic tool by several 
researchers. However, Clink and Pennington (1987) suggested that although 
SDS-PAGE can be used to identify staphylococcal species, this type of analysis 
will not provide the basis for a complete typing method since they showed the 
occurrence of minor differences in polypeptide pattern between strains of the 
same species, though each species did produce a protein pattern distinguishable 
from that of any other (Clink and Pennington, 1987). 
Immuno-blotting is another way of typing proteins. The electrophoresed 
bacterial products are transferred from a gel to (blotted onto) a nitrocellulose 
membrane and then exposed either to antisera (antibodies) raised against a 
specific strain or to pooled human serum, which contains a broad spectrum of 
reactive antibodies. Antibody binding can be detected using enzyme-labelled 
anti-primary immunoglobulins. Depending on the detection system used to 
determine antibody reactivity (colorimetric or enhanced chemiluminescence 
based), as little as 1-5 ng of an average-sized protein can be detected. 
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Genotypic techniques to study microbial strain and species differences have 
been distributed and performed increasingly in clinical laboratories. The 
pulsed field gel electrophoresis (PFGE) technique is an adaptation of 
conventional agarose gel electrophoresis that allows extremely large DNA 
fragments from chromosomal digests to be resolved. PFGE is an extremely 
powerful tool commonly used for genotypic and epidemiology studies for 
pathogenic microorganisms. PFGE requires the preparation of restriction 
digests of DNA. A restriction endonuclease enzymatically cuts double- 
stranded DNA at a specific nucleotide recognition sequence. The fragments 
generated are then separated by size by agarose gel electrophoresis and 
visualised by staining the electrophoretic gel with ethidium bromide and 
viewing under ultraviolet (UV) light. Linhardt et al (1992) showed that PFGE 
is an important epidemiological tool with high discrimination power for 
S. aureus and coagulase-negative staphylococci. Typing of S. aureus is often 
required for the investigation of an outbreak or as part of ongoing surveillance, 
whereas typing of CoNS is often used to determine whether two or more 
strains from a patient represent contamination or infection. 
Since PFGE has been reputed to be highly discriminatory and effective at 
identifying related isolates, PFGE was used in this study to investigate whether 
wild type strains and their corresponding SCVs were isogenic (clonal). 
Isogenic strains should have the same DNA profiles. 
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3: 2 Materials and Methods 
3: 2: 1 Characterising Staphylococcal Strains by Pulsed Field Gel 
Electrophoresis (PFGE) 
PFGE is a DNA fingerprinting method for typing staphylococci and 
other bacteria. It is a variation of agarose gel electrophoresis in which the 
orientation of the electric field across the gel is changed periodically. This 
enables DNA fragments as large as megabases to be separated on the basis of 
size. The organisms under investigation are embedded in agarose plugs and the 
cell wall and the cellular proteins are digested enzymatically. The isolated 
genome is then digested in situ with selected restriction enzymes, such as Smal. 
The staphylococcal chromosome is about 2,800 KB, and when digested with 
Smal (recognition sequence CCCGGG), PFGE provides a profile of about 15- 
20 distinct and well-resolved fragments ranging from 10-800kb. 
The fourteen staphylococcal wild strains which produced stable SCVs 
(Table 2.4) were investigated with PFGE. The protocol used in this Chapter 
is based on the methods of Bannerman et al (1995) and Leonard et al (1995). 
The procedure was spread out through several days of preparations to assure a 
good electrophoresis result as described. The recipes for preparing the 
solutions are found in the Appendix 8: 1: 3. 
3: 2: 1 (A) Day One- Bacterial Culture Preparation 
Fourteen-staphylococcal wild strains were plated on TSA whereas their 
corresponding SCVs were generated as described in (Table 2.4) by plating on 
TSA plates supplemented with gentamicin and incubation overnight at 37°C. 
3: 2: 1(B) Day Two- Preparation of Cell/Agarose Blocks and Cell Lysis 
1. The colonies were resuspended in 5 mL Tris-EDTA buffer (TE) (pH 7.5) 
and the OD550 was adjusted to 1 
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2. Bacterial suspension (600µL) was transferred into a 1.5mL eppendorf and 
centrifuged at 13,000 rpm for 1 minute 
3. The supernatant was discarded and the pellet was resuspended and washed 3 
times in 3x500µL of TE buffer 
4. Following centrifugation at 3000 rpm for 5 minutes, the pellet was 
resuspended into 250µL TE and vortexed. The eppendorf was then placed on 
ice 
5. Low Melting Point (LMP) Agarose 2% wt/vol (Bio-Rad, Hemel Hempstead, 
UK) was dissolved in autoclaved de-ionised water in a 500mL conical flask 
6. The flask with the agarose was placed in the microwave oven and heated 
until the agarose particles were completely dissolved 
7. To prepare the plug moulds (Bio-Rad, Hemel Hempstead, UK), the bottoms 
were sealed with white tape 
The next steps were done one tube at a time 
8. Lysostaphin (lmg/mL) in distilled water (Sigma, Poole, UK) (10µL) was 
added to each eppendorf and very gently mixed (at this stage the eppendorfs 
were not vortexed to prevent the possible artefactual shear-damage of the 
DNA) 
9. Immediately, 250µL LMP agarose solution was added into the eppendorf. 
The contents were mixed gently and briefly by pipeting 
10. Immediately, the agarose/cell mixture was pipetted into the plug moulds 
(2 blocks were prepared per isolate) 
11. The moulds were kept on ice for 10-15 minutes 
12. For each isolate, 1 mL Lysis buffer was pre-warmed at 37°C and added to a 
fresh eppendorf 
13. The plugs were dispensed into the Lysis buffer 
14. The eppendorfs were incubated for 60 min at 37°C 
15. After incubation, 100µL Proteinase K (Sigma, Poole, UK) (10mg/mL) in 
distilled water was added to the eppendorfs and these were then inverted 
several times 
16. The eppendorfs were then incubated at 50°C overnight 
17. Standard reference S. aureus NCTC 8325 was used as a control 
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3: 2: 1(C) Day Three- Digestion of DNA with Restriction Enzyme 
1. The plugs were trimmed to produce 2mm x 3mm slices and placed in a 
1.5m1 eppendorf 
2. PMSF (200µL) (0.5 mg/mL) in TE (pH 8.0) was added for 30 min at 50°C 
3. The PMSF in TE was then aspirated carefully to ensure that the plugs were 
not damaged 
4. The plugs were washed 3 times in 200µL of ice cold TE (pH 8.0) buffer 
5. TE buffer was removed thoroughly from the eppendorfs 
6 The restriction enzyme (RE) Master Mix (Promega, Southampton, UK) stock 
was then prepared. RE Master Mix (100µL) was added to each eppendorf 
(sterile distilled water (85µL), Smal buffer xl0 concentration (10 pL), BSA 
(Bovine serum Albumin) (1µL), Smal (10 units/ µl) (4µL)) 
7. The eppendorfs were incubated at 30°C for 3 hours 
3: 2: 1 (D) Day Four- Preparation of Agarose Gel for 30 Well Gels 
1. The following components (distilled water, x10 Tris-Borate buffer (TBE) 
and PFGE grade agarose) were added to a 25OmL conical flask 
30 Well Gel Distilled Water X10 TBE PFGE Grade 
Agarose 
142.5 mL 7.5mL 1.5g 
2. Agarose was dissolved in a microwave oven at full power for 2 1/2 minutes. 
The flask was removed and swirled carefully and placed again in the 
microwave at full power for another 1 minute. The mixture was then placed in 
a water bath to cool to 50°C 
3. The agarose (50°C) was then poured into the gel mould and left to set for 30 
minutes 
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3: 2: 1 (E) PFGE 
1. Electrophoresis was performed using the CHEF-DRII Drive Module 
electrophoresis cell (Bio-Rad, Hemel Hempstead, UK). The device was set up 
according to the manufacturer's recommendations and instructions 
2.800mL of x 0.5 TBE buffer was poured in to the gel chamber. The Gel was 
placed onto the middle of the gel chamber and the digested plugs were treated 
at 52°C for 8 minutes before loading into wells. At this stage the wells were 
not covered with the buffer 
3. TBE buffer (800mL) was poured very gently to cover the gel then the lid 
was closed 
4. The apparatus was checked for correct assembly and the interlock cable was 
connected to the drive module to run the electrophoresis. The temperature was 
kept constant at 14°C by a cooler (Bio-Rad, Hemel Hempstead, UK) connected 
to the CHEF 
-DRII device 
5. The running parameters were as follows: 
1st Setting 2° Setting 
Run Time 10 Hours 13 Hours 
Initial Switch 5.0 Sec 15.0 Sec 
Final Switch 15.0 Sec 60.0 Sec 
Voltage 200 V 200 V 
3: 2: 1 (F) Day Five- Gel Staining and Image Storing 
1. On the fifth day, after the PFGE run had finished, the gel was transferred to 
a separate container and washed with distilled water at least once 
2. The gel was carefully transferred to a staining box and stained with ethidium 
bromide (1 mg/L in H2O) for 30 minutes. 
3. De-staining was performed in distilled water for 45 minutes 
4. The gel was viewed under a UV transilluminater, photographed and 
processed by imaging software VisionWorks 3.1 from ultra violet Products 
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(UVP Ltd, Cambridge, UK). A separate PFGE profile was generated for each 
strain. 
3: 2: 2 Staphylococcal Protein Profiles by Sodium Dodecyl Sulphate- 
Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Western Blot 
Analysis 
SDS-PAGE is an analytical and/or preparative electrophoresis of 
proteins that ensures dissociation of the proteins into polypeptide subunits. 
SDS and heat is used to denature and solubilise the proteins before they are 
loaded on the gel where SDS-polypeptide complexes migrate through 
polyacrylamide gels in accordance with the size of the polypeptide. The gel is 
composed of a stacking gel into which the sample is loaded and the resolving 
gel where the polypeptides are separated. 
In the current study, protein profiles were prepared as two sets: first, from 
whole cell preparations and second, from three cell fractions- cell wall, 
membrane and cytoplasmic. The two approaches were used to improve 
discrimination between the wild type strains and their corresponding SCVs. 
In the immuno-blotting analyses electrophoresed polypeptides were 
transferred onto nitrocellulose blots which were then blocked to reduce non- 
specific antibody interactions, and probed for immuno-reactivity in two stages: 
an incubation with an unlabelled (polyclonal) primary antisera followed by 
washing, and incubation with a secondary anti-immunoglobulin coupled to a 
detector enzyme activity, in this case horseradish peroxidase (HRP). 
After further washing, the colour was developed by the addition of H202 and 
the blots then photographed. The appearance of purple coloured bands is 
indicative of antibody reactivity. 
ECL (Amersham Biosciences, Buckinghamshire, UK) is a light emitting non- 
radioactive (luminescence) method for detection of immobilized antigens with 
(HRP) labelled antibodies. It is at least 10 times more sensitive than the 
colorimetric detection method, and is therefore useful in the detection of very 
lower quantities of proteins compared to colorimetric systems. 
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3: 2: 2 (A) Whole Cell Preparation 
The method used for protein profile assessment was based on protocols 
used by other researchers (Cheung and Fischetti, 1988; Smith et al., 1991; 
Modun et al., 1994). SDS-PAGE was performed in 11% resolving 
polyacrylamide gels and 4% Stacking gels, as described previously (Sambrook, 
1989). The compositions of the solutions used are found in the Appendix 
8: 1: 1. 
Bacterial suspension (10 mL) in PBS was prepared from colonies grown on 
TSA plates for wild type strains and TSA with gentamicin for SCVs (Table 
2.4). The suspensions had a turbidity of 0.4-0.5 at 550 nm. This start point 
was repeated for whole cell preparation or for cell fractionating. The protocol 
used was as described below: 
1. The 10-ml, bacterial suspension was centrifuged at 13,000xg for 5 minutes 
2. The pellet of bacteria was suspended in lmL PBS and transferred to an 
eppendorf 
3. The suspension was further centrifuged at 13,000xg for 5 minutes 
4. The supernatant was then removed and 350 µL of (80pg/mL lysostaphin 
(Sigma, Poole, UK) and lmg/mL benzamidine (Sigma, Poole, UK) in PBS was 
added to the pellet and tubes vortexed to resuspend the cells 
5. The cell suspension was then incubated for 15-30 minutes at 37°C in a water 
bath 
6.350 µL of 2xSDS PAGE sample buffer was added to the suspension 
7. The eppendorfs were boiled for 5 minutes 
8. The gelatinous suspensions were sonicated for 15 sec with a fine sonicater 
probe 
9. The eppendorfs were finally centrifuged at 13,000xg for 5 minutes to pellet 
any unlysed cells and cell debris 
10.15 pL of the supernatant was loaded per lane of an 11 % SDS-PAGE mini 
gel 
11. Molecular size standards-(prestained protein markers) (Bio-Rad, Hemel 
Hempstead, UK) were run concurrently in parallel wells 
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3: 2: 2 (B) Cell Wall, Membrane and Cytoplasmic Proteins Preparations 
1. To dry cell pellets prepared as described above was added 500µL of the 
following cell wall digestion mixture (80µg/mL lysostaphin, 1 mg/mL 
benzamidine and 0.5 mg/mL PMSF and 30% w/v raffinose in PBS. 
The raffinose was employed as a hypertonic medium to osmotically stabilize 
the protoplasts that are formed during lysostaphin digestion. 
2. The eppendorfs were vortexed to resuspend the cells in the digestion buffer 
and incubated for 15 minutes at 37°C 
3. The suspensions were centrifuged at 13,000xg for 5 minutes 
4. The supernatants containing wall proteins were removed and the pellets 
containing protoplasts were used for further fractionation 
5. To prepare membrane proteins, 500µL PBS was added to protoplast pellets 
and the eppendorfs were cooled on ice for 10 minutes 
6. Protoplast suspensions were then sonicated for 15 second with a fine 
sonicater probe to lyse protoplasts. After sonication, the eppendorfs were 
centrifuged for 10 minutes at 13,000xg 
7. The supernatants containing the cytoplasmic proteins were removed and 
retained. The pellets contained the membrane protein fraction 
8. For SDS PAGE, 500µL of 2xSDS-sample buffer was added to wall or 
cytoplasmic protein preparations. Suspensions were boiled for 5 minutes and 
centrifuged at 13,000xg for 5 minutes 
9. For the membrane protein preparations, 200µL of 1xSDS sample buffer was 
added to the membrane pellet which was boiled for 5 minutes and centrifuged 
at 13,000xg for 5 minutes 
10.15µL of each of the preparations was loaded per lane of an 11% SDS- 
PAGE mini gel 
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3: 2: 2 (C) Electrophoresis and protein visualisation 
The BioRad Mini-Protein II electrophoresis gel system was used for 
electrophoresis of gels. The equipment was assembled, the gels cast and the 
chambers prepared as described in the BioRad instruction manual. The gels 
consisted of an 11% separating gel and 4% stacking gel. A current of 30 mA 
(per mini gel) was applied and the gel was run in a BioRad tank in SDS- 
PAGE electrophoresis buffer (Appendix 8: 1: 1) for about 60 minutes. 
Gels were prepared in duplicate; one was stained and used for visualisation of 
proteins and the other one was used for immunoblotting. Gels that were to be 
stained were washed after electrophoresis three times in PBS for 5 minutes and 
then transferred into a container for staining as described below. 
3: 2: 2 (D) Staining and Destaining the Gels for SDS-PAGE 
Simple Blue T" Safe Stain (Invitrogen, Paisley, UK) was used to stain 
the gels. Gels were covered with the stain (20-mL) for one hour at room 
temperature and with gentle shaking. To destain, the gel was washed with 
water (100 mL) for a minimum of one hour. The gel was then photographed, 
and processed by imaging software VisionWorks 3.1 from ultra violet Products 
(UVP Ltd, Cambridge, UK). The data is presented in Table 3.1 and Figure 3.2. 
3: 2: 2 (E) Transfer of Proteins from SDS-Polyacrylamide Gels to 
Nitrocellulose Filters for Western Blotting Analysis 
1. When handling the gels, gloves were worn to avoid oil from the skin that 
could prevent the transfer of proteins from the gel to the filter and to avoid 
contamination of blots with skin proteins 
2. Two pieces of blotting paper and one piece of nitrocellulose filter (Sigma, 
Poole, UK) were cut to the exact size of the SDS-polyacrylamide gel 
3. The nitrocellulose filter and the blotting papers were allowed to wet from 
beneath by capillary action in the transfer buffer. Then, they were submerged 
in the buffer for at least 5 minutes to displace trapped air bubbles 
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4. The horizontal transfer blotting apparatus (BioRad Transblot system, Hemel 
Hempstead, UK) was set up as follows: the blotting paper was laid to the 
bottom electrode sheet, and the nitrocellulose placed on the blotting paper. The 
SDS-PAGE gel was then placed exactly on the top of the nitrocellulose filter. 
Trapped air bubbles were squeezed out gently with a gloved hand gently. The 
last sheet of blotting paper was placed on the top of the gel. Finally to get rid 
of any air bubbles which could be trapped between gel and membrane, a glass 
pipette was used as a roller over the gel-membrane sandwich 
5. The upper electrode sheet was then placed on the top of the stack. The 
electrical leads were connected. The transfer was carried out at 14V for 20 
minutes. After the electrophoresis the blots were briefly rinsed in PBS, and 
blocked prior to immun probing as described below. 
3: 2: 2 (F) Immuno Probing of Blotted Staphylococcal Proteins: 
Colorimetric-Secondary Antibody Detection Systyem 
1. Nitrocellulose blots of staphylococcal proteins were blocked for 3 hours in 
blocking buffer, washed 3 times for 5 minutes in PBS, and incubated at room 
temperature with rabbit S. epidermidis antiserum (Eurogentec, Seraing, 
Belgium), diluted 1: 100 in blocking buffer (0.1 mL of skimmed milk solution 
per cm2 of filter) 
2. After the primary antibody incubation the membranes were washed three 
times for 10 minutes with PBS and probed with horseradish peroxidase- 
conjugated goat anti-rabbit (HRP-GAR) diluted 1: 2000 in blocking buffer and 
incubated at room temperature for three hours 
3. To visualise immuno-reactive proteins, the membranes were washed with 
PBS three times for 10 minutes and transferred to a shallow tray to which was 
added the HRP substrate chromogen 4-chloro-l-naphthol (Sigma, Poole, UK). 
The substrate (3mg) was dissolved in 10 mL PBS. H202 (10 µL of 30% vol/vol 
in H20) was added and mixed and used immediately upon the membranes (0.1 
mL of the substrate solution per square centimetre of filter) 
4. The progress of the reaction was monitored visually. After 2-3 minutes the 
polypeptides had usually reached the desired intensity. To stop the reaction, 
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the membranes were washed briefly in water and then transferred to a container 
containing PBS 
5. The developed membranes were then dried and scanned for a permanent 
record of the experiment. Data is presented in Table 2.2 and Figure 3.3. 
3: 2: 2 (G) Enhanced Chemiluminescent (ECL) Antibody Detection System 
ECL is as a method of visualising immuno-reactive proteins on 
membrane blots (Amersham International, Pharmacia Biotech, 
Buckinghamshire, UK) ideally suited to the detection of lower quantities of 
proteins that could not be detected by colorimetric methods. 
The difference between the colorimetric and ECL detection system is in the 
way of detecting the secondary antibodies. In chemiluminescence the 
excitation is effected by a chemical reaction. HRP/Hydrogen Peroxide catalyse 
the oxidation of cyclic diacylhydrazides (luminol). ECL is achieved in the 
presence of chemical enhancers such as phenols. The light emission at 
wavelength of 428 nm is detected by a short exposure to blue-light sensitive 
film (Hyperfilm ECL, Amersham /Pharmacia Biotech). 
1. An equal volume of detection solution (1) was mixed with detection solution 
(2). The final volume required is 0.125-mL/cm2 membrane. The membrane 
and the detection solution were incubated for 1 minute at room temperature 
2. Excess detection reagent was then drained off. The nitrocellulose membrane 
with protein side down was put between two transparency sheets (5 Star, UK) 
3. This stage was carried out in a dark room using red safelights. A sheet of 
autoradiography film was placed on the top of the wrapped blots with protein 
side up 
4. The wrapped blots with the film were placed in an x-ray film cassette and 
closed for 15 seconds 
5. The film was removed from the box and immersed in the developer 
(Universal Developer) (Ilford Imaging UK Ltd, Cheshire, UK) tank for 3 
minutes followed by a rinse in a water tank for 30 seconds and finally the film 
was transferred into a fixer (HYPAM) (Ilford Imaging UK Ltd, Cheshire, UK) 
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tank for about 3 minutes. The film was then given a wash in a water tank for 
about 30 seconds 
6. The film was left to dry and subsequently scanned for a record. Data was 
presented in Table 2.3. 
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3: 3 Results 
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FIG 3-1: Pulsed field gel electrophoresis of'Srnai cleaved genoroic DNA of 
three different wild (W) staphylococcal strains and SCVs (S) 
Representative 1 FGE profiles are demonstrated in Figure 3.1 for three different 
staphylococcal strains (S. aureus 11, S. epidermidis 25, S. haeºno/t'tirus 16) 
along with their corresponding SCVs. NC'I'C 8325 is a S. aureus control strain 
shown on the right and left side of the gel. Comparing the DNA profiles I'or 
the wild strains and SCV strains showed that there was essentially no 
difference within the same species, although different species showed difTerent 
DNA profiles. The genomic profiles of cleaved Smal DNA investigated by 
PFGE suggest that the wild strains and their SCVs are isogenic derived from 
the same origin and there is no obvious DNA alterations detected. 
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FIG 3-2: SUS-PAGE of wild type and SCVs whole cell preparation and cell 
fractions. 
Pre-stained protein marker (I and 10), wild whole cell prep (2), S('Vs whole cell prep(3), wild cell 
wall fraction (4), SCVs cell wall fraction (5), wild membrane fraction(6), SCVs membrane fraction 
(7), wild cytoplasmic fraction (8), SCVs cytoplasmic fraction (9) 
Figure 3.2 is a representative gel showing SDS-PAGE: analysis of 
S. epidermidis 7 (wild type and SCV) whole cell and cellular protein fractions 
with at least two additional proteins of 83 kDa in SCVs in whole and cell wall 
protein factions and 34 kDa in the cytoplasmic fraction (indicated by arrows). 
SDS-PAGE profiles for all the staphylococcal SCV strains analysed usually 
revealed extra or missing polypeptides when compared with the equivalent 
protein fraction obtained from their wild type parent. The molecular weights 
of the most prominent extra or missing proteins in SCVs when compared to 
their wild parental strains are presented in Table 3.1 below. 
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Table 3-1: Differences in protein SDS-PAGE expression profiles between 
staphylococcal wild type and SCV strains 
Strains Whole 
Preparation 
Cell Wall 
Fraction 
Cell 
Membrane 
Fraction I 
Cytoplasm 
Fraction 
SE 3 +83, 
-6 0 +83 -60, -45 
SE 4 +77 +83, +60 
SE 7 +83 +83 +34 
SE 8 +77 +77 
SA 11 +83 +83 
SE 13 +83, 
-6 7 +83 
SE 16 +83 +83 
-85 
SH 18 +83, +34 +83 +34 
SA 21 
-77 I 
-ý 
-77 
SE 23 +60 +60 
SE 25 +83 +83 
SE 26 +60 +60 
SA 27 
-45 -45 
SE 28 +83 +83 ý 
_ý 
- 
=Polypeptide missing from SCV; += Extra polypeptide present in SCV; SE=& epidermidis, 
SAS aureus, SH=S haemolyticus 
Table 3.1 summarises the approximate molecular weights of polypeptides 
separated by SDS-PAGE as a comparison between SCVs and wild type strains. 
Proteins were separated from whole cell preparations, cell wall, cell membrane 
and cytoplasmic fractions to screen for any differences in protein expression 
which could be related to the SCV phenotype generated by exposure to 
gentamicin. A protein present in whole cell preps and cell wall fractions of 
around 83 kDa was detected in 9 SCV strains. Cell membrane protein profiles 
were similar in wild type and SCVs; however, proteins of 85,77,60 and 45 
kDa were missing from cytoplasmic fractions in some SCV strains. 
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Although these are preliminary analyses, the data from the above experiments 
indicates that the protein profiles of SCVs generated by exposure to gentamicin 
differ in a number of proteins compared to wild strains. Further studies could 
be directed to separate and identify these proteins in order to study their 
possible relation to known virulence factors or components of metabolic 
pathways. This could contribute to a much more complete understanding the 
pathogenic role of SCVs in BRI. 
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FIG 3-3: Antibody reactivity of Western blots of whole cell preparations for 
different SCV and wild type strains using a colorimetric detection method. 
All strains above are S. epidermidis, except 27 which is S. aureus. Wild (W), SCVs (S) 
Figure 3.3 is a representative western blot showing four different 
staphylococcal strains. The whole cell protein preparations for S. epidermidis 
strains 25,26 and 28 and S. aureus 27 wild and SCVs are shown. The 
molecular weights of the immuno-reactive staphylococcal proteins were 
estimated by referring to pre-stained protein markers. In the figure protein 
bands which are missing from SCVs are indicated by lines. The molecular 
weights of missing or additional proteins in the fourteen SCVs generated by 
gentamicin exposure (Table 2.4) compared to their wild strains are presented in 
Table 3.2 below. 
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Table 3-2: Differences in immuno-reactive protein expression profiles 
between staphylococcal wild type and SCV strains 
Strains Whole 
Preparation 
Cell Wall 
Fraction 
Cell 
Membrane 
Fraction 
Cytoplasm 
Fraction 
SE 3 
-36 1 -51 
SE 4 
-51 
SE 7 
-60 
SE 8 
-40 -40 
SA 11 
-77, -48 
-40 
SE 13 
-40 
SE 16 
-60 -40 
SH 18 
-32 -77 -32 
SA 21 
J -60 
SE 23 j 
-60 
SE 25 40, 
-60, -80 
-77 I 
-60, -40 
SE 26 
-51 -45 
SA 27 
-51 -40, -54 
SE 28 
-40 -48 
=Polypeptide missing from SCV; +=Extra polypeptide present in SCV; SEA epidernudis, 
SAS aureus, SHE haemolylicus 
Table 3.2 summarises the approximate molecular weights of differentially 
expressed SCV immuno-reactive proteins compared with their wild type 
parents. The data obtained above was obtained using two detection methods: 
colorimetric and ECL. Data obtained by the two detection methods were 
generally similar, though the ECL technique generally produced less 
background on the blots. 
Proteins of different molecular weights were missing in all cell fractions from 
SCV strains and the whole cell preparations, though the precise molecular 
weight of the missing immuno-reactive proteins differed considerably between 
strains. For instance, proteins of 51 and 40 kDa were missing from 
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the whole cell preparations of SE strains 26 and 27, but not as far as could be 
determined from corresponding protein fractions of the other SCVs. Immuno- 
reactive proteins of 77,60 and 36 kDa were found missing in SCVs cell wall 
fractions of SE 3 and 13 and SH 18. Membrane proteins of 77,60,54,51,48 
and 40 kDa and the cytoplasimic fractions polypeptides of 60,40 and 32 kDa 
were found missing from some SCVs, but not from all. 
Considered collectively, the data in Table 3.2 suggests that SCVs may be less 
immunogenic when compared to their wild type parents. This may have 
implications for the prolonged survival of SCVs in the host and their 
contribution to BRI. 
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3: 4 Discussion and Conclusions 
The genetic profiles of the fourteen SCVs were compared by PFGE and 
all produced restriction patterns which were found to be similar to their wild 
parental strains (Figure 3.1). This indicates that SCVs are subpopulations and 
not contaminants even though differences in virulence factor expression 
between wild and SCV strains were detected in Chapter two. This supports the 
belief that SCVs are phenotypic but not genotypic variants. 
PFGE was followed by SDS-PAGE to detect any phenotypic changes as 
identified by protein profiles. There were marked differences in protein 
expression profiles between SCVs and their wild type parents. Some SCVs 
were found to express additional polypeptides when compared with parental 
strains. For instance, proteins of approximately 83,77,60 and 34 KDa were 
present in SCV whole cell and cell wall preparations, which were not present in 
similar protein fractions from wild type strains, though as mentioned, increases 
in expression of these proteins were not seen in all SCVs. The protein whose 
expression showed a most consistent increase was the 83 kDa cell wall 
associated protein and whole cell preparations whose expression was 
induced/increased in 9/14 of the SCV strains tested (S. epidermidis [strains 3, 
4,7,13,18,25, and 28], S. aureus [strain 11 ], and S. haemolyticus [strain 16]) 
(Table 3.1). However, polypeptides of 77,67,60 and 45 kDa were missing in 
the whole cell preparations as well as in the cytoplasmic fractions in some of 
the SCVs. The cell membrane fractions did not show any obvious differences 
between SCVs and their corresponding wild strains (Table 3.1). 
One can often characterize the SDS-PAGE profile of a protein sample based 
on information already known about the biological system that is being studied. 
A survey of the recent literature investigating staphylococcal SCVs indicates 
that nothing has been published about phenotypic properties investigated by 
SDS-PAGE comparing wild and SCVs strains. This current study is therefore 
probably the first to recognise some of the differences which might help to not 
only identify SCVs, but also to provide some guidance as to future systematic 
and detailed study of this class of organisms. Due to time and resources 
restrictions it was impossible in the current project to perform any further 
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experimental work to identify the proteins whose expression is modulated in 
the SCV morphological state. However, this is a very promising area for future 
study. Those SCV polypeptides whose expression is up or down regulated 
could be purified and then sequenced. Once the protein is identified, there are 
many techniques which could be used to characterise the role of the gene 
concerned in SCV physiology, and BRI generally (e. g. mutagenesis, over 
expression, reporter-fusion etc). 
A similar study to that described in this Chapter was performed on 
P. aeruginosa SCVs generated by gentamicin exposure (Langford et al., 1989). 
Langford and his colleagues (1989) found that gentamicin induced the 
expression of an outer membrane protease of 34 kDa in SCVs with increased 
protease activity when compared to the wild type strain. This might tempt us 
to think that the staphylococcal SCV proteins identified in the current study as 
being increased in expression relative to wild type, could similarly be virulence 
factors. 
The initial SDS-PAGE protein profile characterization provided a basis for 
western blotting and immuno-analyses using anti-staphylococcal antisera to be 
undertaken. Usually, western blotting and antibody reactivity is used to 
identify the expressed known proteins by challenging the SDS-PAGE profiles 
with sera raised against known antigens. However, that was not the case in this 
study in view of the fact that there was no information about the identity of any 
polypeptide separated. Polyclonal S. epidermidis anti-serum was used in this 
study for this reason. Western blotting results showed a high number of 
polypeptides in the SCV cell membrane preparations to be missing (77,60,54 
and 40 kDa). Proteins of approximately 60,40 and 32 kDa were also found to 
be missing in some SCVs in the cytoplasmic fractions. However, analysis of 
antibody reactivity of blots of whole cell preparations and cell wall fractions 
showed proteins of 77,60,40 and 32 kDa to be absent in several SCVs (Table 
3.2). 
Based on results shown in Table 3.2, it seems that SCVs protein preparations 
are considerably less immunogenic when compared to their wild parental 
strains, particularly with regard to cell surface associated antigens. It can 
easily be imagined that suppressing the immunogenecity of cell surface 
associated protein antigens could be in the SCVs favour by eliciting a less 
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aggressive reaction by the immune system. That could be an important factor 
in the BRI pathogenesis due to SCVs as it may contribute to their persistence 
by affecting the efficacy of clearance by phagocytic cells, thereby leading to 
the chronicity found in BRI. 
Chapter Four 
Staphylococcal Adhesion Assessment by Chemiluminescence Assay 
120 
4: 1 Introduction 
Bacterial biofilms have long been recognised as a common source of 
persistent and relapsing infections (Ziebuhr et al., 2000). Biofilm formation 
appears to be a widespread attribute of bacteria and may allow increased survival 
ability under stressful conditions such as low nutrients or exposure to 
antimicrobials (Costerton et al., 1995, Mah and O'Toole, 2001) 
Biofilm formation plays an important role in the pathogenesis of staphylococcal 
infection. This is particularly true for Staphylococcus epidermidis. Indeed, there is 
an almost direct correlation between the emergence of S. epidermidis as a pathogen 
and its capacity to colonize indwelling medical devices (young and Otto, 2002). 
However, S. aureus is also capable of forming a biofilm, and this presumably 
contributes to its ability to cause at least some forms of infection such as those 
associated with cystic fibrosis. 
The genetic and molecular basis of biofilm formation in staphylococci is 
multifaceted. Two properties at least are responsible for biofilm formation: 
the adherence of cells to a surface and accumulation to form multilayered cell 
clusters. No single mechanism has ever been identified as being solely responsible 
for the adhesion of microbial strains to surfaces (Busscher et al., 1992; Van der 
Mei et al., 1997). 
S. aureus and S. epidermidis often elaborate adherent biofilms which contain 
the capsular polysaccharide-adhesin (PS/A) that mediates the initial cell adherence 
to biomaterials. PS/A has been identified to be important in staphylococcal 
colonization of catheters (Kojima et al., 1990). Biofilm cells produce another 
antigen, termed polysaccharide intercellular adhesion (PIA). PIA has been found 
to act as an adhesin on glass and probably other hydrophilic surfaces (Götz, 2002). 
PIA and PS/A are closely related chemically and immunologically and both are 
synthesized by the ica locus (Gerke et al., 1998; McKenney et al., 1999). PIA had 
been proposed to be functionally distinct from PS/A, with PS/A mediating the 
initial adherence to solid surfaces and PIA mediating the accumulation of cells into 
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biofilms (Mack et al., 1994; Mack et al., 1996). These extracellular 
polysaccharides which mediate adherence to implants and bacterial colonization 
were collectively named slime by Arciola and her colleagues (Aricola et al., 
2003). 
Proteins have been identified that are also involved in biofilm formation, such 
as the accumulation-associated protein (AAP), the clumping factor A (CIfA), 
the staphylococcal surface protein (SSPI) and the biofilm-associated protein (Bap) 
(Götz, 2002). At1E is another protein which binds strongly to vitronectin and is 
involved in binding to plastics (Heilmann et al., 1997). Teichoic acid is another 
substance produced by staphylococci which affects the charge of the cell surface 
which may contribute to the highly viscous appearance of the colonies and strong 
biofilm formation (Götz, 2002). 
Whole plasma and some isolated plasma proteins were found to influence 
bacterial adherence to tested materials (Zdanowski et al., 1993; Keogh and Eaton, 
1994). Hussain et al (2001) have shown that when host plasma proteins are 
deposited on the implanted device, S. epidermidis bind to fibronectin, an 
observation which might play a role in S. epidermidis BRI pathogenicity. From a 
clinical point of view, bacterial binding to plasma-coated rather than non-coated 
materials may more adequately reflect the in-vivo colonization of various materials 
(Zdanowski et al., 1993). 
Much attention has been paid towards evaluating the prevalence of 
polysaccharide production among bacterial strains in an attempt to assess the role 
of polysaccharide production in the pathogenesis of BRI. Colony appearance on 
Congo red agar plates represents a reference method most often used to 
phenotypically detect slime (exopolysaccharide) production for S. epidermidis 
(Arciola et al., 2001; Heilmann and Götz, 1998). However, nowadays more 
reliable techniques have been introduced which are able to specifically identify the 
genes necessary for polysaccharide production, such as ica. In addition, anti- 
exopolysaccharide immunofluorescence is another way to detect polysaccharide 
production (Lyte et al., 2003). 
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Quantitation of microbes adhering to a surface by measuring bacterial ATP 
(adenosine triphosphate) by chemiluminescence is commonly used in studies of 
microbial adhesion to different surfaces. The method is a sensitive tool to quantify 
adherent bacteria during experiments lasting for less than 6 hours and constitutes a 
valuable method to be used in conjunction with various microscopical techniques 
(Stollenwerk et al., 1998). The number of attached bacterial cells is determined by 
measuring the light emission resulting from the reaction between firefly luciferase 
and ATP present in adhered staphylococcal cells. The chemiluminescence assay 
developed has been found to be a relatively rapid alternative method to enumerate 
bacterial cells (Sunderland et al., 1995). 
In this Chapter, the experiments were designed to compare the initial adhesion 
of staphylococcal wild strains and their related SCVs to untreated (plain) plates 
(microtitre 96 well plates) and to human plasma-coated plates. The assessment of 
adhesion by chemiluminescence could contribute to a more complete 
understanding of the initial steps of the pathogenesis of persistent and recurrent 
infections due to bacterial strains with abilities to form biofilms. The ability to 
form a biofilm on the surface of a prosthetic device is probably a significant 
determinant of virulence for these bacteria. 
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4: 2 Materials and Methods 
4: 2: 1 Using Congo Red to Study Phenotypic Variation of Staphylococcal 
Strains 
S. aureus (n=2) and CoNS (S. epidermidis (n=ll) and S. haemolyticus 
(n=1)) wild type strains along with SCVs were initially classified for in-vitro 
polysaccharide production by examining their colonial morphology on Congo red 
agar (CRA). 
CRA was prepared by adding 0.8 g of Congo red (Sigma, Poole, UK) and 36 g of 
sucrose (Sigma, Poole, UK) per litre of MHA (Zeibuhr et al., 1997). The mixture 
was poured in to sterile plates and left to solidify and dry at room temperature. 
A portion of a wild strain colony or SCV was plated out on CR plates and 
incubated for 24 hours at 37°C and subsequently overnight at room temperature. 
In the present study, the original CRA test was optimised adopting a three-colour 
reference scale for a fine classification of colony colour (Arciola et al., 2002). 
The three-colour tones of the scale were as follows: black which was considered as 
a positive result (Figure 4.2), and bordeaux or red interpreted as negative 
(Figure 4.1). Results are presented in Table 4.1. 
4: 2: 2 Adhesion Assay Protocol of Staphylococcal Strains to Plasma Coated 
and Plain Plates 
The chemiluminescence assay of ATP requires the use of analytical 
equipment which measures light emission in an automatic microplate 
Luminometer (Microlumat plus, LB 97V, version 2.0, Berthold technologies Ltd, 
Herfordshire, UK). WINGLOW MS Windows was used as a PC software package 
for analysing the data and automatic transfer and evaluation of measured data was 
processed in Microsoft Excel. The ViaLight MDA (Microbial Detection Assay) 
(LumiTech Ltd, Nottingham, UK) Kit was used for these assays, which were 
carried out in opaque white 96-well microtitre trays with transparent bottoms 
(Berthold Technologies Ltd, Hertfordshire, UK). 
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The light emitted was measured by the luminometer and the results were 
expressed as relative light units (RLU). RLU readings derived from ATP content 
of cells can therefore be used as an indirect measure of the viable cell numbers 
present in the culture sample. The method used is described below. 
1. One colony of wild type strains from TSA plates was inoculated into MHB and 
shaken for 4 hours at 37°C until early-mid log phase was reached. However, five 
colonies of SCVs from TSA/gentamicin plates were inoculated to 
MHB/gentamicin and shaken for 7 hours on a rocker at 37°C to reach a similar 
turbidity since SCVs are slow growing organisms. The suspensions were then 
centrifuged at 3000rpm for 5 minutes and pellets resuspended in 1/10`h strength 
MHB and adjusted to OD (0.7-0.8) at A550 
2. To study the effect of plasma (as a conditioning film) on the adherence of 
staphylococcal strains, 25µL of 50% human plasma (Blood Bank, City Hospital, 
Nottingham-UK) (diluted in water) was transferred into each well of the microtitre 
plate and incubated for one hour at 37°C. At the end of the incubation time, the 
plasma was pipetted out and wells were washed gently three times with distilled 
water to remove unbound plasma proteins. A second set of plates was left 
untreated as a control 
3. Bacterial solution (125µL) was transferred into triplicate wells in the flat- 
bottomed, 96 well microtitre tray, and incubated for 5 minutes at 37°C 
4. The wells were then washed gently with distilled water three times 
5. To obtain a reading for ATP content of the total number of bacteria in the 
suspension, 125µL of each strain was also added to appropriate control wells 
6. Distilled water (125µL) was placed into 2 wells of the plate as a reagent control 
7. Bactolyse (1251iL) was added to all wells and the plates incubated for 10 
minutes at room temperature, and then transferred to the luminometer 
8. ATP monitoring reagent, 25 µL was added automatically to each well 
9. Data were saved in Excel where they were represented in clustered columns, 
which allowed the comparison between experimental categories 
10. The data were represented as % adhesion as the following 
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(RLU of adhered/RLU of total bacterial count obtained in step 5) x 100 
11. For each strain the experiment was done on two occasions in triplicate 
12. Statistical analysis of the data was performed using t-test where the confidence 
level is 95%. Differences were considered significant when t-test P<0.05. Each 
point presented means of groups ± SD. The data for these experiments are found 
in Figures 4.3- 4.5. 
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4: 3 Results 
4: 3: 1 Polysaccharide production assessed by Congo red agar 
Examples of the phenotype of exopolysaccharide-positive and negative 
CoNS colonies as detected by growth on Congo red agar are shown below. 
FIG 4-1: Congo red agar plate showing S. epidermidis 
(SE 28) wild type with red colonies indicating lack of 
exopolysaccharide production by the strain 
Incubation of S. epidermidis (SE 28) wild type on Congo red agar plate for 24 
hours at 37°C followed by 24 h at room temperature yielded red coloured colonies 
indicating lack of exopolysaccharide production by this strain (Figure 4.1). 
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FIG 4-2: Congo red agar plate showing exopolysaccharide non- 
producer S. epidermidis (SE 28) wild type (red colonies) and 
exopolysaccha ride producer SCVs (black colonies). 
In contrast, incubation of S. epidermidis 28 SCVs on Congo red agar produced 
mainly black, exopolysaccharide producer colonies (Figure 4.2). Red colonies on 
these plates were non-exopolysaccharide producing revertants. 
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Table 4-1: Three-colour reference scale for classification of staphylococcal 
colony colour on CRA for identification of exopolysaccharide-producing 
strains 
Strain Wild Strain SCVs 
-I 
1 
Interpretation 
SE 3 (+) Black (+) Black - Both are producers 
SE 4 Red (-) Red Both are non- producers 
SE 7 (+) Black (+) Black Both are producers 
SE 8 (-) Red (-) Red 
I 
Both are non-producers 
SA 11 (+) Black (+) Black Both are producers 
SE 13 (-) Red (-) Red Both are non-producers 
SE 16 (-) Red (-) Bordeaux Both are non-producers 
SH 18 (+) Black (+) Black Both are producers 
SE 21 (-) Bordeaux (+) Black Wild type is non-producer 
while SCV is producer 
SE 23 (-) Red (-) Bordeaux Both are non-producers 
SE 25 (-) Bordeaux (+) Black Wild type is non-producer 
while SCV is producer 
SE 26 (-) Red (-) Bordeaux Both are non-producers 
SA 27 (+)Black (+) Black 
ý- 
Both are producers 
1 
SE 28 (-) Bordeaux (+) Black Wild type is non-producer 
while SCV is producer 
SE= S epidermidis, SA= S aureus, SH= S haemolyticus 
Table 4.1 summarises the colony colour of different staphylococcal strains 
plated on Congo red agar plates. The appearance of black colonies was considered 
to indicate an exopolysaccharide-producer strain, however, production of bordeaux 
or red coloured colonies was considered to indicate exopolysaccharide non 
production. The results from analysis of three SCV strains and their wild type 
parents showed that exopolysaccharide production in SCVs is a phenotypic 
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variation, which corresponded with the appearance of SCVs. Three S. epidermidis 
strains 21,25 and 28 showed bordeaux colony colour for wild type strains, which 
classified them as exopolysaccharide non-producers and black colony colour for 
their equivalent SCVs, classifying the latter as being positive for 
exopolysaccharide production. Other staphylococcal strains did not show any 
colour differences between wild type and SCV. 
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4: 3: 2 Adherence Assays Measured by ATP Chemiluminescence 
Results of adherence assays are presented in Figure 4.3 which shows 
adherence of wild type strains and their related SCVs to plasma-treated and un- 
treated control (plain) plastic plates. Data are presented as the means for three 
groups of strains. 
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FIG 4-3: Adherence of Staphylococcal wild and SCVs to plasma coated 
and plain wells. 
WICR+and S/CR+(1) are strains (3,7,11,18,27) 
W/CR-(I) and S/CR- are strains (4,8,13,16,23,26) 
W/CR-(2) and S/CR+(2) are strains (21,25,28) 
Figure 4.3 summarizes the adherence of wild strains and corresponding SCVs to 
plasma-treated and plain wells. Congo red (CR) positive S. epidermidis SCVs 
3 and 7, S. haemolyticus 18 and S. aureus 11 and 27 showed a significant increase 
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in adherence to plain wells when compared to their corresponding wild type 
parents (la and lb). However, wild type strains showed a significant increase in 
adherence to plasma-treated wells when compared to their corresponding SCVs 
(2a and 2b). 
CR negative S. epidermidis 4,8,13,16,23, and 26 SCV strains showed a 
significant increase in adherence to plain wells when compared to their 
corresponding wild strains (3a and 3b). However, the wild type strains showed a 
significant increase in the adherence to plasma coated wells when compared to 
their related SCVs (4a and 4b). 
S. epidermidis strains 21,25 and 28 showed phenotypic variation in 
exopolysaccharide production associated with entry into the SCV state. 
Wild type strains were CR negative, while their related SCVs were CR positive. 
These strains are shown separately in Figure 4.3 since they behaved differently 
compared to other wild strains studied in this project. Generally, SCVs strains 
showed a significant increase in adherence to both plasma-treated and plain wells 
when compared to their corresponding wild type strains (5a, b and 6a, b). 
This could indicate that exopolysaccharide production may enhance the adherence 
of SCVs to both plasma-treated and plain plastic surfaces, and that might be an 
important feature in the pathogenic role SCVs have in BRI. 
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4: 4 Discussion and Conclusions 
Surface components of staphylococcal cells are important in promoting 
adherence to plastic surfaces. Surface components involved in binding include 
exopolysaccharides, teichoic acids and surface attachment proteins (Götz, 2002). 
The data presented in this Chapter investigated the possible effect of variations in 
exopolysaccharide production on adherence of staphylococcal wild type and SCV 
strains to a plastic surface. The influence of the presence of a conditioning film 
(plasma products) on the adherence was also investigated. 
Assessment of the presence of exopolysaccharide was achieved by the CRA 
method using the colorimetric scale according to Arciola et al (2001). 
Although there are more accurate methods to assess exopolysaccharide production, 
CRA was used for its simplicity and reliability. Although, there is currently no 
published explanation of the mechanism by which growth on Congo red agar 
permits detection of exopolysaccharide, one possibility is that adsorption of Congo 
red to some residue(s) in exopolysaccharide products could elicit the reaction 
which leads to a black colouration, or the reaction is solely pH dependent where 
certain substances in the exopolysaccharide could change the pH and subsequently 
change the colour indirectly, so differentiating the exopolysaccharide producers 
from non exopolysaccharide producers. 
The appearance of either red or bordeaux colonies on Congo red agar plates was 
considered to indicate exopolysaccharide non producers (Figure 4.1). 
However, black colonies were considered as exopolysaccharide producers (Figure 
4.2). Plating the fourteen wild strains along with their corresponding SCVs (Table 
2.4) on Congo red agar plates resulted in differences in Congo red dye adherence 
to these colonies allowing discrimination between exopolysaccharide producer and 
non-producer strains (Table 4.1). 
S. epidermidis 3 and 7, S. haemolyticus 18 and S. aureus 11,27 were CR 
positive along with their related SCVs. However, S. epidermidis 4,8,13,16,23 
and 26 were CR negative along with their corresponding SCVs (Table 4.1). 
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There was a third category which represented by S. epidermidis strains 21,25 
and 28 in which the wild type strains were CR negative but their corresponding 
SCVs were CR positive (Table 4.1), suggesting that for these SCV strains 
exopolysaccharide production was a phenotypic variation. 
Adherence studies were carried out using the chemiluminescence assay for ATP 
levels manufactured by ViaLight TM MDA (Microbial Detection Assay) 
(LumiTech Ltd, Nottingham, UK). The RLU results were used as an indirect 
measure of the viable cell numbers found within the culture sample. 
The percentage of adherence to plasma-treated and plain wells was compared for 
wild type strains against their related SCVs. 
Adherence of wild type strains to plasma coated wells showed a significant 
increase when compared to plain wells (Figure 4.3). However, SCVs generally 
showed insignificant differences in adherence to plasma-treated or plain wells. 
The exception to this was those CR positive SCVs whose wild type parents were 
CR negative, which showed a significant increase in adherence to plain wells 
when compared to plasma coated wells (Figure 4.3). 
Studies of adherence of wild strains and SCVs to plasma-treated and plain wells 
showed that wild type strains showed a significant increase in adherence to plasma 
coated wells when compared to SCVs (Figure 4.3). However, SCVs showed a 
significant increase in adherence to plain wells when compared to their 
corresponding wild parents (Figure 4.3). S. epidermidis CR positive SCV strains 
21,25 and 28 showed a significant increase in adherence to both plasma coated 
and plain wells when compared to their corresponding wild CR negative strains 
(Figure 4.3). 
Based on the data presented in this Chapter, comparison of the adherence of 
SCVs to wild type strains showed that adherence to surfaces is multifactorial. 
Exopolysaccharide production leads to intercellular adhesion, which can also be 
mediated by proteins or non-proteinaceous cell wall structures. 
Extracellular binding proteins, human plasma proteins and cellular hydrophobicity 
all have important roles for the whole conclusive picture of adherence and biofilm 
production by the staphylococci. 
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Previous studies showed that initial bacterial adherence to surfaces is non- 
specific and reversible, which is then followed by a specific adhesion mediated by 
adhesin receptors, which strongly fixes the microorganisms to the surface of the 
biomaterial (Hermann et al., 1988). Based on the Congo red results presented in 
(Table 4.1), along with data from Chapter three (Table 3.1 and 3.2) which showed 
the differences in cell 
-associated protein expression between SCVs and their wild 
type strains, it might be possible to explain the reason behind the adhesion 
differences found in SCV strains and their wild type parents. 
Data in these studies showed that wild type strains, irrespective of whether or not 
they produced exopolysaccharide, were better in adhering to plasma coated wells 
than their related SCVs, which in turn were better than the wild type parents in 
adhering to plain wells. Adherence to plasma proteins is mediated by bacterial 
adhesins (e. g. MSCRAMMS) found on the surface of the staphylococcal cell. 
It is possible that such attachment factors might not be expressed by SCVs or 
might be altered in expression by gentamicin action during SCVs production. 
However, adherence of bacteria to plain wells is probably mediated by the cell 
surface hydrophobicity of the cells, with the presence of exopolysaccharide acting 
as an extra advantage to SCVs promoting adherence to biomaterials. Although 
proof that exopolysaccharide increase hydrophobicity is lacking, Götz et al (2002) 
believed that PIA itself mediates adherence to hydrophobic surfaces. Studies on S. 
aureus mutants with altered teichoic acid structure were shown to be severely 
affected in adherence to polystyrene or glass surfaces and less hydrophobic (Gross 
et al., 2001). 
SCVs that showed phenotypic variation in exopolysaccharide production 
behaved differently than other SCVs with respect to adhesion. Three S. 
epidermidis SCV strains that were producing exopolysaccharide showed a 
significant increase in the adhesion to both plasma coated and plain wells when 
compared to their exopolysaccharide non producer wild type parents. This 
suggests that exopolysaccharide production is still a crucial factor in adherence to 
materials coated with host plasma or other extracellular matrix proteins. 
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The induction of exopolysaccharide synthesis in the presence of environmental 
stresses such as antibiotics may be an important bacterial survival strategy. 
The presence of the antimicrobials would select for resistant SCVs to that 
particular antibiotic, resulting in increased adherence to the implant irrespective of 
the presence of a host-derived conditioning film. Therefore, it is very important to 
understand the various aspects of biofilm formation. Only when we have this 
knowledge will we be able to develop more specific ways to overcome 
staphylococcal biomaterials-related infections due to SCVs. 
Chapter Five 
Analyses of Staphylococcal-Host Cell Interactions: 
(A) The Use of Flow Cytometry to Assess Staphylococcal Internalization 
by Cultured Human Umbilical Vein Endothelial Cells 
(B) The Effect of Staphylococci on Host Production of Cytokines 
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Introduction 
Staphylococci are considered to be primarily extracellular pathogens. 
Since they have been recognized to cause invasive diseases that are persistent 
and refractory to standard therapies, the necessity to understand the 
pathogenesis of such diseases has prompted further study of the possible role of 
bacterial invasion of host cells in staphylococcal disease. It is believed that 
bacteria sequestered from the host immune system inside the cell may provide 
a reservoir of bacteria for recurring infections, and may be more relevant to 
chronic disease. 
The adhesion or the attachment of the bacterium to the host cells is of 
importance in the initiation of microbial invasion and in the progression of 
many bacterial infections. Staphylococcal species have evolved a range of 
surface molecules and structures to enable them to adhere specifically to a 
particular surface or a limited variety of host cell surfaces (Aly and Levit, 
1987; Jonsson et al., 1991; Kiers et at., 2001; McDevitt et al., 1994; 
Ohshima et al., 1990; Park et al., 1996; Patti et al., 1992; Soell et al., 1995). 
Invasion and Internalization of bacteria by host cells utilizes a variety of 
mechanisms including phagocytosis and clathrin-dependent receptor-mediated 
endocytosis (RME) (Mukherjee et al., 1997). To study the mechanisms of 
invasion, several inhibitors specific to those internalization pathways could be 
used. Colchicin, cytochalasin D and monodansylcadaverine (MDC) were used 
by a number of researchers to study bacterial internalization by eukaryotic cells 
(Almeida et al., 1996; Almeida et al., 2001; Jevon et al., 1999; Menzies and 
Kourteva, 1998). 
Effects of bacterial adhesion to host cells can range from no apparent effect 
on the host cell, to altered morphology, induction of cytokine release, apoptosis 
and invasion. Although the outcome of the host-cell interaction is very much 
dependent on the type of host cell with which the bacterium has interacted, 
several reports have documented S. aureus stimulation of endothelial cytokine 
responses (Soell et al., 1995; Wang et al., 2000). 
The production of proinflammatory cytokines such as interleukin-10 
(IL-10), and IL-6 which have been associated with inflammatory diseases and 
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septic shock, and the neutrophil chemoattractant IL-8 all contribute to the host 
defence mechanisms in response to bacterial colonization or invasion, and 
when secreted in excess can also induce various host immuno-pathological 
disorders (Gray et al., 1996; Rabehi et al., 2001; Yao et al., 1996). 
Flow cytometry is an analytical tool that allows the discrimination of 
different particles on the basis of size and colour. It is a technology that has 
also recently been used recently to study host-bacterium interaction due to its 
ability to detect the bacteria present on, or within single mammalian cells in 
suspension and provides rapid, quantitative, multiparameter analyses of 
bacterial-host cell interactions (Fattorossi et al., 1989; Giaimis et al., 1994). 
The bacteria of interest are targeted with a fluorochrome label and single cells 
are scanned and detected through a fluorescence detector. Data obtained may 
be plotted on a histogram representing the number of cells detected and values 
of one or more measurements made on individual cells. WinMDI version 2.8- 
windows 3.95/DOS 7.10 is used to plot the histogram and provides the multiple 
document interfaces for flow cytometry analysis. 
Flow cytometry combined with cytometric bead array (CBA) is used to 
measure cytokines in a particle-based immunoassay. The advantages of the 
technique are that it requires small volume samples, and substantially less time 
compared to conventional ELISA. The bead populations are separated by their 
fluorescence excited by the red laser of the flow cytometer. The light emitted 
is filtered for phycoerythrin (575 nm) (PE) which measures the PE labelled 
anti-cytokine antibody binding to each bead population. 
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5: 2 Materials and Methods 
5: 2: 1 Flow Cytometric Analysis to Distinguish between Adherent and 
Internalised Staphylococci by Cultured HUVECs 
In order to start using the flow cytometry technique, it was first 
important to label the bacteria with a dye that could be detected. BODIPY4' 
Fluorescein (Molecular Probes Europe By, Leiden, Netherlands) is an amine- 
reactive compound, which is pH-insensitive. It emits green fluorescence that is 
collected via a 525-nm bandpass filter by the flow cytometer. 
The cryopreserved HUVECs (Clonetics, CC2519 Lot of 1742) were 
purchased from BioWhittaker Ltd (Berkshire, UK). The cell culture process 
for Clonetics HUVECs was according to the supplier's manual. For the 
maximum efficiency for growing Clonetics HUVECs, Clonetics medium 
(growth medium) EGM-2 BulletKit System, and subculture reagents were used 
(Clonetics, BioWhittaker Ltd, Berkshire, UK). This medium contains human 
epidermal growth factor (hEGF), hydrocortisone, GA-1000 (gentamicin and 
amphotericin B), fetal bovine serum (FBS), vascular endothelial growth factor 
(VEGF), human basic fibroblast growth factor (hFGF-B), long R3-IGF-1 
(human recombinant insulin-like growth factor), ascorbic acid, Heparin, amino 
acids and phenol red as pH indicator. HUVECs were seeded at 20,000 cells 
per well onto 24-well 0.2% gelatin (Sigma, Poole, UK) 
-coated tissue culture 
plates in 1 mL of Clonetics medium and cultured at 37°C in 5%C02 for 1-2 
days until 80-90% confluent at (, ts 56,000 cells per well counted using 
haemocytometer). The viability of the HUVECs was confirmed by staining 
with 0.2% w/v trypan blue (Sigma, Poole, UK). The measurement of HUVEC 
viability was obtained by counting 100 cells and calculating the percentage of 
cells excluding the stain. The viability of the control cultured cells was 
maintained as 98%. 
Bacteria attached to and ingested by HUVECs were quantified using a flow 
cytometer (Beckman Coulter EPICS Altra, Luton, UK) using a fluorescence- 
quenching assay that permits differentiation between attachment and ingestion 
of the bacterium by the cells. Trypan blue (0.2 mg/mL) in distilled water 
(V WR International Ltd, Leicestershire, UK) was found to be the best 
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quenching agent of extracellular fluorescence (Sahlin et al., 1983, Wan et al., 
1993). 
5: 2: 1: 1 Staphylococcal Strain Cultivation and Labelling with 
BODIPY®FL 
All fourteen wild type staphylococcal strains (S aureus and 
S epidermidis and S haemolyticus) were included in this study along with their 
related SCV produced by exposure to gentamicin (Table 2.4). Each strain was 
labelled in duplicate. 
1. Colonies from TSA plates incubated overnight at 37°C were resuspended in 
MHB supplemented with gentamicin for SCVs (Table 2.4) and adjusted to an 
A490 of 0.01. The suspensions were incubated at 37°C, 150 rpm for 4 hours for 
wild strains and 7 hours for SCVs strains 
2. Bacterial suspensions were centrifuged and the pellet washed twice with 
PBS. The turbidity of the suspensions was adjusted to 0.6 at 550nm 
3. BODIPY-FLwas dissolved at 10 mg/mL in dimethylsulfoxide (DMSO) 
(Sigma, Poole, UK) 
5. One-mL of the bacterial suspension was transferred to an eppendorf. 
While vortexing the suspension, fifty microlitre of the reactive dye solution per 
each mL of bacterial suspension was slowly added 
6. The mixture was incubated for 1 hour at room temperature with shaking 
7. The bacterial labeling mixtures were centrifuged for 5 minutes. The 
bacterial pellets were washed three times with PBS and then resuspended in 
one-mL of HUVECs growth medium containing no antibiotics 
8. One of the duplicate bacterial labeling suspensions was used to test the 
efficiency of the fluoresceinating procedure using fluorescence microscopy, 
while the other was used in HUVEC adhesion and invasion assays [5: 2: 1: 3, 
5: 2: 1: 4 and 5: 2: 1: 5]. 
9. Labeling of bacteria with BODIPY-FL dye was quantified in arbitrary units 
defined by flow cytometry which reflected the amount of protein found on the 
surface of the staphylococci. Data are presented in Table 5.1. 
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5: 2: 1: 2 Flow Cytometric Analysis 
Flow Cytometry was used in conjunction with the trypan blue 
fluorescence-quenching technique to investigate any differences in HUVEC 
uptake of wild type and SCV staphylococcal strains 
Measurements were recorded at the following settings: 
Forward scatter (FS) Lin and side scatter (SS) Lin. The x-axis represented 
the degree of forward light scatter and measures cell size. This is expressed 
only in relative terms, not as a unit of size, while the y-axis is a log-scale 
measurement of the fluorescence in each cell. A minimum of 5000 cells was 
measured in each sample. 
An extracellular fluorescence-quenching dye (trypan blue) was used to 
differentiate between adherent (membrane-bound) and internalised 
staphylococci. Trypan blue quenches the fluorescence emitted by the bacteria 
adhered to the cell surface but cannot quench internalized bacteria because the 
HUVEC cell is not permeable to the dye. The fluorescence emitted from inside 
the cell by the labelled bacteria was assessed by the flow cytometry and was 
taken as representative of internalised staphylococci. All the data were 
analysed using (WinMDI 2.8) software. 
5: 2: 1: 3 Staphylococcal Adhesion to HUVECs as Assessed by Flow 
Cytometry (Adhesion Assay) 
Staphylococcal adhesion to HUVECs was studied as described below. 
1. HUVECs monolayers were washed twice with one mL of PBS. One mL of 
EGM-2 BulletKit medium without antibiotics was then added per well 
2. Bacterial suspensions (5x106 cfu) (25 µL) which were labelled with 
BODIPY-FL as described in section 5: 2: 1: 1 and were inoculated into the wells. 
This volume resulted in a multiplicity of infection (m. o. i. ) of approximately 40 
bacteria per endothelial cell. After inoculation of all wells, the 24-well plates 
were briefly and gently shaken on a rotating platform to distribute the bacterial 
inoculum throughout the HUVEC growth medium 
3. The plates were incubated for 15 min at 37°C in 5% CO2 
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4. To stop the internalisation, plates were placed on ice for 5 minutes 
5. Non-adherent staphylococci were removed by washing the cells three times 
with ice-cold PBS 
6. Trypsin 0.025% w/v EDTA 0.01% w/v (0.5 mL) (BioWhittaker) was added 
per well for 2 minutes to detach the HUVEC monolayer from the bottom of the 
plate. 0.5-mL of trypsin-neutralising reagent (BioWhittaker) was then added 
and plates incubated for a further 2 minutes. The cells were removed and 
transferred to clean tubes and centrifuged (200xg, 5min, 4°C) 
7. The cell pellets were resuspended in one mL of cold HUVEC growth 
medium and then processed through the flow cytometry and the number of 
staphylococci per HUVEC was calculated. Results for wild type and SCV 
staphylococci are shown in Figures 5.1 and 5.2 
8. This experiment was repeated three times for each strain 
5: 2: 1: 4 Staphylococcal Internalization by HUVECs as Assessed by Flow 
Cytometry (Invasion Assay) 
The internalization of fourteen staphylococcal wild type strains with 
their corresponding SCVs (Table 2.4) were studied as described below. 
1. Bacterial suspensions were co-cultured with HUVECs in exactly the same 
way as described for the adhesion assay (5: 2: 1: 3) except that gentamicin was 
added to wells containing SCVs strains 
2. The inoculated strains were incubated for 3 hours at 37°C in 5% C02- 
3. After incubation, the monolayers were washed three times with PBS 
4. Trypsin/EDTA (0.5-mL) was added per well for 2 minutes followed by 
0.5-ml, of trypsin-neutralizing reagent. The cells were centrifuged at 200xg 
for 5 minutes 
5. The cell pellet was resuspended in one-mL of growth medium and analysed 
via the flow cytometer as described above. Readings obtained represent the 
total number of staphylococci found in the cell pellet aliquots (the extracellular 
and the internalised staphylococci) 
6. Trypan blue was added to a second aliquot of the HUVEC suspension to a 
final concentration of 0.2 mg/mL and re-processed through the flow cytometer. 
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Readings obtained represent the internalised staphylococci in the HUVEC 
suspension 
7. The experiment was repeated three times for each strain. The data was 
presented as median ±SD. Results for wild type and SCV staphylococci are 
shown in Figures 5.3 and 5.4. 
5: 2: 1: 5 Staphylococci Internalization in the Presence of Inhibitors 
To study the mechanism of invasion, the assays were performed in the 
presence of 10 gM colchicine (Sigma, Poole, UK), 250 gM 
monodansylcadaverine (Sigma, Poole, UK) or 2 gM cytochalasin (Sigma, 
Poole, UK) in the growth medium. Preparation of these stock solutions is 
described in the Appendix (8: 1: 4). The concentrations used were selected 
according to similar studies investigating staphylococcal internalization of 
eukaryotic cells (Jevon et al., 1999). S. epidermidis strains 4 and 25, S. aureus 
strains 11 and 27 along with their corresponding SCVs were studied. These 
strains were chosen because they were the strains that had been shown to be 
subject to internalization by HUVECs in preliminary studies. The method used 
is described below. 
1. Ten µM colchicine, 250 pM monodansylcadaverine or 2 µM cytochalasin D 
were prepared in HUVECs growth medium containing no antibiotic and filter 
sterilized (0.20µm) 
2. Monolayers were then washed three times with PBS. One mL of growth 
medium was placed into each well followed by 25µL of labelled bacteria. 
In the case of SCVs, the growth medium was also supplemented with 
gentamicin 
3. Monolayers were incubated for 3 hours at 37°C 
4. Steps (3-6) in 5: 2: 1: 3 were repeated 
5. The viability of the cells was determined to be s: w 97% in both the control and 
the tested cells, as tested by 0.2% (w/v) trypan blue exclusion method 
6. The number of bacteria internalized in an untreated monolayer was set as 
100% 
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7. The experiment was repeated three times and the readings were represented 
as medians ±SD. Results for these assays are presented in Figures 5.3,5.4 and 
Table 5.2. 
5: 2: 2 Cytokine Production in HUVECs after Stimulation with 
Staphylococci 
The BDA Cytometric Bead Array (CBA) (BD Biosciences, Oxford, 
UK) employs a series of particles with discrete fluorescence intensities to 
simultaneously detect multiple cytokines. Each bead on a CBA provides a 
capture surface for a specific cytokine. The BD CBA system uses the 
sensitivity of amplified fluorescence detection by flow cytometry to measure 
soluble cytokines in a particle-based immunoassay. 
The BD human inflammation CBA kit was used to quantitatively measure 
Interleukin-8 (IL-8), IL-1 P, IL-. 6, IL-10, IL-12p70 protein levels and TNF-a in 
a single HUVEC cell sample. Six bead populations with distinct fluorescence 
intensities have been coated with capture antibodies specific for IL-8, IL-1 ß, 
IL-6, IL-10, TNF-a and IL-12p70 proteins. The six bead populations were 
mixed together to form the CBA which was resolved in a flow cytometer. 
The capture beads, phycoerythrin-conjugated detection antibodies, and 
recombinant standards or test samples are incubated together to form sandwich 
complexes. Following acquisition of sample data using the flow cytometer, the 
sample results are generated in graphical and tabular format using the BD CBA 
Analysis Software. 
CBA has previously been used by several researchers (Chen et al., 1999; 
Collins et al., 1998) for simultaneous detection of several cytokines in single 
assay samples. 
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5: 2: 2: 1 Analysis of Cytokine Levels in HUVECs Co-cultured with 
Staphylococci 
Four staphylococcal strains were co-cultured with HUVECs for 
screening for cytokine release. The four strains were S. epidermidis strains 4 
and 25 and S. aureus strains 11 and 27 which were shown to be internalized 
by HUVECs, as mentioned in 5: 2: 1: 4 and 5: 2: 1: 5. The experiment was 
performed as described below. 
1. One colony from wild type staphylococcus or 5 colonies from 
staphylococcal SCVs were resuspended in 10 mL MHB or MHB with 
gentamicin, respectively. The bacterial suspensions were incubated in a 
shaking incubator set at 200rpm and at 37°C for 4-hours in the case of wild 
type strains, and 7-hours for SCVs. After incubation, the suspensions were 
pelleted and the turbidity was adjusted to 0.7 at 490 nm in fresh HUVEC 
growth medium. 
2. Prior to incubation with bacteria, the HUVEC monolayers (grown in 24-well 
tissue culture plates) were washed with HEPES buffer (BioWhittaker) to 
remove any traces of antibiotics 
3. Fifty five µL aliquot of a mid-log phase bacterial culture was suspended in I 
mL of antibiotic free HUVECs growth medium, and added directly to the wells 
containing the HUVEC cell line. Three wells were used for each bacterial 
strain. The 24-well plate was then incubated at 37°C in a 5% CO2 humidified 
incubator for one hour. 
4. One hundred microlitre of supernatant from infected HUVECs was removed 
after one hour incubation. Supernatants were then centrifuged for 5 minutes at 
13,000 xg and stored at 
-20°C 
5. The HUVEC cell lines were washed three times with HEPES, followed by 
addition to each well of 1.5-mL HUVEC growth medium supplemented with 
80-mg/L lysostaphin and incubated for 30 minutes in order to kill any 
extracellular bacteria. The cell lines were washed three times with HEPES. 
One-mL fresh standard HUVEC medium with antibiotics was added to the cell 
lines, which were then incubated at 37°C in 5% CO2 for up to 24 hours. 
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6. One hundred pL aliquots were collected after 3,6 and 24 hours of 
incubation. They were centrifuged for 5 minutes at 13,000xg and the 
supernatants were stored at 
-20°C until required for cytokine measurement by 
BD CBA and flow cytometry. 
7. At the 24 hour point, trypan blue exclusion was used to assess HUVEC 
viability 
8. For screening for cytokine production, supernatant aliquots which had been 
stored at 
-20 were thawed to room temperature. The mixed cytokine capture 
beads were vortexed, and 50 gL added to the appropriate supernatant assay 
tubes. 
9. Human inflammation PE detection reagent (50µL) (BD Biosciences, Oxford, 
UK) was then added the cytokine assay tubes 
10. The human inflammation standard dilutions (50µL) (BD Biosciences, 
Oxford, UK) were added to the control assay tubes 
11. Fifty µL of each test sample was added to the test assay tubes 
12. The assay tubes were protected from direct exposure to light and incubated 
for 3 hours at room temperature. 
13. Washing buffer (1mL) was then added to each assay tube, and the contents 
centrifuged at 200x g for 5 minutes 
14. The supernatant was carefully aspirated and discarded from each assay tube 
15. Wash buffer (300 µL) was added to each assay tube to resuspended the 
bead pellet 
16. The tubes were vortexed for 3-5 seconds immediately before analysing on 
the flow cytometer 
17. Data acquisition was performed using the BD FACSCompý software. BD 
CellQuestT" Software was used for analyzing samples and formatting data for 
subsequent analysis using the BDTm CBA Software. Data for HUVECs co- 
cultured with S. epidermidis strains 4 and 25 and S. aureus strains 11 and 27 
are presented in Figures 5.5 and 5.6. 
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5: 3 Results 
5: 3: 1 Preliminary Studies of Labelling of Staphylococcal Strains with 
BODIPY-FL 
Table 5-1: BODIPY-FL labelling of staphylococcal strains assessed by flow 
cytometry 
Staphylococcal 
Strains 
Median ± SD (n=6) 
CoNS (Wild) 139.49 t 34.30 
CoNS (SCVs) 81.7 ± 6.27 
S. aureus (Wild) 199.23 t 33.89 
S. aureus (SCVs) 80.64 ±7.01 
Data in Table 5.1 show results of preliminary experiments of labelling of 
staphylococcal strains with BODIPY-FL dye. Labelling is expressed in 
arbitrary units and reflects availability of proteins on the staphylococcal surface 
for binding to the fluorescent tag. 
Fourteen wild type staphylococcal strains along with their related SCVs 
were labelled with BODIPY-FL. Labelling units were used indirectly as a 
measurement of surface proteins per cell. CoNS (S epidermidis strains plus S. 
haemolyticus) and S. aureus SCVs median labelling units were compared with 
their related wild strains. A decrease of 48% in labelling was found in SCVs 
when compared to their wild strains in both CoNS and S. aureus. However, 
S. aureus wild strains showed a significantly higher (P<0.05) surface labelling 
(199.23± 34.30) when compared to CoNS wild strains (139.49 ± 34.30). 
Binding was found to be reproducible for both S. aureus and CoNS and 
labelling with BODIPY-FL was considered to be an appropriate method for 
later use in studies of bacterial adherence and internalization. 
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5: 3: 2 Adherence of S. aureus Wild Strains and S('Vs to HIVE(' ('ells 
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FIG 5-1: Comparison of adherence of S. aureus wild 
and SCVs per HE VEC cell. 
The number of cells of'S. mireus wild type strains 7.11 and 27 adhered per 
IIUVEC cell was compared with adherence of the related S('Vs after 
incubating the monolayers with bacteria for 15 minutes. Figure 5.1 shows that 
there was a significantly higher adherence of wild type strains (10±1 per 
IIUVEC) when compared with their related SCVs (4±1 per IIt VE: C) (P<p, O5). 
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5: 3: 3 Adherence of CoNS Wild Strains and SCVs to HIIVEC ('ells 
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FIG 5-2: Comparison of adherence of CoNS wild and 
SCVs per HUVEC cell. 
The number of cells of CoNS wild type strains adhered per Ill. JVl: (' cell was 
compared with that of their related SCVs after 15 minute co-incubation. 
Figure 5.2 shows that there was not any significant ditlirence between the 
adherence of wild type strains (3±1 per H[IVEC) when compared with their 
related SCVs (2±1 per HUVEC). The data are pooled from all CoNS strains 3, 
4,8,13,16,18,21,23,25,26and28. 
In addition, when the number of cells of S. aureus wild and S('Vs adhering 
to I IUVF, Cs were compared to the number of adherent cells of CoNS strains, it 
was found that the number of S. aureus cells adhering to host cells was 
significantly higher than that of the CoNS. 
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5: 3: 4 Adherence of Staphylococcal Wild Strains and SCVs to HAVE(' 
Cells after 3 Hours Incubation 
U 
y 
O 
V 
s 
N 
L 
0 
18 
16 
14 
12 
I0 
8 
P<0.05 
6 
4 
2 
SA 
wild strains 
SA 
S('Vs 
I'' 0.05 
SE 
wild strains 
SE 
SCV3 
FIG 5-3: Staphylococcal adherence to HL)VECs afer3 
hours incubation. 
SA= S. auneus strains 11 and 27; SES. rpidenWdis strains 4 and 25 
The number of staphylococcal cells of wild type strains adhered per WIVE(' 
cell was compared with that of their related SCVs. Adherence of four 
staphylococcal strains, S. aureus strains II and 27. and S. epidermiclis strains 4 
and 25 (which were internalized by IIUVECs). was also assessed after three 
hour incubation. Figure 5.3 shows that after 3 hours contact with 1I(JVFCs 
adherence of S. aureus and S epidt'rmiclis SCVs to IIUVFCs was significantly 
higher than their corresponding wild parents (P<0.05). 
Longer incubations could result in changes in expression of HUVE('s 
surface receptors or SCV adhesins which might be responsible for this 
noticeable increase in SCVs adhering to I It IVECs after 3 hours incubation. 
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5: 3: 5 Internalization Assays of Staphylococcal Wild Type Strains in the 
Presence of Internalization Inhibitors 
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FIG 5-4: Percentage of wild s trains internalized with and 
without internalization inhibitors. 
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Preliminary experiments (data not shown) showed that only tour out of' 
fourteen staphylococci strains co-cultured with IitJVEC's were internalized. 
These were (S. epidermiclis strains 4,25 and S. uureus strains 11,27. These 
strains were studied in more detail, to investigate the mechanism of 
staphylococcal uptake. 
Based on data presented in Figure 5.4, the percentage of S. uureus cells 
internalized by HUVECs was significantly higher than S. epidermiclis strains 
internalized when incubated in the absence of internalization inhibitors. 
However, setting the number of staphylococci internalized to 100%. in the 
presence of cytochalasin D. the numbers of bacteria internalized by the 
Hi1VECs decreased by 85% in S epidermidis and by 80% in S. aurells. 
In addition, Colchicin also decreased staphylococcal internalization, by about 
20% for both S. epidermidis and S. aureus. 
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However, differences were observed in the extent to which MDC inhibited 
internalization of staphylococci, reducing S. epidermidis internalized by around 
10% and S. aureus by 40%. 
5: 3: 6 Internalization of Staphylococcal SCVs in the Presence and Absence 
of Internalization Inhibitors 
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FIG 5-5: Percentage of SCVs internalized with and without 
internalization inhibitors. 
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Figure 5.5 summarizes the experiments investigating the effect of 
internalization inhibitors on the numbers of staphylococci SCVs internalised by 
HUVECs. Data shown are for S. epidermidis SCV strains 4,25 and S. aureus 
strains 11,27 co-cultured with HUVECs for 3hours (gentamicin was present to 
stabilise the SCVs). 
Comparison of the experiments summarised in Figures 5.4 and 5.5 shows 
that there were differences between wild type strains and their corresponding 
SCVs in the extent to which the internalization inhibitors affected uptake of 
PQ1.0.5 
bacteria by the HUVECs. Based on data presented in Figure 5.4, setting the 
number of SCVs internalized (control) to 100%, Cytochalasin D decreased 
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wild type staphylococcal internalization by 45% in case of S. epidermidis and 
50% for S. aureus. However, Colchicin decreased SCV internalization of 
S. epidermidis and S. aureus SCVs by only 10%. In addition, MDC inhibited 
the number of internalized S. epidermidis and S. aureus SCVs by 95% and 
90% respectively. 
5: 3: 7 Cytokine Production by HUVECs Following Incubation with 
Staphylococcal Wild Strains 
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FIG 5-6: Cytokine release by HUVECs upon stimulation 
with S. aureus or S. epidermidis wild strains for 1 hour. 
Cytokines were detected through different time points. W=wild. 
Data are pooled for S. epidernidis strains 4& 25, and S. aureus 11 &27. 
Q111r  311r 
 6Hr 
 2411r 
The CBA cytokine assay kit was used to quantitatively measure Interleukin- 
8 (IL-8), IL-1ß, IL-. 6, IL-10, IL-12p70 levels and TNF-a in HUVEC 
supernatants collected after incubation for 1,3,6 and 24 hours with wild type 
S. epidermidis strains 4,25 and S. aureus strains 11,27. 
Data in Figure 5.6 show cytokine levels for IL-1ß, IL-6 and IL-8 which were 
released by HUVECs over time. The levels of IL-10, IL-12 and TNF-a 
detected were near the lower limit of assay detection and were not considered 
reliable, and so this data is not represented. 
W/11-1 WAL 
,6 wn lrs 
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Data showed that levels of IL-1 P, IL-6 and IL-8 increased significantly with 
time when compared to HUVEC only controls (data not shown). 
However, after 24 hours cytokine levels began to fall possibly due to 
decreasing HUVECs viability in the presence of wild type staphylococci 
(HUVECs incubated with the bacteria underwent a 45% decrease in viability 
when compared to HUVEC controls cultures (data not shown). 
5: 3: 8 Cytokine Production by HUVECs Following Incubation with 
Staphylococcal SCVs 
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FIG 5-7: Cytokine release by HUVECs upon stimulation with S. 
epidermidis and S. aureus SCVs for I hour. 
Cytokines were detected through different time points. 
S= SCVs. Data are pooled for S. epidermidis strains 4& 25; and S. aureus II& 
27 SCVs. 
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Figure 5.7 summarizes cytokine levels released by HUVECs after being co- 
cultured for I to 24 hours with SCVs from S. epidermidis strains 4,25 and S. 
aureus strains 11,27. IL-1p, IL-6 and IL-8 were detectable after only lh 
incubation, with levels of these cytokines increasing over 24 hours of the 
incubation in a manner similar to that seen with the wild type staphylococci. 
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It was notable that levels of IL-6 produced in the presence of the 
S. epidermidis and S. aureus SCVs were very much reduced compared to that 
produced when HUVECs were incubated with the equivalent wild type 
parental strains. While levels of IL-1 and IL-8 production by HUVECs were 
similar overall between wild type and SCVs, the SCVs were less cytotoxic, and 
HUVEC viability was reduced by only 15% by the end of the incubation 
compared to 45% for the wild type strains. 
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5: 4 Discussion and Conclusions 
The purpose of the work presented in this Chapter was to investigate 
and explore the possibility that SCVs that are persistant intracellularly can 
promote long-term staphylococcal colonization in the host and play a role in 
recurrent chronic infections such as in BRI. 
Adhesion assays in which bacteria were in contact with host cells over a 
relatively short period (15 minutes) revealed that S. aureus wild strains adhered 
more extensively to HUVECs than SCVs; this difference was statistically 
significant (P<0.05) (Figure 5.1) 
. 
Such differences in adherence abilities of 
strains could affect the process of subsequent internalization and the ability of 
these strains to cause persistent infections. However, S. epidermidis SCVs did 
not show any significant difference in their adherence patterns to HUVECs 
when compared to their related wild type strains (Figure 5.2) after 15 minute 
incubation. 
Adherence assays for four staphylococcal SCVs (S. aureus 11,27 and 
S. epidermidis 4,25) after 3 hours of incubation showed a significant increase 
in the numbers of adherent SCVs when compared to their related wild type 
strains (Figure 5.3). These same SCVs had a four fold increase in adherence 
after 3 hours incubation when compared with 15 minutes incubation (Figure 
5.3). 
Although staphylococcal adherence to HUVECs did not show any strain or 
species dependence, internalization was a strain-specific process. Out of 14 
strains tested, only S. aureus strains 11,27 and S. epidermidis 4,25 and their 
corresponding SCVs were internalized after co-culture with HUVECs 
(Figure 5.4 and 5.5). This suggests that adherence was necessary but not 
sufficient to induce internalization by HUVECs, possibly because surface 
proteins and subsequent events including signal transduction must be 
specifically induced prior to internalization. In addition, the host cell 
internalization process is known to require activation and participation of the 
host cell cytoskeleton (Cossart, 1997). Therefore, the mechanism of 
internalization of the wild type staphylococci and their corresponding SCVs 
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was investigated by including different inhibitors of phagocytic pathways such 
as cytochalasin D, colchicines and MDC in assays of internalization.. 
Based on results summarized in Figures 5.4 and 5.5, pre-treatment of 
HUVECs with internalization inhibitors had variable effects upon subsequent 
staphylococcal uptake by HUVECs. Coated pit formation was inhibited by the 
addition of MDC, resulting in approximately 10% and 95% (P<0.05) reduction 
in HUVEC uptake of S. epidermidis wild type strains and their related SCVs 
respectively (Figure 5.3 and 5.4). MDC inhibited HUVEC uptake of S. aureus 
wild strains and SCVs by 40% and 90% respectively. 
The microfilament depolymerization agent cytochalasin D, inhibited 
internalization of S. aureus wild type strains and their related SCVs by 80% 
and 50% respectively (P<0.05). Similar results were obtained with 
S. epidermidis wild types and SCV strains, with uptake showing an inhibition 
of 85% and 45% respectively (P<0.05) (Figure 5.4 and 5.5). Depolymerization 
of microtubules by colchicine reduced internalization S. epidermidis and 
S. aureus wild strains and corresponding SCV by a similar amount, some 20% 
and 10% respectively (P<0.05) (Figure 5.4 and 5.5). 
These data suggest that internalization of SCVs by IIUVECs occurred 
mainly via a receptor-mediated pathway, while their related wild strains were 
mainly internalized by microfilament-mediated pathways. This correlates with 
the identified virulence factors (e. g. surface proteins that promote adherence to 
host cell extracellular matrix proteins) produced by S. aureus when compared 
to CoNS. 
To assess the role of surface proteins in adherence and internalization by 
HUVECs, labelling staphylococci wild type and SCVs strains with 
BODIPY®FL showed a reduction in dye binding to surface proteins by 58.57% 
in CoNS SCVs when compared to their wild type parental strains (P<0.05) 
(Table 5.1). Similarly, dye binding to surface proteins on S. aureus wild type 
strains showed a reduction of 40.79% when compared with the equivalent 
SCVs (P<0.05) (Table 5.1). This suggests that the synthesis of the outer cell 
surface proteins of SCVs had been affected by gentamicin. Since SCVs have 
been found to show decreased ATP production (Chapter three) which is 
essential for a lot of metabolic pathways to operate e. g. protein synthesis, it 
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might be that SCVs could have a defect in protein synthesis or protein 
secretion across the plasma membrane. This might be an explanation for the 
observed decrease in BODIPY®FL binding to SCVs compared to their wild 
strains (Table 5.1). 
Since chronicity is linked with cytokine production, a comparison of 
cytokine production by HUVECs stimulated with staphylococcal wild and 
SCVs strains was undertaken in this study. Levels of the cytokines IL-I P, IL- 
6, IL-8, IL-10, IL-12p70 and TNF-a in the culture supernatants of HUVEC 
cells co-cultured with staphylococci wild type and SCV strains were 
determined by CBA and flow cytometry analysis. After infection with 
staphylococcal strains, HUVECs produced elevated levels of IL-lß, IL-6 and 
IL-8 compared to uninfected controls, which were detected after 1 hour 
incubation (Figure 5.5 and 5.6). The elicited release of cytokines by HUVECs 
infected with wild type staphylococci was found subsequently to increase the 
damage to the cell line, and after 24 hours cytokine levels deceased in cultures 
infected with wild strains. The decrease in cytokine production was associated 
with decreased HUVEC viability by 40%. However, cytokines levels 
continued to increase up to 24 hours in HUVECs infected with SCVs, though 
they were less than the levels found in infected HUVECs with wild type 
staphylococcal strains. HUVEC viability at 24 hours following infection with 
SCVs was 86% when compared with controls viability of 92% indicating that 
the SCV strains exhibited considerably less cytotoxicity than their wild type 
parents. 
Little is known about the endothelial-activating properties of cell wall 
components of gram-positive bacteria. However, lipoteichoic acid (LTA) has 
been found to activate cell adhesion molecule expression (CAM) in HUVECs 
infected by S. aureus (Kawamura et al., 1995). Infection of HUVEC with live 
S. aureus induces ICAM expression and IL-8 release (Beekhuizen et al., 1997; 
Yao et al., 1996). Soderquist et al (1998) found that endothelial cells produced 
IL-6 and IL-8 in response to exposure to S. aureus strains or staphylococcal 
exotoxins such as a-toxin, enterotoxin A and ISST-1. Capsular 
polysaccharide of S. aureus was also found to stimulate the endothelial 
production of IL-6 and IL-8 (Soell et al., 1995). 
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Since infection of mammalian cells is evaluated by the level of cytokines 
released and subsequently the amount of destruction occurring to host tissues, 
the results from this study suggest that SCVs could be associated with 
chronicity found in staphylococcal BRI. That could be due to altered surface 
proteins (virulence factors), different internalization pathways and decreased 
destructive effect on tissues due to decreased cytokine released when compared 
to their wild type strains. Cytokine release has been known to be dependent on 
the strain and/or the virulence of the bacterium and cellular activation by 
different pathogens does not necessarily induce similar pathways of 
intracellular signalling (Rabehi et al., 2001). 
Chapter Six 
General Discussion and Conclusions 
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General Discussion and Conclusions 
One of the major complications associated with the use of implanted 
medical devices is biomaterials-related infections (BRI) due to staphylococcal 
species, in particular, S. epidermidis (Bayston, 1999; Kloos and Bannerman, 1994; 
Haller and Herwaldt, 1988). The staphylococcal BRI are distinguished by their 
chronic nature and resistance to antibiotic therapy, and by the characteristic 
formation of a bacterial biofilm (Mah and O'Toole, 2001). 
Chronic infections such as osteomyelitis and hip replacement infections have 
been associated with the formation of biofilm involving S. aureus SCVs. This led 
Chuard et al (1997) to assume that there is a close association between SCVs and 
biofilm formation. The ability of the staphylococci to form biofilms is a major 
factor in their success as pathogens and is an example of their phenotypic 
flexibility (Brown and Williams, 1985) in their response to diverse environmental 
stimuli. A variety of environmental factors, including sub-lethal concentrations of 
antibiotics and intracellular antibacterial mechanisms, as well as nutrient 
deprivation occurring in biofilms are known to be capable of generating SCVs 
(Massey et al., 2001; Proctor, 1994). 
6: 1 Metabolic Profiling of Staphylococcal SCVs 
Certain physiological characteristics of SCVs including decreased 
metabolism, reduced growth rate, increased resistance to cell-wall-active 
antibiotics, and decreased uptake of aminoglycoside antibiotics, are relevant to the 
main features of BRIs; chronicity with persistence of infection and treatment 
failure or relapse. SCVs have therefore been suggested to represent the true 
biofilm mode phenotype (Bayston and Wood, 1997, Chuard et al., 1997). 
Compared with S. aureus SCVs, very little is currently known regarding infections 
caused by SCVs of the CoNS. 
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One important mechanism by which invasive S. aureus infection tends to persist 
within patients, or induces relapse despite adequate antibiotic therapy is believed 
to occur through the emergence of antibiotic-resistant SCVs (Proctor et al., 1995). 
Massey et al (2001) described how SCVs create an environment that protects wild 
type S. aureus from the lethal effect of aminoglycoside antibiotics. S. aureus 
SCVs were reported in patients with infective osteomyelitis who had undergone 
gentamicin bead administration (Balwit et al., 1994; Von Eiff et al., 1997) and in a 
pacemaker-related infection where a gentamicin-containing sponge was applied to 
the infection site (Seifert et at., 2003). Staphylococcal sub-populations with 
extremely high MICs to gentamicin were isolated from some cases of BRI in a 
study by Tshefu et al (1983) although these workers explained that these infections 
only occasionally result in emergence of resistant organisms even after prolonged 
antibiotic treatment, which could mean that there are additional unknown intrinsic 
factors that might be important in regulating the ability of staphylococcal strains to 
produce SCVs. Differences in SDS-PAGE and immunoblotting profiles between 
strains (such as wild type and SCVs) have been correlated with the antibiotic 
susceptibility/resistance differences observed for some bacteria. For instance, 
Langford et al (1989) related the changes in the outer membrane protein profiles 
which were found in gentamicin-induced P. aeruginosa SCVs, to their resistance 
to aminoglycosides. 
In this current work, it is reported that S. aureus and CoNS SCVs emerged 
during serial passage in broth culture containing increasing gentamicin 
concentrations above the MIC. Results indicated that not all of the clinical isolates 
of staphylococci tested were capable of producing SCVs following gentamicin 
exposure. The majority of the wild type staphylococcal strains which produced 
SCVs were initially sensitive to gentamicin; however, some staphylococci which 
were originally resistant to gentamicin also produced resistant sub-populations 
(SCVs) with higher MICs than the parental wild type strains. Information on 
previous antibiotic therapy of patients from whom these particular strains were 
isolated was not available, but it is conceivable that these strains could be from 
patients who were previously treated with gentamicin where staphylococcal 
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resistance was generated by classical mechanisms. Exposure to higher 
concentrations of gentamicin in the laboratory may have resulted in expression of 
additional or alternative altered resistance mechanisms 
- 
in particular generation of 
SCV phenotype. Alternatively, culture conditions used to isolate the original 
isolate may have allowed reversion of strains exhibiting a SCV phenotype in vivo. 
Such strains would be gentamicin resistant, but it would be impossible to 
determine on the primary isolation plates, if the bacteria isolated were wild type or 
SCV revertants. In support of this possibility, are the results of one of the pilot 
investigations done in the present study which involved assessing the gentamicin 
MIC by Etest for three staphylococcal isogenic strains: the wild parental strain, 
revertants and SCVs. Some of the revertants showed an intermediate antibiotic 
resistance between the wild and SCVs. 
It was important to constantly supplement both agar and broth cultures with 
gentamicin to keep the variants stable and to retain their auxotrophy for 
compounds such as thiamine, thymidine, menadione or proline. This suggests that 
gentamicin could have affected some metabolic pathways which contributed to the 
auxotrophy of these variants. Auxotrophy to menadione and thiamine could be 
due to a defect in electron transport as proposed by Proctor and his colleagues 
(1997 and 1998). Auxotrophy to proline could be the result of a defect in amino 
acid synthesis pathways, while auxotrophy to thymidine is connected to a defect in 
the synthesis of nucleotides. 
Several reports support the observation that some of the metabolic 
characteristics of SCVs are similar to those of other organisms recovered from 
foreign-body infections (Brown et al., 1990; Chuard et al., 1993). These include a 
slow mode of growth and decreased in vitro susceptibility to bactericidal 
antibiotics. The altered growth phenotype arises from defects in menadione and 
haemin biosynthesis resulting in impaired electron transport and decreased cellular 
ATP concentrations, while the auxotrophic characteristics shown by SCVs suggest 
that gentamicin directly or indirectly may have affected several diverse metabolic 
pathways. McNamara and Proctor (2000) found that intracellular S. aureus had an 
altered metabolic state characterised by defective electron transport. Proctor et al 
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(1995) and Von Eiff et al (1997) suggested that the defect in electron transport 
resulted in auxotrophy for menadione or hemin and decreased a-toxin production, 
possibly allowing the bacteria to persist rather than lyse the host cell (Von Eiff et 
al, 1997). These features were found to be characteristics of SCVs which appear 
to be associated with persistent staphylococcal infections (Chuard et al., 1997). 
In the present study staphylococcal SCVs were found to be menadione and/or 
thiamine auxotrophs, and to have decreased levels of ATP production when 
compared to their related wild type strains, suggesting a defective electron 
transport system. These findings confirm the results of earlier studies, and suggest 
that these alterations in metabolism could contribute to the ability of SCVs to 
cause persistent infections and chronic inflammatory changes. It is possible that an 
intra-endothelial reservoir of SCVs could trigger such longstanding inflammation. 
The mechanism of persistence of SCVs inside endothelial cells and the reason why 
SCVs have a less destructive effect on endothelial cells compared to the wild type 
strains are unclear. Decreased haemolysin production by SCVs, delayed coagulase 
production by S. aureus SCVs (Proctor et al., 1995) and a slow growth rate all are 
likely to contribute to their reduced toxicity for endothelial cells. 
This suggestion is also supported by the current results from the API Staph and 
Api Zym studies, which identified differences in the biochemical and enzymatic 
profiles displayed by SCVs and their parental strains. However, there was no 
common enzyme or biochemical defect detected for all pairs of wild and SCV 
strains tested. This suggests that multiple mechanisms may be affected in 
staphylococci resulting in generation of the SCV phenotype. 
Analysis of the growth characteristics of SCVs confirmed that they have 
decreased concentration of ATP when measured by chemiluminescence, and that 
they are slow growing when compared to their related parental strains (Chapter 
Two). In his review, Smith (1998) showed the importance of bacterial growth rate 
on bacterial virulence. He indicated that slow growth led to less stimulation of the 
host immune response which may consequently lead to chronicity of infection 
(Smith, 1998). In addition to their decreased metabolic activity, chronicity could 
also be due to the ability of SCVs to survive intracellularly and to their decreased 
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susceptibility to antibiotics (Vesga et al., 1995). In this present study, SCVs 
showed substantially decreased susceptibility to antimicrobial agents. Several 
factors may contribute to this effect. Firstly, slowly growing micro-organisms 
may be relatively resistant to cell-wall active antibiotics, which require active 
bacterial cell wall synthesis for maximal efficacy (Schnitzer et al., 1943). 
Secondly, SCVs located intracellularly would be exposed to sub-therapeutic 
concentrations of many antimicrobial agents due to their failure to penetrate 
efficiently into eukaryotic cells (Mandell and Vest, 1972). 
Resistance of SCVs to gentamicin has been associated with different 
susceptibility patterns for other antibiotics. Mickelsen et al (1985) stated that 
isolates of a single strain of S. epidermidis usually exhibit the same susceptibility 
pattern, though expression of antibiotic resistance to gentamicin, chloramphenicol, 
erythromycin and clindamycin in some strains of S. epidermidis may be unstable. 
This observation was supported by the work of 0' Connor-Scarlet and Pierson 
(1983). Different susceptibility patterns to antibiotics displayed by SCVs could be 
explained by a decrease in the bacterial uptake of the antibiotic, and resistance to 
gentamicin would render the SCVs resistant to other aminoglycosides such as 
amikacin and netilmicin (Proctor and Peters, 1998). 
6: 2 Phase Variation in SCVs Exopolysaccharide Production 
In this study, it has been demonstrated that some S. epidermidis strains (21, 
25 and 28) showed phase variation in producing exopolymer that facilitates and 
enhances adherence and might consequently affect biofilm formation. 
The detection of staphylococcal strains that are able to increase exopolysaccharide 
production when in the SCV phase, demonstrates the elasticity of these organisms 
to switch from one state to another under certain environmental circumstances. 
Formation of bioflms is proposed to occur in two steps: a rapid initial attachment 
to a synthetic surface which is mediated by polysaccharide adhesin PS/A (Mack et 
al., 1994) and surface proteins such as autolysin (Heilmann et al., 1997) and a 
cellular accumulation process to form mature biofilm which is due to production 
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of polysaccharide intercellular adhesin (PIA) (Heilmann et al., 1996). These two 
polysaccharide adhesins are encoded by the intercellular adhesin operon (ica) 
(Heilmann et al., 1997) and are closely related chemically (McKenney et al., 
2000). Production of PIA has been found to be subject to phase variation (Ziebuhr 
et al., 1999). Recent evidence has indicated that alternating insertion and excision 
of an insertion sequence element (IS257) is one mechanism responsible for ica 
operon switching in S. epidermidis (Ziebuhr et al., 1999). 
It is possible that strains which show phase variation due to antibiotic exposure 
might have advantages in establishing a BRI by enhancing the later stages of 
biofilm formation. However, results of the present study also indicate differences 
between wild type strains and SCVs in their initial interaction with plastic 
surfaces. Wild type strains adhered better to a plasma-coated plastic surface, while 
SCVs attached better to untreated plastic. These data suggest staphylococci are 
likely to be capable of adhering to biomaterials irrespective of whether they are 
coated by host proteins or not 
-a variable that may be dependent on the localised 
environment around any implanted material. The observation that staphylococci 
which did not produce exopolysaccharide also adhered in these in vitro assays, 
supports earlier evidence that initial adhesion to biomaterials depends on factors 
other than exopolymer production. The characteristics of SCVs of S. epidermidis 
isolates (21,25 and 28) support the speculation that SCVs could represent the 
staphylococcal phenotype associated with biofilm formation. Although the wild 
type strains did not produce exopolymer, they still retained their capability to 
adhere to a plasma coated plastic surface. Consequently, the initial step in the 
formation of biofilm could be enhanced for wild type strains since biomaterials are 
covered by host proteins as soon as they are introduced into the body. Bacterial 
adherence to implants is determined by general physiochemical interactions 
between biomaterials and bacteria as well as more specific bridging through 
various proteins. So following adhesion to a surface, a wild type strain may 
undergo a phenotypic change that alters many of its surface molecules and de- 
represses exopolysaccharide synthesis (Davies et al., 1993). In addition, due to 
antibiotic pressure and nutritional deprivation, these wild strains could undergo 
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phase variation resulting in the production of SCVs. This possibility was supported 
by pilot studies undertaken in this project, which demonstrated that SCVs were 
produced by nutritional limitation as well as by antibiotic stress. 
Production of SCVs which are exopolymer producers could therefore strengthen 
the establishment of biofilm by production of intercellular adhesins such as PIA. 
Since these variants are not mutants, they could also revert to their parental state if 
the environmental circumstances change. However, for the invasion of endothelial 
and epithelial cells, sepsis and spreading, it might be advantageous for some 
staphylococcal cells to be able to escape the biofilm network, to become biofilm 
negative and to move on to other tissues. On their passage through the circulation, 
they might regain a biofilm-positive phenotype allowing them to settle down on 
heart valves, the endocardium, etc. Once a staphylococcal biofilm is formed the 
bacteria are very difficult to eradicate, as they are shielded from the immune 
system and resistant to antibiotic treatment. For these reasons, it is very important 
to understand the various aspects of staphylococcal biofilm formation, as this 
knowledge may lead to development of more specific ways of overcoming 
staphylococcal resistance in chronic infections. 
6: 3 Analysis of Staphylococcal-Host Cell Interaction 
Presently, there is no rapid, simple, and reproducible method available for 
simultaneous measurement of association (attachment) and uptake (internalization) 
of staphylococci at the individual cell level. The procedures involving flow 
cytometry described in this study allowed investigations of various aspects of host- 
bacteria interactions. Making use of flow cytometry could be extended beyond 
studying attachment and internalization, and further studies could be possible to 
investigate the phagocytic process and intracellular killing. 
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6: 3: 1 Host Cell Attachment and Invasion 
Initial adherence assays (Chapter Five) showed that staphylococci 
(S. aureus and CoNS) were both able to adhere to HUVECs, irrespective of 
whether or not they were of wild type or SCV status. However, the relative 
adherence of wild type and SCV strains was dependent on the incubation time 
with HUVEC cells. After 15 minutes incubation with host cells, S. aureus wild 
type strains adhered better than SCVs, although for this interaction period there 
was not any significant difference in adherence between S epidermidis wild type 
and SCVs. However, after 3 hour incubation with HUVECs, S. aureus and S. 
epidermidis SCVs adhered better than their wild type strains. Only four wild type 
strains with their corresponding SCVs out of fourteen staphylococcal strains were 
internalized by HUVECs. Extended incubation with host cells could result in 
several changes in surface expression of HUVEC adhesion molecules resulting in 
increased SCV adherence and/or changes in bacterial expression of cell-associated 
proteins for host cell attachment, which could also increase aggregation of SCV 
cells to each other. 
Although adhesion is the first step in host cell invasion, some studies indicate 
that not all bacteria that adhere are capable of invasion. Studies have shown that 
the potential of bacteria to invade varies with cytotoxicity (ability to kill cells) 
(Fleiszig et al., 1996). Differences in adherence and internalization have been 
observed for veterinary mammary pathogens such as S. aureus and can be caused 
by differences in strain virulence (Wanasinghe, 1981). Moreover, streptococci in 
which particular genes encoding adhesin proteins had been inactivated did not 
completely lose their ability to invade HUVECs, indicating that other adhesion 
mechanisms can still mediate attachment, albeit at a diminished level (Stinson et 
al., 2003). It has been demonstrated that endothelial cells are capable of 
phagocytosing S. aureus strains (Vann and Proctor, 1987). This ability indicates 
that endothelial cells play a role in local host defence mechanisms or, alternatively, 
that these cells can act as a hiding place for bacteria. Whether these cells are also 
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capable of killing the ingested bacteria is unknown; most studies have found no 
proof of any intracellular killing (Vann and Proctor, 1987; Visser et al., 1996). 
The ability of the bacteria to survive intracellularly for 24 hours after 
internalization has been considered as an indication of chronicity in in vitro assays 
(Döpfer et al., 2001). Based on this definition, this study has proven that SCVs of 
both S. aureus and S. epidermidis are capable of surviving intracellularly for 24 
hour after being co-cultured with HUVECs, with minimal effects on host cell 
viability when compared to controls. 
Bacterial internalization by host cells is a multifactorial process which is 
frequently strain dependent and specific for host tissue from which any cell line 
used in in vitro models is derived. This could partially explain why some strains 
in this study were successfully internalized by HUVECs and others were not. 
Unfortunately, time limitations meant that it was not possible to include different 
host cell lines in the present study but other researchers have done extensive work 
studying S. aureus internalization by different cell lines (Veltrop et al., 2001; 
Visser et al., 1996). These studies showed that S. aureus strains were internalized 
by endothelial, epithelial and mesothelial cells, all of which were capable of 
digesting intracellular staphylococci. Usui et al (1992) also showed that in vitro, 
different S. aureus strains varied in their internalization by murine fibroblasts. 
This finding was supported by Krut et al (2003) who reported that different 
S. aureus strains differed in their uptake into mammalian cells and showed 
different degrees of virulence and host cell cytotoxic activity. 
Previous studies had shown that staphylococcal infections are both inoculum 
and time dependent (Vann and Proctor, 1987). In this study the incubation times 
used are comparable to the maximum incubation time used by other researchers 
(Vesga et al., 1997; von Eiff et al., 1997). However, the inoculum size may have 
differed in the present work from these published studies, since the intention of the 
current work was not to analyse the effect of inoculum size on internalization, but 
to compare the ability of wild type strains and their related SCVs to be internalized 
by HUVECs, an aim which the inoculum employed (40 bacteria per cell) fulfilled 
satisfactorily. 
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Attachment of staphylococci to eukaryotic cells is in part, dependent on surface 
molecules (mainly proteins) displayed by the bacteria. In this study, labelling the 
staphylococcal strains with BODIPY-FL provided some comparative evidence 
about expression of cell wall or surface associated proteins by SCVs and their wild 
type strains. These proteins could play an important role in adherence of bacteria 
to biomaterials (Götz, 2002), in host cell attachment and internalization (Kiers et 
al., 2001; McDevitt et al., 1994; Ohshima et al., 1990; Park et al., 1996; Patti et 
al., 1992; Soell et al., 1995) and in cytokine production (Soell et al., 1995; Wang 
et al., 2000). All of these factors could affect the ability of a particular strain to 
cause infection. The results of SDS-PAGE and immunoblotting experiments 
presented in Chapters 2 and 3 showed that SCVs have reduced surface protein 
content compared to wild types. This could be due to a decrease in the amount of 
the same proteins found in wild strains or to altered patterns of protein expression. 
The mechanism of invasion for staphylococcal SCVs of HUVECs is poorly 
understood, but investigation of the HUVEC interaction with SCVs showed that 
SCVs are internalized by a mechanism different from that of their related wild 
strains. The mode of internalization is very important and influences the 
intracellular events following internalization (Ernst et al., 1999). This could 
promote intracellular survival by decreasing host cell cytokine production which 
may be a contributor to establishment of a chronic infection. Results from this 
study indicated that SCVs had been internalized by receptor-mediated endocytosis. 
This mechanism involves the direct interaction between bacterial ligands and 
cellular receptors, which leads to the engulfment of the bacteria by the membrane 
and the formation of a tightly adherent phagosome. However, although 
phagocytosis and receptor mediated endocytosis require actin polymerization, they 
are morphologically different and use different host signalling mechanisms (Ireton 
et al., 1996). In contrast, wild type strains were mainly internalized by a classical 
phagocytosis mechanism which involves actin polymerization. This could be 
evidence that the mechanism of internalization is determined by the repertoire of 
bacterial products or proteinaceous molecules found on the cell wall of 
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staphylococci. In Chapter 3 SDS-PAGE SCVs profiles showed extra proteins 
present in cell wall fractions which may be important in influencing internalization 
mechanisms and subsequent cytokine production. 
6: 3: 2 Alternations in SCV Virulence Factor Expression 
The altered enzymatic activity detected in ApiZym profiles (Chapter 2-3) 
reflects altered metabolic activity between wild and SCV strains which may result 
in expression of different surface molecules. SDS-PAGE analysis of proteins from 
staphylococcal whole cell preparations and cell wall fractions, showed differences 
in protein expression profiles between wild type strains and their related SCVs. It 
is tempting to speculate that the observed differences in protein expression could 
account for some of the phenotypic differences seen between wild type and SCV 
strains, and could contribute to the differences in virulence observed. During the 
present study, it was not possible to identify the proteins whose expression 
differed between wild and SCV strains. However, a detailed proteomic 
comparison between SCVs and their wild type parents (using the staphylococcal 
genome database) should be regarded as a priority in any future study of 
staphylococcal SCVs. Proteomic approaches have previously been used to 
identify a number of staphylococcal virulence-associated proteins including some 
involved in attachment to host tissues, proteins involved in biofilm formation; host 
iron-binding proteins, virulence factor such as S. aureus protein A and ISST, and 
proteases (Cheung et al., 1987; Cockayne et al., 1998; Hussain et al., 2001; Liang 
et al., 1995; Takeuchi et al., 1998; Sugai et al., 1989; Voung e1 al., 2000). 
Pelletier et al (1979) compared S. aureus wild type parents with SCVs and showed 
that SCVs were considerably less haemolytic and, therefore, less virulent. 
Pelletier et al (1979), showed also that S. aureus SCVs were as infective as the 
parent S. aureus but were overall less virulent. S. aureus SCVs were also 
significantly more infective than S. epidermidis strains in an endocarditis model 
(Pelletier et al., 1979). Additional studies have indicated that only S. aureus 
whose production of haemolysin is decreased are able to penetrate intracellularly 
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and persist in endothelial cells (Proctor et al., 1995). However, in an in vitro 
model of septic arthritis Jonsson et al (2003) came to the conclusion that SCVs of 
S. aureus were more virulent than the isogenic parental strain due to production of 
a host cell degrading protease by the SCV. In this present study, lipolytic and 
proteolytic activities were increased in three of the CoNS SCVs whose wild type 
parents were isolated from shunt infections. 
This work has shown that in addition to differences in expression of proteases 
and lipases, SCVs also posses a range of virulence factors which differ from their 
related wild type strains. It is difficult on the basis of the data obtained from the 
present study to conclude definitively if SCVs are more or less virulent than their 
wild type strains. However, this could be studied further by studying the relative 
virulence of the SCV and parental strains in an appropriate animal model. 
However, it is possible to speculate that the capacity to produce a resistant from 
such as a SCV is by itself a virulence factor, acting by promoting intracellular 
survival inside HUVECs. Since bacterial pathogens vary their phenotypic 
properties in response to environmental signals, this enables them to optimize their 
interactions with their hosts and thereby to establish productive infections. 
6: 3: 3 SCV Induction of Host Cell Cytokine Expression 
Previous in vitro studies have shown that S. aureus infection of endothelial 
cells can stimulate the release of pro-inflammatory cytokines, and can directly 
cause endothelial cell injury (Pober and Cotran, 1990). Pro-inflammatory 
cytokines such as IL-1 and IL-6 play an important role in induction of the host 
immune response (Fantuzzi and Dinarello, 1996), and also correlate with disease 
severity (Casey et al., 1993). IL-12 and IL-10 are involved in the regulation of 
T-cell differentiation (Romagnani, 1991), while IL-8 is a chemoattractant which 
can facilitate transendothelial migration of neutrophils in an in vitro assay (Yao et 
al., 1996). However, IL-8 can also be produced due simply to direct stimulation of 
endothelial cells with staphylococci (Yao et al., 1996). Previous observations 
have revealed that IL-10 can actually enhance the growth of S. aureus (Kanangat 
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et al., 2001). Thus it is possible that besides shaping immune responses, cytokines 
may also modulate the expression of staphylococcal virulence factors and thereby 
influence the course of an infection from the bacterial perspective. Previous 
studies have shown that host cell cytokine production could be triggered by 
stimulation with bacterial products (van Langevelde et al., 1999), bacterial 
adhesins (Soell et al., 1995), and mineral particles (Shi et al., 1998). 
In this study, it was observed that SCVs adherence to HUVECs increased after 3 
hours incubation (Chapter Five). It might be that cytokine production could have 
altered expression of some staphylococcal cell wall-associated proteins, teichoic 
acid and peptidoglycan, all of which could enhance and increase their adherence to 
HUVECs. However, in the present study cytokine production in staphylococcal 
infections was focused on strains which were internalized by endothelial cells 
(Vriesema et aL, 2000; Yao et al., 1995; Yao et al., 1996). Due to time 
limitations and financial constrains, it was not possible to include all the strains in 
this study, although the effect of all the strains on the viability of HUVECs was 
assessed. HUVEC viability was similar for all strains irrespective of whether they 
could be internalized by the HUVECs or not. It is therefore possible that cytokine 
production may also be similar for all the strains tested, but this suggestion would 
require additional work. 
In this study, both SCVs and their related wild strains (S. aureus and 
S. epidermidis) evoked cytokine production by HUVECs. There was no 
significant difference in cytokine profiles detected following incubation with S. 
aureus or S. epidermidis. This would suggest that S. aureus and S. epidermidis 
produce similar intrinsic factors (mechanisms) stimulating cytokine release by 
HUVECs. 
IL-10, IL-6 and IL-8 were detected at all the time point sampled for both wild 
type and SCV strains, but SCVs showed decreased cytokine production when 
compared to wild type strains. This ability of staphylococcal SCVs to induce 
reduced levels of cytokine expression and to persist intracellularly without 
damaging the host cell could be a key factor contributing to the chronicity of SCV 
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infections, since SCVs once internalised would be protected from the host immune 
response allowing persistence in tissue. 
Apoptotic mammalian cells infected by staphylococci (wild type or SCVs 
strains) could also be considered as a transport vehicle transferring the internalized 
staphylococci to other site of organs or implants where they could establish 
another focus of infection. Moreover, cells undergoing apoptosis could provide an 
additional niche for SCV generation. Although this study was not designed to 
screen the production of SCVs induced intracellularly, findings by Proctor and his 
colleagues support altered S. aureus physiology during intracellular residence 
within endothelial cells (Vesga et al., 1996). They cite evidence to suggest that 
the intracellular milieu of endothelial cells which have phagocytized S. aureus 
may induce between 24 and 48 h the emergence of a subpopulation of 
metabolically hypoactive S. aureus SCVs (Vesga et al., 1996). Another study by 
Menzies and her colleagues (Menzies et al., 1998) showed that the presence of 
apoptosis was observed as early as Ih after S. aureus infection of endothelial 
cells. They speculated that S. aureus SCVs as observed in other studies (Vesga et 
al., 1996) might have arisen in response to stimuli from the environment of 
nutritionally depleted and dying host cells. 
The ability of HUVECs to produce IL-10, IL-12 and TNF-a was confirmed in a 
pilot study using the intracellular pathogen Listeria monocytogenes (data not 
shown). Although HUVECs are clearly capable of producing IL-10, IL-12 and 
TNF-a these were not detectable in later studies with HUVECs infected with 
staphylococci. The difference in cytokine profiles generated by L. monocytogenes 
and staphylococci may reflect different mechanisms of intracellular growth and 
ability of the two bacteria to stimulate different pathways. This could be related to 
the fact that Listeria is a true intracellular pathogen; whereas, staphylococci are 
mainly extracellular pathogens which could be considered as having a less 
damaging effect when compared to the potential cellular damage done by Listeria. 
Bacteria are now routinely examined for the presence of putative virulence 
determinants by SDS-PAGE and immunoblotting. In this study differences in 
polypeptide bands found in between SCVs and their related parental strains could 
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be surface modifications that promote resistance to host immune responses and 
facilitate the intracellular survival potentials. Blots of SCV proteins probed with 
anti-staphylococcal immune sera showed a lower level of antibody reactivity than 
the equivalent protein fractions prepared from wild type staphylococci. This 
finding may reflect a more generalised reduction in the quantity or variety of other 
types of surface antigens expressed by SCVs which may be an important factor 
contributing to reduced cytokine production and ability of SCVs to cause 
chronicity. 
6: 4 Overall Conclusions 
Although the pathogenesis of staphylococci and in particular that due to 
staphylococcal SCVs is complex, this study has highlighted potentially important 
characteristics of SCVs that may contribute to their ability to cause BRIs. 
However, much further research remains to be done to fully understand the 
metabolic changes that comprise the SCV phenotypic shift, and its role in 
staphylococcal disease. As an overall conclusion, in this study the findings 
suggest the following: 
(1) S. epidermidis SCVs could be produced as well as S. aureus SCVs by exposure 
to the antibiotic gentamicin. 
(2) There are differences in virulence-associated factors produced by 
staphylococcal wild type strains and their related SCVs (such as exopolymer 
production, haemolysin, coagulase, proteases, and lipases) which could contribute 
to some aspects of the correlation between SCV formation and BRI. The clinical 
characteristics of persistent and refractory staphylococcal infection may in turn 
reflect the various phenotypic changes associated with SCVs. 
(3) Despite the SCVs displaying phenotypic differences, their genetic make up has 
been conserved, as they are clonal as determined by PFGE. 
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(4) The advantages of SCV production may permit staphylococci to survive much 
longer intracellularly, to revert to the parental strain when the host environment 
changes, allowing the bacteria to disseminate and invade new tissues, thus 
perpetuating the infection and producing late relapses as has been reported by 
others (Proctor et al., 1994; Proctor et al., 1995). Although it is well known that 
delayed coagulase and haemolysin production are the two major reasons for 
S. aureus SCVs intracellular survival (von Elf et al., 1997), there is no clear 
reason for the ability of S. epidermidis SCVs to survive intracellularly when 
compared to their related wild type strains. 
(5) Staphylococcal SCVs (S aureus and CoNS) are less antigenic than their wild 
type parents, which could play a role in chronicity of BRI. This was demonstrated 
by analysing the cross-reactivity of immunoblots of wild type and SCV protein 
extracts against staphylococcal antiserum. Results showed, however, that there 
were similarities in the staphylococcal proteins cross reactivity with anti- 
staphylococcal antibodies between strains (S aureus and CoNS). 
(6) S. epidermidis SCVs showed similarity to S. aureus SCVs in displaying 
menadione and thiamine auxotrophy. This suggests common defects in the 
electron transport system of the staphylococcal SCVs, as well as defects in other 
metabolite pathway reflected in variability in the patterns of auxotrophy seen with 
different strains. 
(7) The ability of some strains of staphylococci to produce detectable 
exopolysaccharide only in the SCV mode raises the possibility that this phase 
variation may contribute to the ability of these variants to produce larger quantities 
and more persistent biofilm than their wild type parental strains. The possibility 
that SCVs may represent the true biofilm phenotype for the staphylococci requires 
additional investigation. Biofilm formation could be studied by using an 
177 
established in vitro model of catheter colonization with staphylococcal strains 
(Raad et al., 1995). 
(8) Differences in the internalization mechanism by HUVECs between SCVs and 
their wild type strains (S. aureus and S. epidermidis) could play a role in chronicity 
and relapsing infection features characteristic of staphylococcal infections. 
(9) This study showed that S. epidermidis SCVs shared a number of similarities 
with S. aureus SCVs (such as auxotrophism, regulation of exopolymer production, 
decreased immunogenicity, host cell internalization mechanisms, and induction of 
HUVEC apoptosis and cytokine production). This may reflect the fact that all of 
SCVs investigated in the present study were produced following a common 
stimulus- exposure to the antibiotic gentamicin. 
(10) This study investigated a wide range of the physiological characteristics of 
S. aureus and CoNS wild strains and their related SCVs. However, this study is 
essentially a foundation work and it will be necessary to extend the analyses 
described in this report to fully investigate the differences which exist between 
S. aureus SCVs and CoNS SCVs and their wild type strains, and what role each 
phenotype plays in the pathogenesis of biomaterial related infections. 
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Appendix 
8: 1 Reagents 
8: 1: 1 Electrophoresis Solutions 
8: 1: 1: 1 SDS-PAGE Running Buffer 
25 mM Tris 
190 mM Glycine 
1% SDS in H2O, 
pH 8.8 
8: 1: 1: 2 12% Separating Gel Preparation (0.375M Tris, p'18.8) 
To make two gels- 
3.35m1 De-ionized water 
2.5m1 1.5 Tris HCL pH 8.8 
100µ1 10% (w/v) SDS in H2O 
4m1 Acrylamide/Bis (30% stock) 
50µ1 10% Ammonium Persulphate in H2O 
5µl TEMED 
8: 1: 1: 3 4% Stacking Gel Preparation (0.125M Tris, p'16.8) 
6.1 ml De-Ionized Water 
2.5m1 0.5M Tris-HCL, pH 6.8 
l00µ1 10% (w/v) SDS in H2O 
1.33m1 Acrylamide/Bis (30% stock) 
50µ1 10% Ammonium Persulphate in H2O 
l0µ1 TEMED 
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8: 1: 1: 4 SDS-PAGE Loading Buffer 
1.62g Tris base 
10m12-Mercaptoethanol 
4g SDS 
4mg Bromophenol 
20g Sucrose 
Make up to 100m1 with distilled water, pH 6.8 
8: 1: 2 Western Blotting Solutions 
8: 1: 2: 1 Western Transfer Buffer 
Glycine 39 mM 
Tris Base 48mM 
SDS 0.037% 
Methanol 20% 
To prepare I litre of transfer buffer (pH 8.3), mix 2.9 g of glycine, 5.8g 
of Tris base, 0.37g of SDS, and 200ml of methanol. 
8: 1: 2: 2 Blocking Solution 
lg dried Skimmed Milk in lOral distilled water 
8: 1: 2: 3 Colorimetric Substrate for Development of Western Blots 
0.03g 4-Chloro-1-Naphthol 
60m1 Transfer Buffer 
6Oµ1 H202 
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8: 1: 3 PFGE Solutions 
8: 1: 3: 1 Reagents for Plug Preparation 
Final 
Concentration 
TE (pH 7.5) 
10mM Tris-HC1(pH 7.5) 
50mM EDTA (pH 7.5) 
Autoclaved de-ionised 
water 
Stock 
Concentration 
1M 
0.5M 
Volume 
5m1 
50m1 
445 
up to 500m1 
TE (pH 8.0) 
10mM Tris-HC1(pH 8.0) 
1 mM EDTA (pH 8.0) 
Autoclaved de-ionised 
water 
Lysis Buffer 
0.5M EDTA 
1M 5m1 
0.5M lml 
494m1 
up to 500m1 
0.5M l Oml 
I% Sarkosyl 25% 400µl 
IOml 
*Lysostaphin Solution 
Lysostaphin 5mg/vial 5mg 
Autoclaved de-ionised 5m1 
water 
up to 5m1 
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Final 
Concentration 
Stoke - --- -- Volume 
Concentration 
***PMSF Solution 
0.1M PMSF 
Isopropanol 
PMSF in TE (pH 8.0) 
1mM PMSF 
ImMTE(pH8.0) 
175mg 
l Oml 
up to l Oml 
O. 1M 100µl 
I mm 10m1 
=10mI 
* Lysostaphin should be dispensed into 0.5 ml microtube and stored at 
-20'C 
**Proteinase K should be dispensed into 1.5m1 microtube and stored at 
-20*C 
*** PMSF: phenylmethylsulphonylfluoride, PMSF; should be dispensed Into 1.5 
microtube and stored at 
-20°C 
8: 1: 3: 2 Running Buffer 
X10 TBE stock Solution 
Tris 
Boric Acid 
0.5M EDTA 
long 
55g 
40m1 
up to 1000ml with autoclaved 
distilled water 
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8: 1: 4 Internalization Assay 
8: 1: 4: 1 Solvents for Substances used to Study the Mechanisms of IIUVEC 
Internalization 
10 µM colchicine (sigma) in ethanol at 0.4% final concentration, 250 µM 
monodansylcadaverine (sigma) 2 µM cytochalasin D (sigma) in DMSO at 1% 
final concentration were prepared in growth medium without antibiotic and 
filtered. Each was added one hour prior to the addition of bacteria and 
incubated at 37°C 
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8: 2 Charts 
8: 2: 1 Api Staph Chart 
Result 
Tests Substrate Reactions /enzymes 
Negative Positive 
0 1 No Substrate Negative control Red 
GLU 2 D-Glucose (Positive control) 
FRU 4 D-Fructose 
MNE I D-Mannose 
MAL 2 Maltose 
LAC 4 Lactose Acidification due to 
carbohydrate utilization Red* Yellow THE I D-Trehalose 
MAN 2 D-Mannitol 
XLT 4 Xylitol 
MEL I D-Melibiose 
NITI + NIT2 / 10 min 
NIT 2 Potassium nitrate Reduction of nitrate to nitrite 
Clorless-light Red 
pink 
LYM A+ZYM ß /10 min 
PAL 4 D-naphthyl-acid Alkaline phosphatase 
phosphate Yellow Violet 
VPI + VP2 /10 min 
VP I Sodium Pyruvate Acetyl-methyl-carbinol iolet- production Clorless-light 
pink pink 
RAF 2 Raffnose 
XYL 4 Xylose 
SAC I Sucrose Acidification due to Red Yellow 
carbohydrate utilization 
MDG 2 a-methyl-D-glucoside 
NAG 4 N-acetyl-glucosamine 
Orange- 
ADII I Arginine Arginine dihydrolase Yellow 
red 
Rcd- 
URE 2 Urea Urease Yellow 
viole t 
The acidification tests should be compared to the negative (0) and positive (GUI) controls. 
* When MNE and XLT are preceded or followed by positive tests, then an orange test should be considered 
negative. 
ADi and rl RE under anaerobic conditions. 
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8: 2: 2 Ani Zym Chart 
The API ZYM strip is composed of 20 cupules, especially designed for 
the study of enzymatic reactions. The enzymatic tests are inoculated with a 
dense suspension of organisms, which is used to rehydrate the enzymatic 
substrates. The metabolic end products produced during the incubation period 
(6 hours) are predicted through colored reactions revealed by the addition of 
ZYM A (Tris-hydroxymethyl-aminomethane, hydrochloric acid, sodium lauryl 
sulfate) and ZYM B (Fast Blue BB, 2-methoxyethanol) 
No. Enzyme Assayed For 
1ý Control 
`2 JI Alkaline phosphatase 
Result 
Negative iii! tEiiiIJII 
-- Colourless 
Violet 
3f Esterase Violet 
4 Esterase Lipase Violet 
Lipase Violet 
6 Leucine arylamidase Orange 
7 Valine arylamidase Orange 
8 Cystine arylamidase Orange 
9 Trypsin Orange 
10 a-chymotrypsin Orange 
I1 Acid phosphatase J Violet 
12 Naphthol-AS-BI-phosphohydrolase Blue 
13 a-galactosidase Violet 
14 ß-galactosidase Violet 
15 ß-glucuronidase Blue 
16 a-glucosidase Violet 
17 ß-glucosidase 
iJ 
Violet 
18 I N-acetyl-ß-glucosaminidase Brown 
19 a-mannosidase Violet 
20 a-fucosidase Violet 
MM 
Y 
V 
7 
O 
Ö 
U 
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8: 2: 3 Antibiogram Chart 
Antibiotic 
Penicillin (P) 
Resistance Value 
4 
Tetracycline (TE) 2 
Chloramphenicol (C) I 
Erythromycin (E) 4 
Methicillin (Meth) 2 
Trimethoprim (W) 1 
Clindamycin (Da) 1 4 
Gentamicin (Cn) 2 
Rifampicin (Rd) 1 
Amikacin (AK) 4 
Netilmicin (NET) ------ ---- --- 2 
Cefiuoxime (Cxm) 1 
Vancomycin (Va) -------- 4 
Spiramycin (SP) 2 
Fusidic acid (FD) 1 
Teicoplanin (Tec) Recorded as *S or **R 
----------- --- -- Ciprofloxacin (Cip) Recorded as S or R 
* S= susceptible 
, 
R= resistant. 
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8: 3 Chemicals 
8: 3: 1 BODIPY®FL, STP Ester, Sodium Salt 
(Molecular Probes Cat. B-10006, Netherlands) Stored at 5-20°C. Protect 
material from long term exposure to light. The dye has an amine-reactive 4 
sulfo-2,3,5,6-tetrafluorophenyl (STP) ester group. 
